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ABSTRACT 
 
In the scope of this thesis, enantiomerically pure 5’- and 6’-substituted pinene-fused-
bipyridine- (pinene-bpy-derivatives) and N-pyridine ligands (pinene-N-py derivatives) 
have been prepared. The 6’-bromo-substituted pinene-bpy derivatives can act as 
precursors for the synthesis of several 6’-subsituted pinene-bpy derivatives. 
Tetradentate ligands have been prepared starting from these 5’ and 6’-substutiuted 
pinene-bpy derivatives, the pinene-bpy moieties are linked either directly or with a p-
xylyl-bridge. All ligands have been entirely characterized, some of them with X-ray 
analysis. 
 
The tetradentate ligands containing a p-xylyl-bridge were used for the formations of 
supramolecular aggregates such as hexanuclear, circular helicates, which were 
characterized in solution. The tetradentate ligands, where the two bipyridine moieties 
are directly linked, were used for the formation of mononuclear silver(I)-complexes. 
 
An extended protonation study was carried out with the non-substituted bi- and 
tetradentate pinene-bpy-derivatives. In one case, it was shown, that a proton can fix the 
ligand in a conformation analogous to that of metal complexes. 
 
 
 
 
 
 
 
 
 
 
 
  IX 
  
 
ZUSAMMENFASSUNG 
 
Im Rahmen der vorliegenden Arbeit wurden neue enantiomerenreine 5’- und 6’- 
substituierte, mit Pinen annellierte Bipyridin- (Pinen-bpy Derivate) und N-Pyridin- 
Liganden (Pinen-N-py Derivate) hergestellt. Die 6’-Brom substituierten Pinen-bpy 
Derivate stellen dabei geeignete Zwischenstufen für die Synthese von weiteren 6’-
substituierten Pinen-bpy Derivate dar. Tetradentate Liganden konnten ausgehend von 
diesen Pinen-bpy-Derivaten hergestellt werden, wobei die beiden Pinen-bpy Einheiten 
direkt oder über eine p-Xylyl-Brücke verbunden sind. Alle diese Liganden konnten 
vollständig charakterisiert werden, einige auch mittels Röntgenstrukturanalyse. 
 
Die mit p-Xylyl verbrückten tetradentaten Liganden wurden für die Synthese von 
supramolekularen Aggregaten verwendet. Diese hexanuklearen Zirkularhelicate 
konnten in Lösung charakterisiert werden. Mononukleare Silber(I)Komplexe wurden 
mit den direkten verbrückten tetradentaten Liganden hergestellt und charakterisiert. 
 
Eine ausgedehnte Studie über das Protonierungsverhalten wurde mit den nicht-
substituierten di- und tetradentaten Pinen-bpy-Liganden durchgeführt. Dabei konnte in 
einem Fall gezeigt werden, dass ein Proton, analog zu Metallkationen, die 
Konformation eines tetradentaten Liganden fixieren kann.  
 
X 
SYNTHESISED LIGANDS 
All ligands are listed in the general schemes below. They are numbered in the text 
according to these charts. 
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L1: [5,6]-pinene-bpy 
N
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L2: [4,5]-pinene-bpy 
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L3: {5’-p-MeO-Ph}-[5,6]-pinene-bpy 
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L4: {5’-p-MeO-Ph}-[4,5]-pinene-bpy 
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L5: {6’-Br}-[5,6]-pinene-bpy 
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L6: {6’-Br}-[4,5]-pinene-bpy 
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L7: {6’-Ph}-[5,6]-pinene-bpy 
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L10: {2-DAMI}-[5,6]-pinene-py 
chart A: Pinene-bpy derivatives 
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L14: {6’-p-MeO-Ph}-[5,6]-CHIRAGEN[m-xyl] 
chart B: CHIRAGEN[bridge] derivatives 
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L15: [5,6]-CHIRAGEN[0] 
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L20: [4,5]-CHIRAGEN[0] 
 
chart C: CHIRAGEN[0] derivatives 
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ABBREVIATIONS 
 
2-DAMI 2-(1-N,N-dimethylamino-isopropyl)- 
Bpy 2,2’-bipyridine 
CD ciruclar dichroism spectroscopy 
DEPT Distortionsless Enhancement by Polarization Transfer 
DMAA N,N-dimethyl-acetamide 
EI-MS electron-impact ionization mass spectrosopy 
ESI-MS electrospray-mass spectroscopy 
FAB-MS fast atom bombardement mass spectroscopy 
HETCOR heteronuclear correlation experiments 
HMBC hetereonuclear multiple bond correlation 
HMQC hetereonuclear multiple quantum correlation 
HOAc acetic acid 
LDA lithium diisopropylamide 
MLCT metal to ligand charge transfer 
m-xyl m-xylene 
NMR nuclear magnetic resonance 
NOE nuclear Overhauser effect 
Oac acetate 
Ph phenyl 
PS proton sponge 
p-MeO-Ph p-methoxy-phenyl 
p-xyl p-xylene 
Py pyrdine 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TMA trimethylamine 
TMEDA N,N,N’,N’-tetramethylethylendiamine 
UV/Vis ultraviolet-visible spectroscopy 
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2  Introduction 
 
 INTRODUCTION 
 
 
1. Helicity in natural and in artificial structures 
 
A helix is a geometric motif, which is found in natural as well as in artificial structures 
on a macroscopic, microscopic and even on a molecular level. The definition of the 
word “helix” given by the American Heritage Dictionary of the English Language [1] 
is the following: “1. A three-dimensional curve that lies on a cylinder or cone, so that 
its angle to a plane perpendicular to the axis is constant (figure 1). 2. A spiral form or 
structure, ...“ It comes from the ancient Greek word ‘έλιξ, which means “winding, 
convolution, spiral”. 
 
 
 
 
 
 
 
 
figure 1: left (M) and right (P) handed helices[1]. 
 
From the point of view of chirality* (definition: The property of any kind of object, 
that the object itself and its mirror image are not congruent), helices are intrinsically 
                                              
* Chirality from the ancient Greek word: χείρ: hand. Our hands are chiral, they act as object 
and its mirror image. Chirality on molecular level can be defined as following: Any molecule 
lacking an improper symmetry axis Sn is chiral, although proper rotational axes of any rank 
may be present.[2] The concept of chirality is defined for the first time in Appendix H of the 
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chiral. The left-handed M-helix (minus, anticlockwise rotation) is the mirror image of 
the right-handed P-helix (plus, clockwise rotation). 
Helicity can be observed in the spiral arms of galaxies, in snail shells or in microscopic 
structures such as right- or left-handed quartz[4] (figure 2) as well in human art, 
architectures and technology (figure 3). 
 
   
figure 2: natural helical objects. 
 
  
 
figure 3: artificial helical objects. 
 
In chemistry or biochemistry helicity is present in various systems.[5] α-Amylose is a 
macromolecule with a helical structure that contains six glucose units per helical 
turn.[6] Deoxyribonucleic acid (DNA) exists as a double helix (figure 4) in which the 
two strands are connected by hydrogen bonds between complementary bases and π-
stacking.[7,8] It stores and transmits our genetic make-up and therefore is essential for 
                                                                                                                                             
‘Baltimore Lectures’ by Lord Kelvin.[3] This Appendix is the publication of a lecture given 
by Lord Kelvin in 1893. 
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life. Peptides can adopt an α-helical structure or form larger helical arrays, as found, 
for example found in the collagene triple helices.[9] 
In artificial supramolecular architectures helicity can be introduced by conformational 
restrictions of macromolecules,[10] inter or intra-molecular hydrogen bonds[11,12] or 
coordinating metal ions.[13,14] 
For the latter J. M. Lehn introduced in 1987 the term helicate for the description of a 
polymetallic double-stranded helical complex, actually a metal containing helix (figure 
4).[15] It is formed by the contraction of the word helix with the suffix  –ate, 
characterizing host-guest complexes between (pre)organized receptors (ligands) and 
metal ions in the same way as coronates and cryptates. 
 
 
figure 4: X-ray structures of a double-stranded α-DNA[8] and a trinuclear double-stranded 
helicate.[15] 
 
Nowadays the term helicate is used more generally for any metal complex, which 
contains at least one ligand strand and two or more metal centres. 
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2. Linear and circular helicates 
2.1. General aspects of helicates 
 
Since the introduction of the term helicate in 1987 (only a few double- and triple-
stranded helicates were known before this date)[16-22], the research in this field has 
intensified and the number of publications has been increasing. Piguet[23] reviewed 
this subject in 1997 (containing ca. 200 references since 1987), Albrecht[24] in 2001 
(containing ca. 200 references since 1997). 
Mainly two different types of helicates can be distinguished: linear and circular ones. 
In linear helicates the metal cations define the helical axis, and the ligands wrap 
around these forming the helices. In circular helicates the metal cations are arranged in 
a circular fashion (figure 5; cf. Francis turbine in figure 2). 
 
Linear helicates 
M P
helical axis
 
Circular helicates 
 
M P
 
 
figure 5: linear and circular helicate. 
 
In both cases two different forms of chirality can be considered. The first one is the 
orientation of the bridging ligands in the complex, which determines the sense of 
rotation of the resulting helix (figure 5). The ligands can be arranged in a clockwise 
(P-helix) or anticlockwise (M-helix) fashion. 
The second one is the chirality at the metal centre. Already two bidentate ligands 
introduce helical chirality on an octahedral metal centre (figure 6). A convention can 
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be formulated for any complex, where two skew lines define uniquely a helical system 
in a coordination entity. The descriptors ∆/Λ (not following the CIP rule[25]) are 
generally used and officially recommended by IUPAC. 
b
b
Λ ∆
a a
Λ b
b
aa
∆
 
figure 6: helical chirality at an octahedral (OC-6) centre and the skew line system. 
 
In cases of two orthogonal oriented lines (e.g. two unsymmetrical tridentate ligands on 
an octahedral centre in a meridional fashion (figure 7), or two bidentate ligands on a 
tetrahedral centre) another convention can be used for more clarity (oriented line 
system, chiral descriptors ∆r / Λr ).[26] 
 
b
a
a
b
b
a
a
b
Λ ∆ Λ ∆  
figure 7: octahedral complex with two tridentate ligands and the oriented line system.[26] 
 
In a helicate, the metal centres possess the identical absolute configuration 
(homochiral, figure 8). Heterochiral systems lead either to side-by-side arrangements 
(alternating absolute configuration, not helical) or to irregular helicates (random 
absolute configuration). 
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∆ / ∆
Λ / Λ
chiral, helical chiral, side-by-side chiral, irregular
∆ / ∆
∆ / ∆
∆ / ∆
∆ / ∆
∆ / ∆
∆ / ∆
Λ / Λ
 
figure 8: chirality at polynuclear complexes. 
 
Side-by-side arrangements with an even number of metal cations are achiral (mirror 
plane), the arrangements with an odd number of metal cations are still chiral, but not in 
a helical fashion. For polynuclear species, more complicated chiral and achiral, 
irregular helicates and side-by-side arrangements are possible due to different 
combinations of ∆r /∆- and Λr /Λ- metal cations. 
Achiral ligands lead to racemic mixtures of two enantiomeric helicates. Chiral 
enantiopure ligands are in general expected to form helicates in a more or less 
diastereoselective manner.  
Most of the helicates published are formed by self-assembly processes, just by simple 
mixing of ligands and labile metal cations such as silver(I) or copper(I). These self-
assembly processes are often controlled by self-recognition. If only complexes, with 
one kind of ligand per coordination compound (homoleptic) are formed, a sorting of 
the ligands proceeds by self-recognition during the self-assembly of the metallo-
supramolecular aggregates. There are several different methods of controlling self-
recognition: [24] 
• Control by the number of binding sites: The mixing of bis-, tris- and tetra- 
bidentate ligands can lead only to the homoleptic, double-stranded 
helicates.[27] 
• Control by coordination geometry: e.g. One ligand prefers a tetrahedral 
coordination geometry at the metal, leading to double-stranded helicates, while 
another can form octahedral metal complexes (→ triple-stranded helicates). The 
mixture of these ligands with two different metals leads to the sorting not only 
of the ligands, but also of the metals.[27] 
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• Size control: A further possibility of controlling self-recognition in the 
formation of helicates is to use rigid ligands with significant differences in the 
distances between the metal binding sites.[28] 
• Self recognition by chiral ligands: another important possibility is the use of 
chiral centres in ligands strands. A racemic mixture of chiral ligands can lead to 
homoleptic helicates and therefore to diastereoselective formation of 
helicates.[29] 
• Template control: The templating ability of counterions can control the self-
recognition of the self-assembly of helicate-type ligands.[30] 
 
 
2.2. Linear helicates 
 
The characteristics of linear helicates can be described in different ways:  
• Number of central atoms in the helical axis: di-, tri-, tetra- and polynuclear 
species (figure 9). 
• Number of strands, wrapping around the helical axis: single-, double- and 
triple-stranded helicates (figure 9). 
• Different types of strands: identical strands lead to homoleptic, different strands 
to heteroleptic helicates. 
 
 
 
           dinuclear     trinuclear    tetranuclear 
 
 
single-           double-         triple- 
stranded helicates 
figure 9: different types of helicates. 
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• Binding site of strands: a strand with a sequence of similar binding units leads 
to homotopic helicates (figure 10). Strands possessing different binding units 
provide a directionality within the strands. These heterotopic helicates exist in 
two diastereomeric forms according to the orientation of the coordinated 
binding units (head-to-head or head-to-tail). 
• Saturation: when the stereochemical requirements of the metal ions are fulfilled 
by the donor atoms of the strands, the helicate is saturated (figure 10). 
Unsaturated helicates need other ligands to complete the coordination sphere. 
 
X X
Strands
Helicates
saturated
unsaturated
X X
saturated
unsaturated
X X
saturated
unsaturated
heat-to-head head-to-tail
homotopic heterotopic
 
figure 10: homotopic and heterotopic strands provide different helicates 
 
Many examples of linear helicates with nearly all variations of the points mentioned 
above are known and reviewed in the articles of Piguet[23] and Albrecht.[24] A few 
remarkable examples of linear helicates are discussed here. 
First of all, a special case will be treated: single-stranded, dinuclear and trinuclear 
helicates. While ligands with fixed conformations (L21) (chart 1) lead to single-
stranded dinuclear helicates[31], where the helicity can easily be attributed, a problem 
arises with ligands, which can still change the conformation upon complexation, such 
as L22.[32] 
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N
N
N N N
N
X
N N
N
N
N
N N
N
X=(CH2)2
L21 L22 L23  
chart 1: ligands for single-stranded dinuclear complexes 
 
The resulting hetero-dinuclear cation [Cl(CO)3Re(L22)Ru(bpy)2]2+ (figure 11) still 
corresponds to the definition of a heterotopic single-stranded helicate despite the 
unusual conformation of the ligand strand, which is obviously not compatible with our 
intuitive representation of a helix (figure 1, p.2). 
 
 
figure 11: crystal structure of [Cl(CO)3Re(L22)Ru(bpy)2]2+. [32] 
 
A general approach considers the segmental ligand L22 (or its symmetrical analogue 
L23, chart 1) as a strand adopting P or M helicity (or T conformation) (scheme 1).[33] 
According to this statement, almost any dinuclear complex possessing a linear 
nonplanar (P or M configuration) chelating strand may loosely be described as a 
single-stranded helicate .[34]  
N
N N
NM M
bpy A bpy B
A
B
A
B
A
B
T P M
 
scheme 1: possible conformation of L23 acting as bis-bidentate chelate bridging ligand. 
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Nevertheless, an example of a single-stranded trinuclear complex, synthesised by our 
group [35] and obtained in a enantiopure form should be mentioned (scheme 2). 
 
N
N
N
N
[Ru(CH3CN)4Cl2]
LiCl, MeOHS
RRRR
S
L24 ∆-[RuL29Cl2] 
N
N
N
N
N
N
S
RRRR
S
L25
 
 
 
 
 
 
 
 
scheme 2: single-stranded, trinuclear complex [{∆-RuL24}3-µ-L25](PF6)6.[36] 
 
Starting from the enantiopure ligand L24, available in a few steps from myrtenal, the 
ruthenium complex [RuL24Cl2] was obtained with predefined absolute 
configuration.[37] By reacting this building block [RuL24Cl2] (3 eq.) with ligand L25 
(1 eq.), only one enantiomer of the trinuclear complex is formed. To achieve absolute 
control of the stereoselecetivity in this complex (it contains 27 elements of chirality!), 
chirality is introduced step by step. Starting from R,R-(-)-myrtenal (8*2 stereogenic 
carbon atoms have configurations determined by nature), one enantiomer of L24 
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(RRS,SRR) and L25 (RRS,SRR) is obtained (4*2 stereogenic carbon atoms have 
configurations determined by stereoselective synthesis). L24 predetermines the 
absolute configuration ∆ at the metal centre. By reacting this ∆-building block with 
L25, the configuration at the ruthenium centres (configuration is determined at 3 metal 
centres by stereoselective synthesis) does not change and therefore the trinuclear 
species contains three homochiral metal centres (an important property of a helicate). 
But as already discussed above, the strand of this trinuclear complex can change the 
conformation, and therefore the helical wrapping of the strand around the metal is only 
one of several possible conformations. 
The synthesis of [{∆-RuL24}3-µ-L25](PF6)6 in six steps is in contrast with the next 
example discussed here: a self-assembly process published recently by Hannon et 
al.[38], where enantiopure dinuclear double-stranded helicates were synthesised by a 
one-pot synthesis starting from the commercially available materials for the ligands 
(pyridine-2-carbaldehyde and R- or S-1,1’-binaphthalene-2,2’-diamine, scheme 3) and 
a silver(I) source. 
 
 
 
NH2
NH2
N
O
NH2
NH2 or +
1,1'-binaphthalene-2,2'-diamine
S-(-)-
pyridine-2-carbaldehyde
EtOH,
reflux
R-(+)-
  
scheme 3: formation of enantiopure ligands R-L26 and S-L26. 
 
The enantiopure ligand R- or S-L26 is formed in-situ and reacts readily with silver(I) 
acetate to form the enantiopure helicates, which precipitate by addition of ammonium 
hexafluorophosphate giving P∆∆-[Ag2(R-L26)2](PF6)2 or MΛΛ-[Ag2(S-L26)2](PF6)2, 
respectively (figure 12). The CD-spectra† of both enantiomers are described and show 
the expected opposite signals. 
                                              
† Circular dichroism is a standard method for detecting enantiopure, optically active species. 
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figure 12: the two enantiomers of a dinuclear, double-stranded helicates: 
P∆∆-[Ag2(R-L26)2](PF6)2 and MΛΛ-[Ag2(S-L26)2](PF6)2.[38] 
 
Another example of enantioselective synthesis of helicates were carried out by 
Williams et al..[39,40] They used chiral bis(oxazolyl)pyridine ligands L27-L29 (figure 
13). These ligands were used in rhodium catalysed enantioselective hydrosilylation of 
ketones by Nishiyama and co-workers in 1991 to achieve high enatiomeric excess.[41] 
The S,S-enantiomer of L27 and L28 form the dinuclear, double-stranded helicates 
P∆∆-[Ag2(S,S-L27)2](BF4)2 and P∆∆-[Ag2(S,S-L28)2](BF4)2 (figure 13). The R,R-
enantiomers lead to corresponding MΛΛ-entaniomers. When a racemic mixture of L27 
or L28 was used, the 1H-NMR-spectrum was identical to that of the pure one and no 
CD-signal was observed. No trace of the mixed, heteroleptic species was observed. 
This establishes the homochiral self-recognition during self-assembly, which means 
that the chirality of the first ligand to be complexed induces the choice of the chirality 
to the second. Another interesting feature of these helicates is the linear coordination 
geometry of the metal centres (L-2). It is one of the rare cases, where the linear 
coordination geometry reveals chiral complexes. 
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N
N
OO
N
R R
L27: R= -CH2-C6H5
L28: R= -CH3
L29: R= -C6H5
 
 
 
 
 
figure 13: ligands L27-L29, schematic representation of the double-stranded helicate and the 
X-ray structure of P∆∆-[Ag2(S,S-L27)2]2+.[39,40] 
 
Williams et al. published another remarkable example of stereoselective control of the 
helical configuration at metals centres.[42] L30 described in this publication 
comprises three bidentate sites, one bpy unit and two amino acids (figure 14). The 
amino acids were expected to induce stereoselectivity in the coordination of metal ions 
and the different binding sites should allow to complex two different metal ions. 
Instead, a surprising observation of diastereoselectivity was reported, only the achiral 
bpy chelating unit is occupied by a metal cation. Moreover, they observed anion 
binding at the amino acid site in the solid state (figure 14). 
 
 
N NNH
HO
O
HN
OH
OL30  
 
figure 14: L30 and the “pseudo-trinuclear”, triple-stranded helicate [FeL303]Cl2.[42] 
 
The 1H-NMR of the diamagnetic low spin iron (II) complex [FeL303]2+ revealed a 
mixture of diastereomers in a ratio of 2:1, but on heating to 60 °C, the weaker set of 
signals disappeared, indicating a thermodynamically controlled diastereoselectivity (∆-
[FeL303]Cl2 ). In the crystal, the structure is held together by coordinative bonds 
between the iron and the bpy moieties and as well as hydrogen bonds and electrostatic 
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interactions between the chlorides and the protonated amino residues of the ligand 
(figure 14). 
 
 
2.3. Circular helicates 
 
Circular helicates are oligonuclear complexes with a cyclic arrangement of metal ions 
and several bridging ligands wrapping around the metals centres. Only a few circular 
helicates have been published and all show similar characteristics.  
• Firstly, the number of metal cations and the number of ligands wrapping around 
them are identical. Helicates with n = 3-6 are known (figure 15). 
• The highest possible molecular symmetry of circular helicates is Dn (n-fold 
symmetry axis and n C2-symmetry axes). 
 
 
A  
B  
monodentate ligand
C
 
 
D  
 
F  
G  
 
H  
figure 15: schematic representation of circular helicates with n = 3-6. 
 
• All ligands used in circular helicates consist at least of one C2-symmetry axis 
leading always to homotopic helicates (no head-to-head or head-to-tail 
arrangements possible). 
• As already described earlier, all metal centres in a helicate are homochiral (cf. 
figure 8). 
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• Achiral ligands lead to racemic mixtures of the helicates, chiral enantiopure 
ligands induce diastereoselectivity during complex formation. 
 
 
2.3.1 Trinuclear, circular helicates (n = 3) 
The known trinuclear helicates can be schematically represented by structure A (figure 
15): Three ligands with two binding sites wrapping around three tetrahedral metal 
centres. 
The first type of ligands (bis(oxazolyl)pyridine, L27 and L28) have been already 
mentioned, they form dinuclear double-stranded helicates (figure 13)[39,40]. The 
slightly modified ligand R,R-L29 forms the trinuclear, circular helicate P-[Ag3(R,R-
L29)3](BF4)3 in the solid state (figure 16). The coordination geometry of the silver(I) 
ions is one of the rare chiral cases of A-2. An interesting feature to note is that while 
compound S,S-L27 leads to an enantiopure P-helicate (figure 13), the R,R-enantiomer 
of L29 forms as well a P-circular helicate. Williams et al. detected an equilibrium of 
several complexes depending on solvents, silver/ligand ratio and concentration.[39] 
 
 
 
 
 
figure 16: schematic representation and X-ray structure of P-[Ag3(R,R-L29)3]3+.[40] 
 
In the same year, Lehn et al. published an analogous case.[43] A 1:1 mixture of ligand 
L31 (figure 17) and [Cu(MeCN)4]PF6 stirred overnight leads to a mixture of three 
different species: the racemic dinuclear double-stranded helicate [Cu2L312]2+, the 
racemic trinuclear circular helicate [Cu3L313]3+ and an achiral tetranuclear side-by-
side arrangement [Cu4L314]4+ (figure 17).  
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All these three self-assembled species convert into a single species [Cu2L312](PF6)2, in 
the solid state upon crystallisation. 
 
N NN N
L31
 
 
figure 17: ligand L31 forms three different species in solution: [Cu2L312]2+, [Cu3L313]3+and 
[Cu4L314]4+.[43]  
 
The complex formation with L32 was thoroughly studied by Constable et al.[44] 
(figure 18). This ligand forms double-stranded dinuclear helicates in methanol with a 
slight preference to one diastereomer (ratio 10:7). Dissolving these helicates in 
acetonitrile a variety of species could be observed (from dinuclear up to pentanuclear 
species). In the solid state a “quasi-racemic” circular helicate was obtained. The chiral 
substituents on the bpy units do therefore not influence the stereoselectivity (figure 
18). 
 
 
N
NN
N
L32
 
 
 
figure 18: L32 and the X-ray structure of P-[Cu3L323]3+, M-[Cu3L323]3+.[44] 
 
A last example leading to a structure A (figure 15) was published by Thummel et al.. 
[45] The trinuclear circular helicate can be formed from ligand L33 with tetrahedrally 
coordinating metal ions (Cu(I)). This achiral ligand leads to the racemic mixture of the 
helicate (figure 19). 
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NN NN
L33  
 
figure 19: L33 and the X-ray structure of [Cu3L333]3+.[45] 
 
 
2.3.2 Tetranuclear, circular helicates (n = 4) 
Three different types of tetranuclear circular helicates are known to exist (figure 15). 
Structure B is formed by tris-bidentate ligands with an octahedral geometry at the 
metal centres. Structure C is the unsaturated analogue of D, which is formed by bis-
tridentate ligands on octahedral metal centres. 
The ether-linked tris(bpy) ligand L34 (figure 20) forms a tetranuclear circular helicate 
[Fe4L344]8+ with iron(II) ions (figure 20).  
 
N N O N O NN N
L34  
 
figure 20: L34 and [Fe4L344]8+.[46]  
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Each of the metal ions possesses a pseudo octahedral coordination geometry and binds 
to two terminal and one central bipyridine unit of three different ligand strands L34, 
resulting in a structure similar to B.[46] 
Ligand L35 reacts with [Ni(CH3CN)6](BF4)2 to form the racemic unsaturated 
tetranuclear circular helicate [Ni4L354(CH3CN)8](BF4)8 (figure 21). Acetonitrile 
molecules acts as monodentate ligands to complete the coordination sphere.[47] 
 
 
 
N N N
NN N
L35  
 
figure 21: L35 and [Ni4L354(CH3CN)8](BF4)8.[47] 
 
The same phenomenon was observed within our group.[48] The achiral ligand L36 
leads to the racemic mixture of the circular helicate [Zn4L364](PF6)8, the chiral ligand 
L37 to one diastereomer (M ∆∆∆∆ rrrr -[Zn4L374](PF6)8) in the solid state (figure 22). In 
solution the trinuclear helicate is formed as minor species In case of L37, both 
diastereomers are present.  
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L36 L37  
          
figure 22: L36, L37 and X-ray-structures of [Zn4L364](PF6)8 and [Zn4L374](PF6)8.[48] 
 
 
2.3.3 Penta- and hexanuclear, circular helicates (n = 5,6 ) 
Ligand L38 (figure 23) reacts with nickel (II) to form a trinuclear triple-stranded 
helicate [Ni3L383]6+ which could be structurally characterized (figure 23).[49] 
With iron(II) ions a similar helicate [Fe3L383]6+ is initially obtained . However, it was 
found that the triple-stranded helicate is the product of kinetic control of complex 
formation. Under thermodynamic control, the pentanuclear [Fe5L385]10+ or 
hexanuclear circular helicates [Fe6L386]12+ are obtained (figure 23).[50]  
Here, the nuclearity depends on the nature of the counter-ions which can act as 
templates and support the formation of a defined macrocyclic helicate. The 
pentanuclear coordination species [Cl {Fe5L385}]9+ (F, figure 15) is formed in the 
presence of chloride anions. X-ray structural analysis shows that one chloride ion is 
located in the interior cavity of the complex (figure 23). The coordination geometry at 
the iron centres is very similar to that described for [Fe4L344]8+ with each iron binding 
to two terminal and one central bpy of three different ligands. With the larger bromide 
anion a mixture of pentanuclear and hexanuclear complexes is observed by ESI mass 
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spectrometry and the anions BF4-, SO4 2-, and SiF6 2- also support the formation of the 
hexanuclear circular helicate [Fe6L386]12+(G) (figure 23).[46] 
[Fe6L386]12+ possesses six hexacoordinated iron centres arranged as a hexagon with 
ligands L38 wrapping around those centres. This complex was not characterized by X-
ray diffraction. [46] 
 
N N
N
N
N
N
L38  
 
figure 23: L38 and [M3L383]6+, [Fe5L385]10+ and [Fe6L386]12+.[27,46] 
 
However, another hexanuclear circular helicate [Ag6L396]6+ was crystallized and 
structurally characterized by our group (figure 24). [51] The six silver ions are pseudo-
tetrahedrally coordinated by bpy units, and the six ligands L39 have a helical 
arrangement around the hexagon of metal ions (H) (figure 15). Due to the chirality at 
ligand L39, an enantiomerically pure circular helicate (P)-[Ag6L396]6+ is obtained. In 
solution, the hexanuclear circular helicate [Ag6L396]6+ is in equilibrium with the 
corresponding tetranuclear species [Ag4L394]4+. This equilibrium was shown to be 
pressure dependent. [52] 
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figure 24: L39 and an enantiopure hexanuclear circular helicate (P)-[Ag6L396]6+.[51] 
 
The octanuclear cobalt(II) complex [Co8L4012]4+ is related to the circular helicates 
although this coordination compound does not have the earlier mentioned 
characteristics of circular helicates (figure 25).[53] 
 
figure 25: the octanuclear Co(II)-complex.[53]
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3. Mononuclear helical metal complexes 
 
Up to now helicity has been discussed in linear and circular helicates, but it can occur 
readily in mononuclear complexes (described in general on page 6). The polydentate 
ligands, which are expected to form polynuclear complexes such as helicates or side-
by-side arrangements, can also form mononuclear helical complexes. A few selected 
examples with polydentate ligands will be discussed here. 
As mentioned earlier, ligand L24 forms mononuclear complexes and determines 
moreover the chirality at an octahedral metal centre (scheme 2, p.11). The (RRS;RRS)-
enantiomer of L24 forms the ∆-enantiomer of the complex [RuL24Cl2].[37] 
Constable et al.[54-57] and Potts et al.[58] have shown that the quinquepyridine L41 
and its substituted analogues L42-L46 (chart 2) may act as pentadentate ligands to 
give mononuclear single-stranded helical racemic complexes with transition metals. 
Large metal cations such as silver(I) almost fit into the cavity of the quinquepyridine, 
leading to a slight helical twisting of the strand in the crystal structure of [AgL41]+ 
(figure 26).[54] Unsaturated complexes such as [CoL42Cl2][58] and 
[CoL45(CH3OH)(OH2)](PF6)2[56] (figure 26) show a more pronounced shallow 
helical twist about the equatorial plane of a pentagonal bipyramidal seven-coordinated 
metal centre. The two axial coordination sites are occupied by chloride anions or 
solvent molecules. 
N
NN
N N
R1 R1
R2R2
L41: R1= H; R2 = H
L42: R1= H; R2 = S-CH2CH2CH3
L43: R1= Me; R2 = H
N
NN
N N
R1 R1
R2 R2
L44: R1= H; R2 = H
L45: R1= H; R2 = Cl
L46: R1= Me; R2 = H  
chart 2: quinquepyridine derivatives for the formation of mononuclear helical complexes. 
 
In contrast, unsaturated double-stranded helicates can be obtained by substitution at 
the 6, 6’’’’-position of the quinquepyridines (L43, L46)[59] or by other transition 
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metals such as copper(II) and nickel (II) with ligands L42-L46.[57] Surprisingly, the 
assembly of L41 with cobalt(II)acetate leads to an analogous double-stranded helicate 
[Co2L412(OAc)]3+.[55] 
 
 
 
figure 26: [AgL41]+[54] and [CoL45(CH3OH)(OH2)](PF6)2.[56] 
 
Within our group a whole series of mononuclear complexes were synthesised starting 
from diastereomeric ligands L15 and L47 (chart 3).[60] These ligands form with 
several metals saturated and unsaturated mononuclear complexes with different 
coordination geometries and predetermine the chirality at the metal centre. Silver(I), 
palladium(II) (figure 27) and zinc(II) (only with L47, figure 28) form saturated 
mononuclear complexes. The coordination geometry of these complexes can be 
considered as a very distorted (flattened) tetrahedron or a helically twisted square. 
 
S       S
N
N
N
N
H H
R       R
N
N
N
N
HH
R RRR R R R R
L15 L47  
chart 3: tetradentate ligands: CHIRAGEN[0]. 
 
  
 
figure 27: crystal structure of [AgL15]+, [PdL15]2+ and [PdL47]2+.[60] 
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With other metals such as copper(II) (figure 28), cadmium(II) and zinc(II) (with L15, 
figure 28) unsaturated mononuclear complexes were obtained. Obviously, other 
ligands are required to fill up the coordination sphere. 
  
figure 28: crystal structure of [ZnL47]2+, [ZnL15ClO4] and [CuL15Br]+.[60] 
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4. Protons as a coordinating central cation 
 
The smallest cation known is the proton. An interesting question is: Is it possible, that 
the proton can act as a coordinating centre and therefore can a ligand induce helicity to 
this proton core? 
Only a few examples are known, where the proton is exchanged between four donor 
atoms of one or two ligands and the conformation of the ligand remained fixed. 
Sauvage et al. published in 1986 a mono-protonated catenane (figure 29).[61] The 
macrocycles are interlocked and the 2,9-diphenyl-1,10-phenanthroline fragments are 
entwined. The molecular topography is strikingly similar to its copper(I)-analogue, the 
two phenanthroline units are facing each other with a dihedral angle of 61°. Although 
in the solid state, the acidic hydrogen atom is located on one of the four nitrogen sites 
(figure 29), the 1H-NMR spectrum corresponds to a symmetrical species, indicating a 
fast exchange of the binding between the four nitrogen atoms. 
 
figure 29: a mono-protonated catenane.[61] 
 
Another example, not as obvious as the previous one, was reported by Albrecht-Gary 
et al..[62] They observed a mono-protonated species of L48 (chart 4). The 1H-NMR of 
HL48+ is highly symmetrical, consistent with a folding of the flexible strand L48 
around a single proton coordinated to two bpy subunits. This observation was 
confirmed by molecular modelling calculations with Hyperchem, which showed that 
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the most stable conformation in a vacuum was a folded structure with stacking 
interactions between the aromatic parts. 
N N
H
N
H
N
O O N N
L48
N
NN
N
L49  
chart 4: ligand L48 and L49. 
 
The most recent example was published by Kress et al. in 2001.[63] These authors 
reported an unexpected protonation of L49, a well known ligand (its crystal structure 
was published by Che et al. in 1994)[64] (figure 30). This mono-protonated structure 
(syn boat-boat) is markedly different from the free ligand (syn chair-chair), suggesting 
the proton is exchanged between the four nitrogen atoms, maintaining the ligand in its 
unusual conformation. 
 
figure 30: crystal structure of L49[64] and its protonated form.[63] 
 
These examples show that a proton can act in the time average as a coordinating centre 
for up to four nitrogen donor atoms. In one case a helical structure of two 
phenantroline moieties was observed[61], whereas in the other structurally 
characterized cases a symmetrical coordination occurs located on a mirror plane, again 
in the time average. 
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 RESULTS AND DISCUSSION‡ 
 
 
1. Ligand Syntheses 
 
1.1. Introduction 
The aim of Hayoz’s work in 1992[65] was the development of a chiral building block 
of the type cis-[Ru(diimine)2Cl2] in order to synthesise enantiopure§, polynuclear 
complexes (scheme 4). The ligand, which allows the formation of this building block, 
has to fulfil several criteria. First of all, it should contain two diimine units (strong 
complexation properties of diimines). Second, the bridge between these two diimine 
units must fix the conformation and therein contain centres of chirality, which are easy 
to synthesise in an enantiopure form. Finally, it should be easy to modify the length of 
the bridge. 
 
N
N Cl
N
N
Cl
Ru
chiral bridge
diimine 
unit
diimine 
unit
complexation
with Ru(II)
Λ-cis-[Ru(diimine)2Cl2]
N
N
N
N
R R
R
R
 
scheme 4: tetradentate ligand for the synthesis of chiral building blocks. 
  
Hayoz therefore introduced a pinene moiety into a bpy system (scheme 5) in order to 
introduce chirality. Myrtenal or α-pinene (both available in nearly enantiopure form) 
were used as the source of chirality to synthesise the corresponding [4,5]-pinene-bpy 
and [5,6]-pinene-bpy derivatives, respectively. An advantage of these ligands is their 
                                              
‡ Some results were taken from diploma work carried out either under my supervision 
(Christophe Bonte, Tobias Christen) or in the group (David Mauron, deceased). 
§ Enantiopure is used in an approximate sense. In most cases terpenes of ca. 97-98% 
e.e. are used for the syntheses. 
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ability to be stereoselectively deprotonated and coupled via a bridge to form 
enantiopure tetradentate ligands: the [4,5]-CHIRAGEN[bridge] and [5,6]-
CHIRAGEN[bridge] ligands. These CHIRAGEN-ligands fulfil the above mentioned 
and desired ligand properties. They contain two bpy units, which potentially can form 
complexes with one or two metal cations. Finally, different bridges between the two 
pinene-bpy units can be introduced in a stereoselective manner by deprotonation with 
a sterically demanding base such as LDA and further reactions with a dihalide 
compound. 
 
[4,5]-pinene-bpy
[5,6]-pinene-bpy N
N
N
N
Bridge
[5,6]-CHIRAGEN[Bridge]
N
N
N
N
Bridge
[4,5]-CHIRAGEN[Bridge]
O
N
N
N
N
(-)-α-pinene
(-)-myrtenal
 
scheme 5: synthetic strategy. 
 
 
1.2. New ligands 
 
In this thesis, a new family of tetradentate ligands ([5,6]-CHIRAGEN) has been 
synthesised (scheme 6). On the one hand, directly bridged [5,6]-CHIRAGEN[0] 
derivatives were used for the formation of mononuclear metal complexes, on the other 
hand [5,6]-CHIRAGEN[p-xyl] derivatives were synthesised for self-assembly studies. 
All these new ligands are substituted either at the 5’-position (R1 = H, R2 = p-MeO-Ph) 
or at the 6’-position (R1 = p-MeO-Ph, R2 = H; R1 = Ph, R2 = H). CHIRAGENS with 
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these substituents are derived from the analogous [5,6]-pinene-bpy derivative, that 
means the length of bridge can be varied easily in one step. The precursors for the 
[5,6]-pinene-bpy derivatives are the corresponding 5- or 6- substituted 2-acetyl-
pyridines. 
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scheme 6: new ligand family. 
 
For protonation studies, another type of tetradentate ligand was synthesised. Since 
1968 [66] the remarkable basicity of 1,8-bis-(dimethylamino)-naphthalene (scheme 7) 
has been known and well studied [66]. This molecule was given the nick-name “proton 
sponge”, in accordance with its ability to take up protons. Our idea was to introduce 
this bis-dimethylamino moiety into our well known chiral skeleton of pinene-py 
derivatives to form the tetradentate ligands. This was realised with ligand L19, which 
is derived from L10 by a direct coupling in a similar way as for the other 
CHIRAGEN[0] ligands (scheme 7). 
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N N
N
N
N
N
L19 L10
N
N
1,8-bis-(dimethyl-
amino)-naphtalene
 
scheme 7: proton sponge analogue 
 
 
1.3. Nomenclature 
 
The skeleton of all bpy ligands are derived from pinene and bpy, therefore they are 
called [4,5]-pinene-bpy, [5,6]-pinene-bpy, or generally pinene-bpy derivatives** (chart 
5). The connectivity between the pinene and bpy is given by the number in the square 
brackets, which correspond to the carbons of the bpy where the pinene unit is attached. 
In curly brackets, the substituent at the second pyridine ring and its position is given. 
The name for ligand L10 is also mentioned in chart 5. 
 
{R}-[4,5]-pinene-bpy{R}-[5,6]-pinene-bpy
N
N
N
N
5
6
4
5
6'
5'
R1
R2
R2
R1
5'
6'
N
5
6N
{2-DAMI}-[5,6]-pinene-py
L10
 
chart 5: nomenclature of pinene-bpy derivatives. 
 
The tetradentate ligands have been called CHIRAGEN derivatives, (from CHIRAlity 
GENerators) due to their ability to induce a predetermined configuration at metal 
                                              
** The IUPAC name of these ligands are very complicated. E.g. [4,5]-pinene-bpy is called by 
IUPAC: (6R, 8R)-5,6,7,8-tetrahydro-7,7-dimethyl-3-(2’-pyridyl)-6,8-methano-isoquinoline 
and [5,6]-pinene-bpy (5R, 7R)-5,6,7,8-tetrahydro-6,6-dimethyl-2(2’-pyridyl)-5,7-methano-
quinoline. 
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centres upon complexation.[37,67,68] Again the same rules mentioned above were 
used: in curly brackets the substituents attached to second pyridine ring is given and in 
square brackets, the connectivity of the pinene to the first pyridine ring. At the end of 
the name, the bridge between the two pinene-bpy moieties is also given in square 
brackets. These bridges can be either p- or m-xylene bridges [p-xyl] or [m-xyl], or the 
two pinene-bpy moieties are linked directly together [0]. The ligand L19 is thus called 
{2-DAMI}-[5,6]-CHIRAGEN][0] (chart 6). 
{R}-[5,6]-CHIRAGEN[bridge]
N
N
R1
N
N
R1
R2R2
6' 6'
5' 5'
bridge
N
N
N
N
{2-DAMI}-[5,6]-CHIRAGEN[0]
L19
5
6 6
5
 
chart 6: nomenclature of CHIRAGEN derivatives. 
 
 
1.4. Mechanistic aspects of the annellation step 
 
The synthesis of the pinene-bpy derivatives (L1, L2) is described in the literature[69] 
and shown in scheme 8. Starting from acetyl-pyridine (3), the 1-(2-acetylpyridyl)-
pyridinium bromide (4) was synthesised according to the improved method of 
Mürner[70] (the bromide salt is easier to handle compared to the originally described 
iodide and no side product is observed). The 1-(2-acetylpyridyl)-pyridinium bromide 
(4) reacts with pinocarvone (1) (oxidation of α-pinene[71]) or myrtenal (2) in a 
mixture of ammonium acetate and glacial acetic acid or formamide to give the 
corresponding pinene-bpy derivatives (L1, L2). 
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N
O N
O
N
Br
Br2, py
NH4OAc
HOAc
N
N
N
N
O
NH4OAc
Formamide
O
3
L2
4
L1
1 2
 
scheme 8: synthesis of pinene-bpy derivatives. 
 
The synthesis of the substituted pyridines was reported for the first time by Kröhnke et 
al. in 1961 (scheme 9). [72-74] The pyridinium salt 5 undergoes a Michael addition 
with an α,β-unsaturated carbonyl compound 6 to form a dicarbonyl compound 7, 
which can be isolated. The aza-ring closure with ammonium acetate in glacial acetic 
acid and the loss of the pyridinium bromide occurs, giving a 2,4,6-trisubstituted 
pyridine 8 (proposed mechanism of Kröhnke[75], scheme 9). Improved procedures 
gave better yields. For example, a one-pot synthesis with the starting materials heated 
in a mixture of ammonium acetate and glacial acetic acid, yielded the corresponding 
pyridine, without isolation of the dicarbonyl compound 7.  
Br
O
R2R3
6
Br
R1
O
N
5
N
R1
O
O
R2
R3
R1
O
Br
NH4OAc
NH Br
7
-H2O, 
-AcOH
8
NR1 R2
R3
R1
O
OAc/AcOH
-
1)
2)
 
scheme 9: mechanism proposed by Kröhnke.[75] 
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A more detailed mechanism for the formation of pinene-bpy derivatives is shown in 
scheme 10. The first step starting from the 1-(2-acetylpyridyl)-pyridinium bromide (4) 
is the Michael addition. Treatment of 4 with base forms the enolate 9, which adds to 
the α,β-unsaturated carbonyl compound (pinocarvone (1)) forming intermediate 10. 
After hydrolysis the dicarbonyl compound 11 is formed. The next step is the aza- ring 
closure with ammonium acetate and simultaneous or subsequent loss of the pyridinium 
halide finally yielding the desired [5,6]-pinene-bpy (L1).  
X
X
X
4
O
N
HH
N
N
N
H2O
H
N
N
N
HOH
H
N
OAc
-AcOH
X
X
9
NH
ON
N
N
N
N H
H
H
O
N
H
N
X
H
O
-H2O, 
-AcOH
NH4OAc
X
NH-H2O
X
N
O
O
N
L1
10
O
O
N
H
N
11
X
N
N
H
-
1
base
 
scheme 10: detailed mechanism. 
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1.5. Precursors for the pinene-bpy and pinene-N-py derivatives 
 
The two key molecules for the formation of pinene-bpy or pinene-N-py derivatives are 
the α,β-unsaturated carbonyl compounds ((+)-pinocarvone (1) or (-)-myrtenal (2)) and 
the acetyl derivatives 3, 12-16 (chart 7). For unsubstituted pinene-bpy derivatives (L1, 
15N-L1 and L2, scheme 8), commercially available acetyl-pyridine (3) is used. For 5’-
substituted pinene-bpy derivatives (L3, L4) 2-acetyl-5-(p-methoxyphenyl)-pyridine 
(12) was synthesised. 6’-substituted pinene-bpy derivatives were synthesised starting 
from three different acetyl compounds (13-15). The 2-acetyl-6-bromo-pyridine (13) is 
the precursor for the corresponding 6’-bromo-pinene-bpy derivatives (L5, L6), which 
can be used for the synthesis of several 6’-substituted pinene-bpy derivatives (L5-L9; 
L54-L59, cf. scheme 20, p. 45). An analogous species containing only one pyridine 
ring can be synthesised from 2-N,N-dimethylamino-2-methyl-butan-3-one (16). 
 
O
N
O
NBr
O
N
O
O
N
O
N
O
N
O
O
O
1
13 14
3 122
15 16
 
chart 7: precursors for the synthesis of pinene-bpy and pinene-N-py derivatives. 
 
1.5.1 Precursors for 5’-substituted pinene-bpy 
For the formation of 5’-substituted pinene-bpy derivatives, 2-acetyl-5-(p-
methoxyphenyl)-pyridine (12) is used. We developed an alternative four-step synthesis 
(method A in scheme 11) for the acetyl-pyridine 12, compared to the published 
method by Sauvage et al. (method B in scheme 11).[76] The iodination of the 
commercially available 2-amino-pyridine (17) was carried out according to a known 
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procedure[77] (I2, DMSO). The side product, 2-amino-3,5-diiodo-pyridine, was 
separated from the 2-amino-5-iodo-pyridine (18) by an acid-base extraction. At pH 4, 
the desired product remains mainly in the aqueous layer, but the diiodo product 
transfers to the organic layer. By increasing the pH to 14, pure 2-amino-5-iodo-
pyridine (18), also commercially available, can be extracted.  
The next step, bromination of the amino function, is described in the literature for this 
compound (18) [78] and for some analogous molecules.[79-82] With sodium nitrite, a 
diazonium cation is formed, which reacts with HBr3 (formed by bromine in aqueous 
hydrobromic acid) giving 2-bromo-5-iodo-pyridine (19) via an alkaline work up and 
destruction of bromine with sodium thiosulfate. 
 
N
I
NH2
N NH2
I2, DMSO
N
I
Br
1) HBr (65%), Br2
2) NaNO2
BO
OH
OH Pd(PPh3)4, toluene
K2CO3, H2O
O
N
Br
O
N
O
1) n-BuLi, THF
2) DMAA
N
Br
O
N
O
N
O
O
N
N
Method A Method B
17
18
20
19
12
H2O2, HOAc
Me3SiCN
CH3CN, Et3N
MeMgI, C6H6
Ni(PPh3)2Cl2
THF
H  /H2O
 
scheme 11: two different routes for the synthesis of the key intermediate 12. 
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The iodo-substituted pyridine is much more reactive than the bromo-substituted one 
with regard to its reaction with an organoboron compound. This cross-coupling 
(Suzuki cross-coupling)[83-86] was the method of choice for the introduction of an 
aryl substituent at the 5-position of the pyridine ring. The reaction was carried out by 
refluxing the two starting materials in a two phase mixture (toluene/aqueous potassium 
carbonate) in presence of small amounts of a palladium(0)-catalyst, (Pd(PPh3)4. 
Finally, the bromo-substituent (20) is transformed into an acetyl group according to 
known procedures[87,88]. Compound 20 was reacted with n-butyllithium to form the 
anion, which reacts with N,N-dimethyl-acetamide yielding the desired precursor 12. 
 
 
1.5.2 Precursors for the 6’-substituted pinene-bpy 
The precursors for the 6’-substituted pinene-bpy were synthesised starting from 2,6-
dibromo-pyridine (21) according to the procedures mentioned above (scheme 12). With 
n-butyllithium and N,N-dimethyl-acetamide the 6-bromo-2-acetylpyridine (13) is 
prepared, which can be used to synthesise either directly 6’-bromo-pinene-bpy 
derivatives (table 1, p.43) or 6’-substituted 2-acetyl-pyridines (14, 15). The 
introduction of the aryl-substituent (Ph, p-MeO-Ph) is carried out via the Pd(0)-
catalysed Suzuki cross-coupling reaction of the corresponding aryl boronic acid 
derivatives with 6-bromo-2-acetylpyridine (scheme 12). 
 
NBr
O
N
O
R
B
OH
OH
Pd(PPh3)4, toluene
K2CO3, H2O
R
R=H, OMe
NBr Br
1) n-BuLi
2) DMAA
21 13
R = H: 14
R = OMe : 15
 
scheme 12: synthesis of the 6’-substituted acetyl-pyridines 13, 14 and 15. 
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1.5.3 Precursors for the pinene-N-py derivatives 
When the idea to synthesise an analogue of 1,8-bis-(dimethylamino)-naphthalene 
(proton sponge, cf. scheme 7) to increase the basicity of the normal CHIRAGEN[0] 
(L1) emerged, ligand L50 appeared to be the most accessible (scheme 13).  
 
N
N
N
N
L50 L51
N
N
 
scheme 13: synthetic approach to a proton sponge analogue. 
 
The key step for the synthesis of the ligand L50, would be the coupling of the pinene-
N-py ligand L51. This coupling reaction (well known in our group and discussed later) 
consists of two steps. The first is the deprotonation with LDA, the second the coupling 
in presence of iodine. Deprotonation could take place at two competitive positions 
within L51, but only one would lead to the desired product L50 (scheme 14). 
 
NN
L51
1) LDA, THF -40°C
desired position
undesired position
?2) I2
 
scheme 14: key step: deprotonation. 
 
To avoid this problem, the undesired position can be substituted. Two methyl- or two 
phenyl-groups can protect the position against unwanted deprotonation. Therefore, the 
desired tetradentate ligands L19 and L52 should be obtained easily from the 
corresponding pinene-N-py derivatives L10 and L53 (scheme 15). 
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N
N
N
N
L10
N
N
L52
N
N
N
N Ph
Ph
Ph
Ph
L53
N
N Ph
Ph
L19  
scheme 15: synthetic strategy for L19 and L52. 
 
For the preparation of these pinene-bpy derivatives, the acetyl compound 16 (scheme 
16) and 27 (scheme 17) would be the precursors. 2-N,N-dimethylamino-2-methyl-
butan-3-one (16) is synthesised from 3-methyl-2-butanone (22) in two steps by 
bromination and subsequent reaction with dimethylamine (scheme 16). 
 
O Br2 O
Br
HNMe2
CCl4 N
O
22 23 16  
scheme 16: synthesis of 2-N,N-dimethylamino-2-methyl-butan-3-one (16). 
 
The bromination of 1,1-diphenyl-propan-2-one (24) to form 1-bromo-1,1-diphenyl-
propan-2-one (25) was carried out under analogous reaction conditions (scheme 17).  
 
O Br2 O
Br
HNMe2
CCl4
HNMe2
NMe2
O
O
N
2724 25
26  
scheme 17: synthetic scheme for the formation of 26. 
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But the next step (a nucleophilic substitution) to obtain 1-N,N-dimethylamino-1,1-
diphenyl-propan-2-one (27) was unsuccessful. Instead of the desired product 27, N,N-
dimethyl- 3,3-diphenyl-propionamide (26) was isolated in a nearly quantitative yield 
(scheme 17). The spectral data for 26 corresponds to that published. [89-91] 
This is a new synthetic route for the formation of 26, which can be explained by a 
Favorskii rearrangement (scheme 18).[Kende, 1960 #86; Favorskii, 1985 #85] In the 
first step the base (dimethylamine) deprotonates compound 25 by formation of the 
enolate 28, which undergoes an intramolecular substitution reaction yielding a 
cyclopropane 29. By addition of the substrate (dimethylamine can act as base, but also  
as substrate) to the intermediate 29, the ring opening is initiated, which leads to the 
more stable carbanion 30. 
 
O
Br
H
O
NMe2
28
30
O
Br
NMe2
O
29
H
O
NMe2
O
NMe2
Base25
26
 
scheme 18: explanation by Favorskii rearrangement. 
 
 
1.6. Syntheses of pinene-bpy and pinene-N-py derivatives 
 
1.6.1 [5,6]-pinene-bpy derivatives 
The syntheses of [5,6]-pinene-bpy derivatives were carried out according to the 
procedures for compound L1[69,70] (table 1). The first step is the formation of the 
pyridinium salts starting from the corresponding acetyl-pyridine derivatives by 
reaction with halogens and pyridine. The reaction with bromine is carried out in two 
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stages. The bromination of acetylpyridine (3) is followed by the reaction with pyridine 
yielding the pure pyridinium salt (4) (table 1, entries 1,2). The reaction with iodine is a 
one-pot synthesis (entries 3-5), adding iodine and pyridine to the acetyl derivatives and 
heating for two hours under reflux. By precipitation with diethyl ether, not only the 
desired salt, but also pyridinium iodide precipitates (the ratio of the mixture is given in 
table 1). The latter does not influence the following step, and it is therefore not 
removed. This next step is the reaction of the pyridinium salts with (+)-pinocarvone 
(1) and ammonium acetate yielding the corresponding [5,6]-pinene-bpy derivatives 
(for mechanistic aspects see 1.4, p.34). In entry 2, ammonium acetate with enriched 
15N-isotope (10%) was used. 
 
NR1
O
N
X
R2
N
O
R1
R2
NH4OAc
HOAc
N
N
R1
R2
X2, py
O
 
entry  R1 R2 salt, yield X-;ratio (salt : py X) Yield 
1 3 H H 4,  Br¯; pure L1, 741 
2 3 H H 4,  Br¯; pure 15N-L1, 532 
3 12 H p-MeO-Ph 31, 85 I ¯; 1.1 : 1 L3, 30 
4 13 Br H 32, 92 I ¯; 1.1 : 1 L5, 50 
5 14 Ph H 33, 100 I ¯; 2 : 1 L7, 55 
1 Synthesis described in literature[69,70]; 2 15N (10%)-labelled ammonium acetate was used; 
table 1: synthesis of [5,6]-pinene-bpy derivatives. 
 
The 6’-substituted [5,6]-pinene-bpy can be prepared in two different ways. The first 
(used for the synthesis of {6’-phenyl}-[5,6]-pinene-bpy (L7)) is described in table 1, 
entry 5. The other method uses the {6’-bromo}-[5,6]-pinene-bpy (L5) as the key 
intermediate (table 1, entry 4), which can be coupled with an aryl boronic acid using a 
Pd(0)-catalysed Suzuki cross-coupling reaction (scheme 19). {6’-p-methoxyphenyl}-
[5,6]-pinene-bpy (L9) was synthesised in this way. 
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N
N
Br
B
OH
OH
MeO
N
N
MeO
Pd(PPh3)4, toluene
K2CO3, H2O
L5
L9  
scheme 19: Suzuki cross-coupling reaction with Pd(PPh3)4. 
 
The key intermediate L5†† can be used for the preparation of several 6’-substituted 
[5,6]-pinene-bpy in just one step (scheme 20). In our group a variety of such ligands 
have been synthesised. In most of the cases the Suzuki cross-coupling reaction with 
Pd(PPh3)4 and a boronic acid derivative was the method of choice for the formation of 
these ligands. For the synthesis of L54, o-methoxy-phenyl boronic ester was used[93] 
and for L56, L57 and L59 p-phenylene-bis-boronic acid, m-phenylene-bis-boronic 
ester and 2,5-thiophenediyl-bis-boronic acid were used respectively.[94] The ligand 
L58, with the incorporated ferrocene moiety, was synthesised by Quinodoz[95] in a 
slightly different manner, by reaction of dilithioferrocene/TMEDA with ZnCl2 and 
subsequent reaction with the key intermediate L5, the ligand L58 was formed in the 
presence of a catalytic amount of Pd(PPh3)4, according to known procedures.[96-99] 
The quaterpyridine derivative L55 synthesised via a double pyridinium salt by 
Constable et al[44,100-102] can be prepared by a Ni(0)-mediated coupling reaction 
described for other bromo compounds [103,104] starting from the key intermediate 
L5. 
                                              
†† An analogous compound was synthesised starting from β-pinene. [92] 
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scheme 20: application for the key intermediate L5. 
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1.6.2 [4,5]-pinene-bpy-derivatives 
The analogous reactions of the pyridinium salts with (-)-myrtenal (2) and ammonium 
acetate in formamide lead to the corresponding [4,5]-pinene-bpy derivatives (table 2). 
 
NR1
O
N
I
R2
NNH4OAc
Formamide
O
N
R1
R2
 
entry Salt R1 R2 Yield 
1 4 H H L2, 651 
2 31 H p-MeO-Ph L13, 24 
3 32 Br H L14, 29 
4 33 Ph H L15, 52 
1 described in literature[69,70] 
table 2: [4,5]-pinene-bpy 
 
For 6’-bromo-[4,5]-pinene-bpy, the analogous coupling reaction as for 6’-bromo-[5,6]-
pinene-bpy can in principle be carried out for the synthesis of the 6’-substitued-[4,5]-
pinene-bpy analogues mentioned in scheme 20. 
 
1.6.3 [5,6]-pinene-py-derivative 
The same methodology was used for the formation of 2-substituted [5,6]-pinene-N-py 
derivatives such as {2-DAMI}-[5,6]-pinene-py (L9) (scheme 21).  
N
O
N
I
N
N
N
O
NH4OAc
HOAc
O
I2, py
16
34 L9  
scheme 21: synthesis of the pinene-N-py derivative L9. 
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1.7. [5,6]-CHIRAGENS[bridge]-derivatives 
 
The nucleophilic substitution reaction, for the formation of the [5,6]-
CHIRAGEN[bridge]-derivatives (table 3), was carried out in two steps. The 
deprotonation of [5,6]-pinene-derivatives with a sterically demanding base, such as 
LDA, occurs stereoselectively (at low temperature –40° C). Reaction of this anion 
with a dibromo-compound (α,α’-dibromo-p/m-xylene) only one of three possible 
diastereomers of the corresponding tetradentate ligand is formed. The bridge is 
attached in anti-position with regard to the methyl-groups of the pinene moieties (S,S-
diastereomer). 
 
S S
N
N
R1
N
N
R1
Bridge
R2R2
1) LDA, THF -40°C
2) α,α−Dibromo-p/m-xylene
N
N
R1
R2  
Entry  R1 R2 Bridge yield (%) 
1 L4 H p-MeO p-xyl L11, 72 
2 L5 Ph H p-xyl L12, 68 
3 L6 p-MeO H p-xyl L13, 95 
4 L6 p-MeO H m-xyl L14, 13 
table 3: {R}-[5,6]-CHIRAGEN[bridge]. 
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1.8. CHIRAGEN[0]-derivatives 
 
The syntheses of the CHIRAGEN[0] derivatives were carried out in analogous manner 
as described above (table 4). After the formation of the anion, iodine is added to form 
the desired CHIRAGEN[0]derivatives via an oxidative coupling reaction. The 
CHIRAGEN[0]derivatives are purified by recrystallisation. 
 
N
N
R1
R2
N
N
R1
N
N
R1
R2R2
H H
S       S
1) LDA
2) I2
 
entry  R1 R2 yield (%) 
1 L1 H H L15; 72 
2 15N-L1 H H 15N-L15; 73 
3 L3 H p-MeO L16; 16 
4 L5 Ph H L17; 68 
5 L6 p-MeO H L18, 53 
6 
N
N
L16
 
  L19, 20 
table 4: {R}-[5,6]-CHIRAGEN[0]. 
 
In contrast to the nucleophilic substitution, this oxidative coupling with iodine is not 
completely stereoselective. Even though the S,S-diastereomer is the major product, the 
R,R-diastereomer is formed in a small amount (observed by 1H-NMR-spectroscopy, 
but not isolated). This formation of two compounds, that are configured differently at 
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the bridgehead, indicates that the oxidative coupling occurs via a radical intermediate 
(scheme 22),[60] Although the radical is configurationally less stable than the 
carbanion. The R,S-diasteromer (meso form) is not formed. Model studies show that 
the coupling most probably occurs via a Li+-templated complex (introduced through 
LDA). In this template, both the S,S- and the R,R- configurations are sterically 
feasible, whereas the R,S is highly disfavoured. 
N
N
Li
I2
N
N
N
N
Li
S       S
N
N
N
N
H H
R       R
N
N
N
N
HH
+
 
scheme 22: proposed mechanism via radical Li+-template. 
 
The synthesis of the [4,5]-CHIRAGEN[0] (L20) was carried out according to the 
procedures described by Fletcher [36]. The reaction mechanism is analogous to that 
one of the CHIRAGEN[bridge] derivatives. Only the S,S-isomer is formed by the 
oxidative coupling (scheme 23). 
N
N N
N
H H
N
N
1) LDA
2) I2
L1 L20  
scheme 23: [4,5]-CHIRAGEN[0] (L20). 
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1.9. Characterizations of bidentate and tetradentate ligands 
 
1.9.1 X-ray analysis 
Suitable crystals for X-ray analysis were obtained from the [5,6]-pinene-bpy 
derivatives L3, L5-L7 and L9 and from the [5,6]-CHIRAGEN derivatives L12, L18 
and L19. The X-ray analyses were carried out by Professor Helen Stoeckli-Evans at 
the University of Neuchâtel. 
 
All these ligands (figure 31-figure 35) crystallise easily in pure solvents (chloroform or 
acetone) or in mixture of solvents (chloroform/methanol; dichloromethane/methanol). 
In three cases (L5, L6, L9), the absolute configuration could be determined by X-ray 
analysis (bromide substituent for L5 and L6, a chloroform molecule for L9 in unit 
cell). In the other cases, the configuration is assigned to the known configuration of the 
α-pinene used. The bond lengths and the angles have the expected values. As in 
bpy[105], the dihedral angle between the two pyridine rings is small in ligand L5, L7 
and L18. This coplanarity is due to CH-N’ interactions and to π-π-stacking.  
 
  
figure 31: ORTEP-plots of bromo-pinene-bpy derivatives L5 (left) and L6 (right). 
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figure 32: ORTEP-plots of [5,6]-pinene-bpy derivatives L3 (top), L7 (left) and L9 (right). 
 
 
figure 33: ORTEP-plot of L12. 
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figure 34: ORTEP-plot of L18. 
 
 
figure 35: ORTEP-plot of L19. 
 
In L3 and L9, as well as in [5,6]-pinene-bpy (L1)[106], and [5,6]-CHIRAGEN[0] 
(L15)[60], the twist angle varies from 6° to 10°,  and on one of the bpy units of L12 it 
amounts to 23°. For L6 a twist angle of 29° is measured. For the 5’-substituted pinene-
bpy the torsion angle between the phenyl and the pyridine is comparable to that in a 
biphenyl system. 
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 L3 L5 L6 L7 
Empirical formula C24 H24 N2 O C17 H17 Br N2  C17 H17 Br N2  C23 H22 N2  
Formula weight  356.45 329.24 329.24 326.43 
Crystal shape Block Rod Block Block 
Crystal colour Colourless Colourless Colourless Colourless 
Crystal size [mm] 0.50 x 0.50 x 
0.50 
0.50 x 0.10 x 
0.08 
0.38 x 0.30 x 
0.23 
0.53 x 0.30 x 
0.30 
Crystal system Monoclinic Orthorhombic Orthorhombic monoclinic 
Space group P 21 P 21 21 21 P 21 21 21 P 21 
a [Å] 9.1016(9) 6.1546(5) 6.5403(8) 10.8641(16) 
b [Å] 9.3289(7) 13.5496(13) 11.3397(10) 6.3600(8) 
c [Å] 11.1653(12) 17.5877(16) 20.395(2) 13.0544(17) 
α [°] 90 90 90 90 
β [°] 96.651(13) 90 90 90.312 
γ [°] 90 90 90 90 
Volume [Å3] 941.64(15) 1466.7(2) 1512.6(3) 902.0(2) 
Z 2 4 4 2 
F(000) 380 672 672 348 
Density (calculated) [g/cm3] 1.257 1.491 1.446 1.202 
Linear absorption coefficient µ [mm-1] 0.077 2.794 3.619 0.070 
Temperature [K] 153(2) 153(2) 293(2) 293(2) 
Radiation used  Mo Kα Mo Kα CuKα Mo Kα 
Wavelength [Å] 0.71073 0.71073 1.54180 0.71073 
Scan method φ oscillation φ oscillation ω/2Θ ω/2Θ 
No of reflections measured 7352 10465 6472 4520 
No of independent reflections 3477 2871 2219 2260 
No of observed reflections 2978; I> 2σ(Ι) 1760; I> 2σ(Ι) 2163I> 2σ(Ι) 1520; I> 2σ(Ι) 
θ range [°] 2.74-25.94 2.32-25.96 4.34-59.60 2.43-27.48 
R 0.0278 0.0315 0.0314 0.0494 
wR2 0.0639 0.0510 0.0801 0.0967 
R (all data) 0.0351 0.705 0.0320 0.0850 
wR2 (all data) 0.0664 0.0574 0.0808 0.1118 
Absolute structure parameter -0.8(12) 0.002(13) 0.01(3) 0(6) 
table 5: crystallographic data of the ligands L3, L5-L7. 
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 L9 L12 L18 L19 
Empirical formula C24 H24 N2 O * 
CH3Cl 
C54 H50 N4 C48 H48 N4 O2 C34 H50 N4 
Formula weight 475.92 754.98 710.89 514.78 
Crystal shape Plate Rod Rod Rod 
Crystal colour Colourless Colourless Colourless Colourless 
Crystal size [mm] 0.35 x 0.30 x 0.10 0.60 x 0.20 x 0.10 0.50 x 0.30 x 0.20 0.50 x 0.15 x 0.15 
Crystal system Monoclinic orthorhombic monoclinic orthorhombic 
Space group P 21 P 21 21 21 C 2 P 21 21 2 
a [Å] 6.6825(5) 11.4989(5) 20.7692(18) 11.4893(8) 
b [Å] 7.4085(4) 14.7712(8) 6.0863(4) 20.8542(16) 
c [Å] 23.4403(18) 25.1410(16) 14.9639(13) 6.4198(4) 
α [°] 90 90 90 90 
β [°] 94.080(10) 90 99.673(10) 90 
γ [°] 90 90 90 90 
Volume [Å3] 1157.52(14) 4270.3(4) 1864.7(3) 1538.19(19) 
Z 2 4 2 2 
F(000) 496 1608 756 564 
Density (calculated) [g/cm3] 1.365 1.174 1.266 1.111 
Linear absorption coefficient 
µ [mm-1] 
0.416 0.068 0.078 0.065 
Temperature [K] 153(2) 153(2) 153(2) 153(2) 
Radiation used Mo Kα Mo Kα Mo Kα Mo Kα 
Wavelength [Å] 0.71073 0.71073 0.71073 0.71073 
Scan method φ oscillation φ oscillation φ oscillation φ oscillation 
No of reflections measured 9156 31668 7379 12014 
No of independent reflections 4208 8128 3471 2938 
No of observed reflections 3435; I> 2σ(Ι) 4620; I> 2σ(Ι) 2907; I> 2σ(Ι) 1789; I> 2σ(Ι) 
θ range [°] 2.61-25.92 2.24-25.95 1.99-25.89 1.95-25.93 
R 0.0299 0.0326 0.0334 0.0417 
wR2 0.0657 0.0487 0.0819 0.841 
R (all data) 0.0403 0.0760 0.0425 0.0774 
wR2 (all data) 0.0684 0.0558 0.0847 0.0926 
Absolute structure parameter -0.06(5) 2(2) -1.4(15) 1(4) 
table 6: crystallographic data of the ligands L9, L12, L18 and L19. 
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Computational methods[107] yield a twist angle of 40° due to steric hydrogen 
repulsion. In the crystal structure of L3, a torsion angle of 34° is found. 6’-substituted-
pinene-bpy derivatives have analogous structures to 2’-phenylpyridine with a 
calculated minimum of 25°, due to competing steric hydrogen repulsion and CH-N’-
interactions. The torsion angles found in our crystals vary from 10° (L18) to over 14° 
(L6) and 25° (L12) to 32° (L7). The variation of all these angles is most likely the 
consequence of different packing in the crystals. 
All three [5,6]-CHIRAGEN-ligands have a molecular C2-axis, which is vertical to the 
bridge. Whereas L18 and L19 keep this C2-axis in the crystal, as in the [5,6]-
CHIRAGEN[0] L15[60], L12 has no crystallographic C2-axis, (one bpy conformation 
is coplanar, the other has a twist angle from about 23°). The plane angle between the 
two pyridine rings bearing the pinene moieties varies slightly, for L15 a plane angle of 
79° is found, for L12 81°, L19 81° and for L18 85°. 
The detailed data of the crystal structure of these compounds are shown in two tables 
(table 5 and table 6). 
 
 
1.9.2 NMR-spectroscopy 
The most important method for the characterization of the ligands is the analysis by 
1H-NMR and 13C-NMR spectroscopy. Since the structure of [5,6]-pinene-bpy and 
[4,5]-pinene-bpy is well characterized[65] (1D-NOE difference techniques were 
needed for the complete assignment), the assignment of the extended pinene-bpy 
systems is straightforward. All CHIRAGEN derivatives have a C2-axis, thus the 1H-
NMR-spectra keep the simplicity of the pinene-bpy ligands, only the peaks of the 
bridge protons are added. The parts of the 1H-NMR-spectra of the 5’-substituted 
ligands L3, L11 and L16 are shown in figure 36 (aromatic protons) and in figure 37 
(aliphatic ones). Only small chemical shifts between the three different ligands could 
be observed, an exception is the aliphatic proton 7 at the bridge. While in L3 the 
chemical shift of proton 7 is at 3.2 ppm, it is shifted downfield to 3.4 ppm in L11 and 
to 4.5 ppm in L16. The signals of proton 3’ and 7 in the CHIRAGEN[0] (L16) are 
broad, and surprisingly, they show a NOE interaction.  
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figure 36: 1H-NMR-spectra of 5’-substituted derivatives. 
 
The protons 1’’ at the p-xylene-bridge of L11 are diastereotopic and thus a significant 
difference in the chemical shift is observed. One proton is shifted up to 3.9 ppm, the 
other to 2.8 ppm. For the 6’-substituted [5,6]-CHIRAGEN[p-xyl] ligands the same 
phenomena are observed.  
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figure 37: 1H-NMR-spectra of 5’-substituted derivatives. 
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The aromatic part of the 1H-NMR spectra of the five [5,6]-CHIRAGEN[0] is shown in 
figure 38. As mentioned above, the signals of proton 3’ is broad in all cases. 
 
3 4 *
6.8 7.0 7.2 7.4 7.6 7.8 8.0 8.2 8.4 8.6 8.8 9.0 
(ppm) 
{2-DAMI}-[5,6]-CHIRAGEN[0] (L19) 
5’ 3 
*
9’ 
4 
8’ 3’ 4’ 
{6’-p-MeOPh}-[5,6]-CHIRAGEN[0] (L18) 
*
4 
5’ 3 4’ 
3’ 
6’ 
[5,6]-CHIRAGEN[0] (L15) 
*
8’ 
4 
9’ 
3 4’ 3’ 
6’ 
{5’-p-MeOPh}-[5,6]-CHIRAGEN[0] (L16) 10’/4 
8’ 
{6’-Ph}-[5,6]-CHIRAGEN[0] (L17) 
5’ 3 9’ 4’ 
3’ 
*
 
 
 
 
 
 
O
N
N
2
3
4
5
6 7
8
9
10
12 13
2'
3'
4'6'
8'
9'
13'
1''
5'
 
 
 
 
 
figure 38: 1H-NMR-spectra of several [5,6]-CHIRAGEN[0]. 
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1.9.3 UV/Vis spectroscopy 
All ligands of the family L1-L10 show absorptions in the UV-region, corresponding to 
π-π*-transitions. The spectra of the corresponding [4,5]-, and [5,6]-pinene-bpy 
derivatives are very similar. The spectra of L1 and L6 are shown in figure 39, the 
spectra of L3, L8 and L9 in figure 40. The spectra of the CHIRAGEN derivatives 
show all absorptions at the same wavelengths as the corresponding [5,6]-pinene-bpy 
derivatives, with ε-values nearly doubled. 
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figure 39: UV/Vis-spectra of L1 and L6. 
 
-
5'000
10'000
15'000
20'000
25'000
30'000
35'000
240 290 340 390
λ [nm]
ε [
M
1  c
m
 -1
]
L3
L8
L9
 
figure 40: UV/Vis-spectra of L3, L8 and L9. 
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1.9.4 CD spectroscopy 
As previously observed[36], pinene-bpy derivatives and CHIRAGEN[bridge] 
derivatives are nearly void of any CD-activity. CHIRAGEN[0]-ligands, however, 
show distinct exciton couplets in the range of the π-π*-absorptions (figure 41 and 
figure 42). The most pronounced CD-activity is measured in the spectrum of L16 
(figure 42), which can be explained by the hypothesis of an intramolecular π-stacking 
of the two methoxy-phenyl-groups. 
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figure 41: CD-spectra of CHIRAGEN[0]derivatives L16, L19 and L20. 
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figure 42: CD-spectra of CHIRAGEN[0]derivatives L16 and L18. 
 
 
60  Results and Discussion 
 
2. Complex formation and characterization 
 
The tetradentate [5,6]-CHIRAGEN derivatives can be divided into two different 
groups depending on the bridge between the two [5,6]-pinene-bpy moieties. The first 
group contains those ligands with a p-xylene bridge. The inclusion  of the bridge leads 
to the formation of polynuclear species and prevents intramolecular, mononuclear 
complexation. The second group is formed by directly bridged two [5,6]-pinene-bpy 
moieties. These [5,6]-CHIRAGEN[0] derivatives can be used for the formation of 
mononuclear complexes.[60] 
 
 
2.1. Complexes with CHIRAGEN[p-xyl]-derivatives 
 
It is well known, that the [5,6]-CHIRAGEN[p-xyl] (L39) forms a hexanuclear circular 
helicate with labile metals such as silver(I) and copper(I) (scheme 24),[51] where the 
chirality of the ligand predetermines the configuration at the six homochiral metal 
centres and furthermore the chirality of the circular helicate.  
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scheme 24: synthesis of the hexanuclear, circular helicate C1 (with Ag(I)) 
and C2 (with Cu(I)).[51] 
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The enantiopure ligand L39 leads to a Λ-configuration at the metal centres and 
therefore to a P-helicate (self-recognition by self-assembly). 
 
 
2.1.1 Synthesis 
Herein we present similar hexanuclear circular helicates with the synthesised [5,6]-
CHIRAGEN[p-xyl] derivatives (L11, L12, L13) described in the previous chapter 
using silver(I) or copper(I). From L11 the complexes C3 ([Ag6L116)](PF6)6) and C4 
([Cu6L116)](PF6)6) were obtained (scheme 25), from L13 C5 ([Cu6L136)](PF6)6) 
(scheme 26) and from L12 C6 ([Cu6L126)](ClO4)6) (scheme 27).  
The silver(I) complex C3 (scheme 25) was obtained by reaction of the ligand L11 
(dissolved in CHCl3/CH3CN) with an equimolar amount of AgPF6 salt (dissolved in 
CH3CN). After 10 minutes the solvent was evaporated under reduced pressure and the 
complex C3 was obtained in almost quantitative yield and no further purification was 
needed. The analogous copper(I)-complex C4 was obtained in the same manner using 
the precursor [Cu(CH3CN)4]PF6[108] as metal cation source (yield: 99%). By addition 
of the ligand (dissolved in CHCl3/CH3CN) to the copper(I)-solution in CH3CN, a deep 
red colour appeared immediately, the characteristic colour for a copper(I) complex 
with bpy ligands. 
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scheme 25: synthesis of C3 and C4 with ligand L11. 
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For the complex C5 (scheme 26), the same method described above was used. The 
metal source was the [Cu(CH3CN)4]PF6-salt.[108] The complex was isolated by 
precipitation with diethyl ether to remove traces of free ligand and it showed again the 
characteristic deep red colour. 
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scheme 26: synthesis of C5 with ligand L13. 
 
The complex C6 was obtained by using another metal cation source such as 
[Cu(CH3CN)4]ClO4 (scheme 27).[109] The complex C6 was isolated by precipitation 
with diethyl ether (yield 99 %). 
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scheme 27: synthesis of C6 with ligand L12. 
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Crystals suitable for X-ray analysis for these complexes could not be isolated. The 
structure representations in scheme 25 to scheme 27 show computer models using the 
program Molden.[110] The X-ray data of C1 were used as starting point. But the 
structures can be analysed in solution and deduced by analogy to the known 
complexes C1 and C2. 
 
 
2.1.2 Characterization of the silver(I)-complex C3 
The length of the bridge between the two pinene-bpy moieties of all [5,6]-
CHIRAGEN[p-xyl] (L11-L13) was designed for the formation of polynuclear species 
and it should inhibit the formation of mononuclear complexes. The 1H-NMR-spectrum 
of the silver(I)-complex C3 shows a symmetrical species (figure 43b), which cannot 
be attributed to a mononuclear complex. The assumed polynuclear complex is highly 
symmetrical, all ligands wrapping around the metal centres are chemically equivalent. 
The C2-symmetry of the free ligand (figure 43a) is preserved in the complex.  
Comparing the complex with the free ligand, the largest shift in the 1H-NMR-spectrum 
(∆δ=1.33 to high field) is due to the aromatic protons on the bridge (3’’, 4’’, 5’’ and 
6’’ chemically equivalent), associated with a dramatic change of the chemical 
environment. Other protons such as 7 and 8 are shifted to high field by a significant 
amount. The protons of the bridge and most of the aliphatic ones are broad at 25° C, 
indicating a fast exchange between two or more different species. 
The comparison of the chemical shifts of the complexes C1 and C3 shows only slight 
changes, assuming both complexes have a similar structure (table 7). The structure of 
C1 was determined by X-ray analysis and showed a hexanuclear circular helicate. The 
protons 6’ (∆δ=0.30) and 4’ (∆δ=0.16) show the largest difference in chemicals shifts, 
which is caused by the influence of the methoxy-phenyl group attached at carbon 5’. 
 
 6' 5' 4' 3' 3 4 3'' 7 8 9a 9b 10 12 13 1a'' 1b'' 
C1 8.44 7.43 7.98 8.27 8.21 7.83 5.89 2.82 1.39 1.57 2.55 3.01 1.17 0.08 2.41 3.73 
C3 8.74 --- 8.14 8.24 8.29 7.85 5.95 2.89 1.22 1.60 2.59 2.97 1.22 0.14 2.46 3.83 
∆δ 0.30 --- 0.16 -0.03 0.08 0.02 0.06 0.07 -0.17 0.03 0.04 -0.04 0.05 0.06 0.05 0.10 
table 7: comparison of the chemical shifts of C1[51] and C3. 
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The broadening of the signals in 1H-NMR-spectrum was also observed in C1, where 
the hexanuclear species is in equilibrium with a tetranuclear one depending on 
concentration, temperature and pressure.[52] 
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chart 8: numbering of the ligand L11. 
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4’  4                           3’’ 1b’’        10 7  9b          9a 8 
13’                   1a’’  *       12              13 6’   3’/3        9’     8’  
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9’      8’ 
1b’’      7     10  9b  8        9a 
13’                 1a’’          12        13 
a) free ligand L11 
b) silver(I)-complex C3 
c) copper(I)-complex C4 
 
figure 43: 1H-NMR-spectra of the ligand L11 in CDCl3 and the complexes C3 and C4 in 
CD3CN. 
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1H-NMR-measurements of C3 were carried out at different temperatures (figure 44). 
At 60 °C all signals sharpened, the hexanuclear form is favoured at higher 
temperature. At lower temperatures (0 - 40 °C) a doubling of the signals attributed to 
the protons at the bridge concomitant with a broadening of all signals is observed. The 
exchange between the two species slowed down and the signals of the second species 
becomes observable (at least for the signals of the protons 3’’). 
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figure 44: temperature dependence of 1H-NMR-measurements of C3 in acetonitrile at 25 °C. 
 
A doubling of all signals (the aromatic part is shown in figure 45) occurs on changing 
the solvent. The non-coordinating solvent nitromethane inhibits the fast exchange of 
the two species in equilibrium. 
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figure 45: aromatic part of the 1H-NMR of C3 in nitromethane. 
 
Electrospray mass spectroscopy is the method of choice for the analysis of helicates, 
which are kinetically labile species. With this technique species in solution can be 
determined in a qualitative way.  
In complex C1 (structurally analysed in the solid state as hexanuclear circular 
helicate), electrospray mass spectroscopy shows several species present in solution.  
[Ag6L396](PF6)33+, [Ag4L394]PF62+ and [Ag2L392]+ appear all at the same nominal 
mass (1566.5), showing however different isotopic pattern. The same is observed for 
[Ag6L396](PF6)24+ and [Ag3L393]PF62+ at a mass of 1138.6. Other signals are due to 
[Ag6L396]PF65+ (881.9), [Ag5L395]PF64+ (924.7), [Ag5L395](PF6)23+ (1281.2) and 
[Ag4L394]PF63+ (995.6). Always present are as well the peak AgL39+ at 711.2 (the 
isotopic pattern corresponds to several species [AgnL39n]n+) and AgL392+ at 1313.9. 
In the case of C3 only a few peaks could be observed (figure 46). AgL11+ 
( =ˆ [AgnL11n]n+ at 922.5) and AgL112+ (at 1737.5 ) have high intensities. Two other 
peaks correspond to the hexanuclear species. The study of the isotopic pattern of the 
peak at 1457.95 shows an overlapping of two species, one corresponds to the hexamer 
([Ag6L116](PF6)24+), the other one to the trimer ([Ag3L113]PF62+).  
 
Results and Discussion  67 
  
 
 
 
 
 
 
[AgnLn]n+ 
[AgL2]+ 
4+ 
5+ 2+ 
 
figure 46: electrospray mass spectroscopy of C3. 
 
The results from NMR and ESI-MS investigations have to be interpreted with caution. 
The formation of the circular helicates is strongly dependent on the concentration. 
While the NMR-technique is applicable for concentration in the range 0.01M to 0.1M, 
the maximum concentration for ESI-MS is around 10-3M. The species observed in the 
ESI-MS are more stable at low concentration, but they are only minor species or not 
even observed in the NMR. 
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2.1.3 Characterization of the copper(I)-complexes C4, C5 and C6 
The copper(I)-complexes of L11 (C4) (scheme 25), L12 (C6) (scheme 27) and L13 
(C5) (scheme 26) show similar behaviour in solution, which have already been 
observed for their analogue C2.[51] 
The 1H-NMR spectra of these complexes show highly symmetrical, polynuclear 
species (mononuclear ones are inhibited by the geometry of the ligands). All 
copper(I)-complexes show sharp signals in the 1H-NMR-spectra, which is in contrast 
to the silver(I)-complexes (C4 in figure 43c, C5 in figure 47b). No broadening occurs 
through exchange by various species. Otherwise the spectra show similar 
characteristics as compared to its silver(I)-analogue. The signals of the protons at the 
bridge are sharp and show again a large upfield shift (∆δ = 1.50 ppm for C4, ∆δ = 1.60 
ppm for C5, ∆δ = 1.69 ppm for C6). Protons 7 and 8 are shifted significantly to high 
field. 
The spectra of C5 and C6 show an additional phenomenon. The protons of the 6’-
subsituents are strongly shifted highfield (∆δ = 1.04 ppm for 8’, ∆δ = 0.78 ppm for 9’ 
in both ligands and ∆δ = 0.38 ppm for 10’ in L12, figure 47). 
All protons signal of C4 are shifted by nearly the same amount as compared to its 
analogue C2, again the largest differences occur by protons 6’ and 4’, induced by the 
methoxy-phenyl group at 5’ (table 8). 
The comparison of C2 with the complexes C5 and C6 shows remarkable differences 
in the chemical shifts (table 8), especially for the protons 3’, 4’, 3, 7 and both 1’’. An 
explanation for this could be the slightly different geometries of the ligands. The 6’-
substituents (themselves shifted to high field) are pointing towards the metal centre. 
Therewith it influences strongly the second ligand coordinated to the same centre.  
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 6' 5' 4' 3' 3'' 3 4 7 8 9a 9b 10 12 13 1a'' 1b'' 
C2 8.17 7.40 7.98 8.31 5.70 8.3 7.87 2.69 1.33 1.59 2.54 3.02 1.12 0.02 2.27 3.68 
C4 8.48 --- 8.16 8.33 5.78 8.32 7.88 2.77 1.40 1.63 2.58 3.05 1.17 0.09 2.33 3.80 
∆δ 0.31 --- 0.18 0.02 0.08 0.02 0.01 0.08 0.07 0.04 0.04 0.03 0.05 0.07 0.06 0.12 
C5 --- 7.28 7.68 7.68 5.69 8.12 7.9 2.93 1.45 1.77 2.64 3.1 1.12 0.14 2.56 4.26 
∆δ --- -0.12 -0.30 -0.63 -0.01 -0.18 0.03 0.24 0.12 0.18 0.1 0.08 0.00 0.12 0.29 0.58 
C6 --- 7.35 7.71 7.71 5.69 8.1 7.91 2.92 1.45 1.75 2.63 3.12 1.21 0.14 2.57 4.26 
∆δ --- -0.05 -0.27 -0.60 -0.01 -0.20 0.04 0.23 0.12 0.16 0.09 0.10 0.09 0.12 0.30 0.58 
table 8: comparison of the chemical shifts of C2[51] and C4, C5 and C6. 
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chart 9: numbering of the ligand L13. 
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figure 47: 1H-NMR-spectra of the ligand L13 and its copper(I)-complex C5. 
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The electrospray mass spectrum of C2 does not show a peak corresponding to the 
hexanuclear species, which is in contrast with the X-ray analysis (figure 48)[111]. 
Only peaks of the penta- ([Cu5L395]PF64+ at 869.4 and [Cu5L395](PF6)23+ at 1207.4), 
tetra- ([Cu4L394]PF63+ at 936.6) and trinuclear ([Cu3L393]PF62+ at 1071.8) species 
could be observed (figure 48). Peaks corresponding to CuL39+ ( =ˆ [CunL39n]n+ at 
666.5) and [CuL392]+ (at 1270.6.5) are also present. These results are in accordance 
with the concentration dependence observed for the silver(I)-complexes. At low 
concentration several species with different nuclearities, but mostly with the  
ligand/metal ratio of  1:1 are in equilibrium. 
2+ 
3+ 
3+ 4+ 
[CuL2]+ 
[CunLn]n+ 
 
figure 48: ESI-MS of C2[111] 
 
A similar behaviour was observed for the complexes C4, C5 (figure 49) and C6. In 
each case, the major peak [CuL]+ (the isotopic pattern show again the superposition of 
several charged species [CunLn]n+) and the peaks corresponding to [CuL2]+ and 
[Cu2L]2+ are present (table 9). The pentanuclear species can be observed in each case, 
whereas peaks of the tetranuclear complex in C4 and the trinuclear complex in C4 and 
C6 are present. The ESI-mass spectra were recorded at different concentrations (not 
determined), which could explain the absence of some peaks in several spectra. But it 
is apparent, that at low concentration several species are in equilibrium. 
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 [Cu5L5]X4+  [Cu5L5]X23+  [Cu4L4]X3+ [Cu3L3]X2+  [CunLn]n+  [CuL2]+  [Cu2L]2+  
C2 869.4 1207.4 936.6 1071.8 666.5 1270.6 --- 
C4 1134.4  1560.9  1219.8 1390.0 879.4  1693.8  470.2  
C5 1133.4  1560.6  --- --- 879.4 1691.8 470.12 
C6 1048.0 1430.50  --- 1277.5 817.38  1573.6  441.2 
 For the complexes C2,[111]1 C4 and C5 the counterions X- is PF6-, for C6 ClO4-. 
table 9: peaks observed in the ESI-mass spectroscopy for the complexes C2, C4-C6. 
 
 
 
 
 
 
 
2+ 
3+ 4+ 
[CuL2]+ 
[CunLn]n+ 
[Cu2L]2+ 
HL+ 
 
figure 49: ESI-MS of C6. 
 
 
2.1.4 Characterization of the complexes C3 to C6 (UV/Vis- and CD) 
With the knowledge, that several species are in equilibrium at low concentration, the 
UV/Vis and CD-spectroscopy should be interpreted with caution. Several species can 
be in equilibrium at the concentration used for UV/Vis and CD-spectroscopy. The 
UV/Vis spectra are similar (εmax at similar λ) to those of the free ligands (figure 50). 
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figure 50: UV/Vis spectra of C3, C4 and C5. 
 
The MLCT band for C4, C5and C6 was not observed due to low concentration of the 
solutions. 
From the CD-spectra, the configuration at the metal centres can be assigned (figure 
51). The bands around 345 nm for C3 and C4, around 317 nm for C5 and around 306 
nm for C6 are in the positive range. The exciton coupling theory predicts for this effect 
an absolute configuration Λ, which is in line with the configuration found in the crystal 
structure of C2. [51] 
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figure 51: CD-spectra of C3, C4 and C5. 
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2.2. Complexes with CHIRAGEN[0]-derivatives 
 
2.2.1 Synthesis 
The [5,6]-CHIRAGEN[0] is designed for the formation of mononuclear complexes, as 
metal cations can fit into the cavity, which is defined by the two pinene-bpy units. 
Complexes C8 and C9 are synthesised by adding a solution of AgPF6 in acetonitrile to 
an equimolar solution of the ligands L16 and L18 in mixtures of chloroform and 
acetonitrile. After stirring the solution for several minutes, the solvent was removed 
and the solid obtained in a nearly quantitative yield was analysed without further 
purification. 
 
 
2.2.2 NMR-spectroscopy 
The 1H-NMR-spectra of both complexes C8 and C9 show symmetrical species, the 
C2-symmetry of the ligand is not broken and therefore the silver(I)-complexes are still 
C2-symmetric (figure 52b). The broad signals (protons 3’, 7 and 9a) in the free ligand 
(see figure 52a) become sharper upon complexation, indicating that the conformation 
of the ligand is fixed. 
Compared to the published complex C7[60], only slight changes in the chemical shifts 
are observed (table 10). In complex C8, the signals of the protons 6’ and 4’ are 
influenced by the methoxy-phenyl group attached to 5’ and show a slight difference of 
the chemical shift as compared to C7.  
In complex C9, proton 5’ nearby the methoxy-phenyl group shows a similar 
behaviour. Other differences can be explained by the geometry of the complex. The 
6’-substituents are pointing towards the metal centre. Therewith it influences strongly 
the second ligand coordinated to the same centre. This phenomenon has already been 
observed for the analogous hexanuclear species. Furthemore, the protons of the 
methoxy-phenyl group are shifted to high field (∆δ = 0.76 ppm for 8’, ∆δ = 0.54 ppm 
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for 9’) as compared to the free ligand (also observed in the hexanuclear species, figure 
47). 
 
 
 
 
 
 
 
6’        3’/4’ 3  9’  4    8’   
13’                                  *      12           13 
7                  10 9b  8                 9a 
13’                                            12      13 
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figure 52: 1H-NMR of the free ligand L16 and its complex C8. 
 
 6' 5' 4' 3' 3 4 7 8 9a 9b 10 12 13 
C7 8.76 7.57 8.06 8.19 7.93 7.58 3.98 2.61 1.47 2.81 2.94 1.35 0.56 
C8 8.98 --- 8.21 8.21 7.99 7.55 4.10 2.61 1.51 2.85 2.98 1.40 0.63 
∆δ 0.22 --- 0.15 0.02 0.06 -0.03 0.12 0.00 0.04 0.04 0.04 0.05 0.07 
C9 --- 7.79 7.95 8.16 8.15 7.52 4.08 2.6 1.46 2.81 3.01 1.39 0.65 
∆δ ---  0.22  -0.11  -0.03  0.22  -0.06  0.10  -0.01  -0.01  0.00 0.07  0.04  0.09  
table 10: comparison of the chemical shifts of C7, C8 and C9. 
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2.2.3 ESI-mass-spectroscopy 
The electrospray mass spectra of both complexes (C8 and C9) is in accordance with 
the observations from the NMR-experiments (figure 53). For both complexes the main 
peak corresponds to the mononuclear species AgL+. The isotopic pattern of these 
peaks are almost identical to the calculated one (figure 54). 
 
 
figure 53: ESI-MS of complex C9. 
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figure 54: calculated (left) and measured (right) isotopic pattern at 819.27 of C8. 
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2.2.4 UV/VIS- and CD-spectroscopy 
From the CD-spectra measured in acetonitrile the absolute configuration can be 
attributed to ∆ (negative effect of the exciton couplets at 337 nm, figure 55). While 
ligand L16 already show intenses CD-activity (figure 42) assuming a similar structure 
as in the complex by π-π-stacking, complex C9 shows a much larger CD-effect than 
the free ligand L18, which implies a conformation change. The corresponding UV-
spectra are shown in figure 56. 
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figure 55: CD-spectra of C8 and C9. 
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figure 56: UV/Vis spectra of C8 and C9. 
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3. Protonation Studies 
 
 
The ability of L15 (chart 10) to form mononuclear complexes with several metal 
cations has been well studied in our group.[60,111]  Cations such as Ag(I), Pd(II), 
Cu(II) and Zn(II) fit into the cavity defined by both pinene-bpy-units. Ligand L15 
wraps around the metal in a helical fashion. This was the motivation to investigate the 
protonation behaviour of the ligand L15. Can the proton, as smallest cation, act as a 
complexing agent and fix the conformation of the ligand? If the ligand can be fixed in 
one conformation, does it correspond to a helical conformation comparable to that one 
in metal complexes?  
In order to understand the protonation behaviour of L15, an extended study was 
carried out not only for L15, but also for bpy, L1, L19 and L20 (chart 10).  
N
N
N
N
N
N
N
N
N
N
N
N
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L1
L15 L20L19
H
H
H
H
H
H
 
chart 10: ligands used for extended protonation studies. 
 
Since ligand L1 has a similar structure to bpy, similar protonation behaviour should be 
observed and was used as a reference for the latter ones (L15, L19 and L20).  
L15 and L20 have similar structures, both consist of two directly linked pinene-bpy-
moieties. While in L15 all four nitrogen donor atoms can point into the cavity and 
therefore can bind cations in this cavity, the nitrogen atoms in L20 are arranged to be 
outside this cavity and both bpy units react independently. 
L19 with its two dimethylamino-functions was designed as analogue to the proton 
sponge (1,8-bis-(dimethylamino)-naphthalene, scheme 7) and it should show a more 
pronounced basicity than the ligands containing two bipyridine moieties (L15 and 
L20). (pKa –values of py, bpy , trimethylamine (TMA) and the proton sponge (PS) are 
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pKa(py) = 5.3;[112] pKa(bpy) = 4.5;[113] pKa(TMA) = 9.8[112] and pKa(PS) = 
12.4[66]). 
The methods to study the protonation behaviour were spectrophotometric titration’s 
(UV/Vis and CD-spectroscopy) and NMR-experiments. In the latter, several nuclei 
were the object of the observation. 1H-NMR were used to gain an initial insight into 
the protonation behaviour. The use of NMR-inverse-detection techniques allowed the 
observation of other nuclei (13C, 15N), obtaining results in a reasonable time and with 
small amounts of product. 
 
 
3.1. Protonation behaviour of [5,6]-pinene-bpy (L1) and bpy 
 
First of all, [5,6]-pinene-bpy (L1) and bpy will be discussed. Both ligands contain two 
nitrogen donor atoms, which can be protonated. From bpy it is known, that the first 
protonation changes the conformation from trans to cis. The proton is shared between 
both nitrogens.[114-116] The second protonation leads again to a trans-conformation. 
The pKa-value for the mono–protonated bpy in water is pKa = 4.5, but varies 
depending on the percentage of organic solvents in aqueous solution and the ionic 
strength.[113,115,117-127] The UV-spectra of bpy and [5,6]-pinene-bpy (L1) were 
measured in 60% (v/v) methanol/water solution with an ionic strength of 0.1M (NaCl). 
Hydrochloric acid was used as proton source (figure 57). Since both ligands show 
similar behaviour upon protonation, only L1 will be discussed. 
 
figure 57: UV/Vis spectra L1 upon protonation. 
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The UV-spectrum of the free ligand L1 shows an absorption maximum at 293 nm 
(figure 57). Upon protonation a bathochromic shift appears (from 293 nm to 312 nm). 
An analogous phenomenon was described for bpy in several 
publications.[114,115,127-130] The UV-spectra were recorded in a pH-range from 10 
to 2, in which only mono-protonated species can be formed.[113-115] The pKa were 
calculated with the programme Specfit. (pKa = 3.9±0.1 for bpy; pKa = 4.2±0.1 for L1), 
which is in accordance with the literature.[126] 
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figure 58: 1H-NMR-titration of L1. 
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The NMR protonation studies were carried out for L1. A 1H-NMR-spectrum was 
recorded after each addition of 0.1 equivalent of the trifluoroacetic acid solution to the 
ligand L1 (figure 58).  
Large shifts in the spectra were observed until the addition of two equivalents of acid. 
Only the aromatic protons show a remarkable shift, whereas the aliphatic ones are 
almost uninfluenced (complete spectra shown in the Appendix). The signals of the 
protons in para-position (4, 4’) with regard to the nitrogen and in meta-position (5’) 
show similar downfield shifts (figure 58). Proton 6’ in ortho-position shows a less 
pronounced downfield shift. The protons 3 and 3’ in meta-positions show initially a 
slight downfield shift but afterwards they return to their original position. 
The chemical shifts of the carbons were recorded by indirect detection (1H-13C-HMQC 
for the short range couplings 1JC,H and 1H-13C-HMBC for long range couplings 2JC,H to 
4JC,H). Knowing from the 1H-NMR that only the aromatic protons show remarkable 
shifts upon protonation, the 13C-spectra were recorded in the region from 100-170 
ppm. Due to the much larger acquisition times for 2D-spectra, measurements were 
recorded after additions of 1.0 equivalents of the acid solutions.  
All signals corresponding to carbons, which are in para- or in meta-position (3, 3’, 4, 
4’, 5 and 5’) with regard to the nitrogens showed downfield shifts upon the addition of 
two equivalents of acid (figure 59). Further additions of acid did not influence the 
chemical shifts further. Carbons in ortho-positions were shifted upfield (2, 2’ and 6’) 
or remained at the same chemical shifts (in case of 6). 
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figure 59: 13C-chemical shifts of L1 upon protonation. 
 
Finally, the most important information about protonation can be obtained by the 
observation of the chemical shift of 15N. 1H-15N-HMBC were recorded either on a 700 
MHz Bruker Avance DRX spectrometer‡‡, which allowed these 2D indirect-detection 
experiments to be measured in a short time, or on a 400 MHz Bruker Avance DRX 
with the 15N-labelled product 15N-L1. 
The chemical shifts of the nitrogens in the free ligand are at –77 and –72 ppm for N(A) 
and N(B) respectively (nitromethane used as reference). They are shifted upfield (–134 
ppm) upon protonation (figure 60). 
                                              
‡‡ These measurements were carried out at Bruker Biospin in Fällanden. 
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figure 60: 15N-chemical shifts of L1 upon protonation. 
 
All these observations lead to the following conclusion: The free ligand L1 and the 
mono-protonated species are in equilibrium upon protonation, as it can be seen in the 
UV-spectra (figure 57). The mono-protonated form is stabilised in the cis-
conformation of the ligand by hydrogen bonding (scheme 28) and the proton is shared 
between both nitrogens, which is in accordance with the 15N-experiments (figure 60). 
 
N
N
NN
H
+H
-H
 
scheme 28: equilibrium between L1 and its mono-protonated form HL1+. 
 
This is in accordance with the bathochromic shift observed in the UV-spectra. This 
bathochromic shift can be explained as follows. Although the free ligand is mostly in 
the trans-conformation, it can rotate around the bond between both pyridine rings. 
Therefore in the experimental time scale, the aromatic system is not conjugated over 
both rings. Upon protonation the coplanar cis-conformation is stabilised and π-
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conjugation through both pyridine rings occurs (scheme 29).[115] Therefore the 
energy difference of the π-π*-transition is reduced, and a red-shift is observed. 
N N
H
N N
H
N N
H  
scheme 29: π-conjugation of the mono-protonated bpy.[115] 
 
By analysing the NMR-spectra, it is not easy to determine if L1 is protonated once or 
twice upon the addition of two equivalents of acid. Nevertheless, it should be taken 
into account, that the solvent is not water and therefore the acid/base behaviour 
changes. In water TFA is a strong acid (pKa = -2), but in acetonitrile (a protophobic 
solvent) this behaviour changes dramatically. TFA with a pKa of 12.65, in acetonitrile, 
is no longer a strong acid and it is less acidic than the protonated pyridinium cation 
(pKa = 12.33).[131] In addition, TFA forms with its conjugated base a dimeric species 
(HA2-).§§ In the solvent used in the present investigation (CHCl3/CH3CN: 3/1) the acid 
strength of TFA is probably even lower. Therefore, the protonation of L1 follows the 
equilibrium: 
2 HA + L1 HL1 +    H(A)2  
 
This is in agreement with all NMR-titrations, where always two equivalents of TFA 
were needed to reach the mono-protonated species. 
The conclusion with a mono-protonated species in a cis-conformation is in line with 
the 15N-NMR-spectra. The identical chemical shift of both nitrogen atoms is consistent 
with a sharing of the proton between them (scheme 30).  
NN
H
NN
H
 
scheme 30: sharing of the proton between both nitrogen donor atoms in L1. 
 
                                              
§§ Equilibrium constant of the dimerisation in acetonitrile is logKf(HA2-)= 3.88.[131] 
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From the 1H-NMR-spectra it can be seen, that the protons in meta (5’)- and para (4, 
4’)-positions are influenced strongly upon protonation, whereas proton 6’ undergoes 
only a slight downfield shift (figure 58). This is in accordance with the chemical shifts 
observed for pyridine and its protonated form. [132] The exceptions are represented by 
proton 3 and 3’. The expected downfield shift upon protonation is cancelled by other 
effects. The conformational change can be a explanation, since 3’ and 3 are influenced 
by each other in the cis-conformation. 
In the 13C-spectra, the carbons in meta- and para-position are shifted to low field, 
these in ortho-position to high field (figure 59). This is as well in accordance with 
observations for pyridine and the pyridinium cation. [133] 
 
 
3.2. Protonation behaviour of [4,5]-CHIRAGEN[0] (L20) 
 
Ligand L20 represents an analogous case to the [5,6]-pinene-bpy (L1), which consists 
of two [4,5]-pinene-bpy moieties linked directly together. The four nitrogen donor 
atoms of both bpy-units are orientated in such a way, that the formation of 
mononuclear complexes is inhibited (chart 10, p.78). The protonation behaviour is 
expected to be similar to that of the [5,6]-pinene-bpy (L1). No intramolecular proton 
transfer between the two bpy units can take place and therefore each bpy-unit will be 
independently protonated. In addition to the techniques (UV/Vis and NMR-
spectroscopy) used for [5,6]-pinene-bpy (L1), CD-spectroscopy was performed to 
study the protonation behaviour. 
The spectrophotometric titration’s were carried out under the same conditions as those 
described for the [5,6]-pinene-bpy (L1). Only the solvent mixture was changed to 
methanol/water (90% v/v) because of solubility reasons. The UV-spectra (figure 61) 
show a bathochromic shift from 288 nm for the free ligand to 312 nm in the protonated 
species. In the pH-range of 10 to 1.5, L20 can be protonated twice.  
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figure 61: UV-spectra of the free ligand L20 and its protonated species. The arrows indicate 
spectral changes upon protonation. 
 
 
The CD-spectra of L20 show as well an analogous bathochromic shift (from 295 for 
the free ligand to 324 nm for the protonated species). The nature and the intensity of 
the CD-signals do not change upon protonation. 
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figure 62: CD-spectra of the free ligand L20 and its protonated species. 
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figure 63: 1H-NMR-titration of L20. 
 
The 1H-NMR-titrations were carried out in the same manner as for [5,6]-pinene-bpy 
(L1). After each addition of the acid solution which corresponds to 0.2 equivalents, a 
1H-NMR-spectrum was recorded (figure 63). After 3 equivalents, the addition were 
made in 1.0 equivalent steps.  
The 1H-NMR-spectra do not show any doubling of the signals, ligand L20 keeps its 
C2-symmetry upon protonation due to the fast proton exchange between both bpy units 
on the NMR time scale. Large changes in the spectra can be observed upon the 
addition of 4-5 equivalents of acid (figure 64), mostly in the aromatic part (complete 
spectra shown in the Appendix). The proton in para-position (4’, ∆δ = 0.39 ppm) and 
in meta-position (5’, ∆δ = 0.40 ppm) are shifted downfield upon protonation. The 
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protons in ortho-position (6, ∆δ = 0.19 ppm; 6’, ∆δ = 0.17 ppm) show a less 
pronounced downfield shift, but proton 6 is more influenced upon protonation (firstly, 
to lowfield and then back to highfield). Proton 3’ (meta-position) remains at the same 
chemical shift (∆δ = 0.11 ppm), whereas 3 is slightly shifted to low field (∆δ = 0.27 
ppm). The proton at the bridge (7) show a slight high field shift upon protonation (∆δ 
= 0.28 ppm, cf. Appendix). 
 
7
7.2
7.4
7.6
7.8
8
8.2
8.4
8.6
8.8
0.0 1.0 2.0 3.0 4.0 5.0 6.0
eq. CF3COOH
δ [
pp
m
] 6'
3
3'
6
4'
5'
N
N
N
N
2
3
4
5
6 7
8
9
10
12 13
2'
3'
4'
5'
6'
H H
 
figure 64: 1H-chemical shifts of L20 upon protonation. 
 
The inverse detected 13C-experiments reveal, that all carbons in meta- and para-
position are shifted to lowfield, the carbons in the ortho-postion are shifted highfield. 
Carbons 6’ show a less pronounced highfield shift as compared to the other ones 
(figure 65). 
From the 1H-15N-HMBC-experiment, the chemical shifts of the nitrogens can be 
determined (figure 66). Both nitrogens of the two bpy-moieties show a large shift to 
high field. The nitrogen N(A) (up to –158 ppm) is more influenced than N(B) (up to    
–112 ppm). 
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figure 65: 13C-chemical shifts of L20 upon protonation. 
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figure 66: 15N-chemical shifts of L20 upon protonation. 
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All these observations lead to the following conclusion: Upon protonation, the free 
ligand and the diprotonated species are in equilibrium. Both bpy units of the 
diprotonated species are in the cis-conformation. This protonation takes place via 
several other equilibria, where mono-protonated species can be present (scheme 31).  
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scheme 31: equilibria between L20 and its protonated forms. 
 
This is in accordance with the UV/Vis- (figure 61) and CD-measurements (figure 62), 
where no intermediate spectrum can be attributed to a mono-protonated form. The 
bathochromic shift in the UV-spectra (figure 61) and also in the CD-spectra (figure 62) 
can be explained by the cis-conformation of both bpy-moieties (analogous to [5,6]-
pinene-bpy (L1), figure 57). The protonated ligand retains in a similar conformation as 
the free ligand (open form), since the intensity and the nature of the CD-signal does 
not change. If L20 did change the conformation, which is comparable to metal 
complexes described with L15 [60,111] a similar large CD-signal should appear, due 
to a strong exciton coupling. 
The information obtained from the NMR-experiments supports the conclusion. As in 
the previous case (L1), twice the number of acid equivalents are needed, due to the 
formation of the relatively stable dimer: 
4 HA + L20 H2L20 +    2 H(A)2
2
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The 15N-experiments indicate that the acidic proton is favourably located on the 
nitrogen N(A) (larger shift to high field, figure 66). But a sharing of the proton 
between the nitrogens N(A) and N(B) can be taken into account. (scheme 32).  
This is in agreement with the 1H-NMR, where the protons 3 and 6 show a more 
pronounced shift compared to 3’ and 6’.  
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scheme 32: equilibrium of two diprotonated species. 
 
The similarities of the proton and carbon-spectra for L20 and L1 support the model, 
where each bpy unit is independently mono-protonated. No intramolecular proton 
exchange between both bpy units of L20 is observed.  
 
 
 
3.3. Protonation behaviour of [5,6]-CHIRAGEN[0] (L15) 
 
L15 is the most interesting case of all three pinene-bpy derivatives. Its geometry 
allows a proton exchange between both bpy-moieties and therefore a particular 
protonation behaviour is expected. 
L15 is the least soluble of all pinene-bpy derivatives. In the solvent mixture used for 
L1 and bpy (methanol/water 60% v/v), it was impossible to dissolve L15. The solvent 
mixture used for UV/Vis and CD-titration was methanol/water (90% v/v). But also for 
NMR-measurements solubility problems occurred. The free ligand is only soluble in 
chloroform, the protonated species in acetonitrile. A solvent mixture (CDCl3, CD3CN; 
3:1) was finally used for these NMR-investigations. 
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In spectrophotometric titrations, two different protonation steps could be observed. In 
the UV-titration (figure 67), a hypochromic effect appears upon the first protonation, 
but with the addition of more acid a bathochromic effect leads to the final spectrum. 
All these spectra were fitted with the programme Specfit and the pKa values were 
calculated (pKa1 = 8.2±0.1, pKa2 = 2.5±0.1 (methanol/water 90% v/v). 
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figure 67: UV-spectra of the L15 and its mono- and diprotonated species. The arrows indicate 
spectral changes upon protonation. 
 
An interesting effect was observed in the CD-spectra (figure 68). While the free ligand 
shows only slight CD-activity, a large intensity increase is observed upon protonation.  
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figure 68: CD-spectra of L15 and its mono- and di-protonated species. 
 
The second protonation leads to the bathochromic shift, which was already observed in 
the UV-spectra. The CD-signal does not change its intensity upon the second 
protonation. Analogous UV- and CD-spectra were observed for the same solvent 
mixture and acid (TFA) used in the NMR-spectroscopy. 
The 1H-NMR-titrations (and all other NMR-experiments) were carried out in the same 
manner as described previously. The 1H-NMR-spectra (figure 69) do not show a 
doubling of the signals. Ligand L15 keeps its C2-symmetry upon protonation due to 
the fast proton exchange between both bpy-moieties on the NMR time scale. Two 
opposite trends are observable in the 1H-NMR-titrations (figure 69). Up to the addition 
of two equivalents, most of the proton signals are shifted upfield. An opposite effect 
leads to a low field shift of these protons by adding six equivalents of acid. These 
protons are 6’, 5’, 4’, 3’ and 7. Proton 4 shows the opposite shift (first to low field and 
then back to high field). The broad signals of the protons 3’, 7 and 9a in the free ligand 
sharpens upon protonation (complete spectra shown in the Appendix). 
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figure 69: 1H-NMR-titration of L15. 
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figure 70: 13C-chemical shifts of L15 upon protonation. 
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figure 71: 15N-chemical shifts of L15 upon protonation. 
 
The most important and significant experiments were again the indirect detected 1H-
15N-HMBC-experiments (figure 71). The two nitrogen atoms N(A) and N(B) show 
quite different behaviour. While the signal of the nitrogen N(A) is first shifted to 
highfield  (-125 ppm) the second signal corresponding to N(B) is not influenced upon 
the first protonation. 
The opposite effect occurs in the second protonation step. N(B) is shifted dramatically 
to highfield (∆δ = -164 ppm), whereas N(A) is slightly shifted back to low field (∆δ = 
-107 ppm). 
All these observations lead to the following conclusions: The first protonation leads to 
a change of the conformation of the ligand (closed form). The second protonation does 
not influence this closed conformation, but leads to the cis-conformer of both bpy units 
(scheme 33).  
This is consistent with the UV-spectra (figure 67). The first protonation leads only to a 
slight hypochromic effect. The pyridine rings B can still freely rotate and therefore no 
π-conjugation over both pyridine rings of each bpy unit is taking place. The large 
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change in the CD-activity upon the first protonation is due to a strong exciton coupling 
(figure 68). Similarly, this exciton coupling is observed in the metal complexes with 
L15, where the cation is fixed in the cavity of the ligand. The proton is therefore able 
to play a similar role, as the metals. 
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scheme 33: conformation change of L15 upon protonation. 
 
In contrast to the metal complexes, where the cations are bound to all four nitrogen 
donor atoms, the proton is only bound to the two N(A) nitrogen atoms near to the 
bridge. This can be explained by the large chemical shift of N(A) in the 15N-
experiment, whereas N(B) is not influenced by this proton. Both nitrogen atoms N(A) 
share the proton. 
1H-NMR-spectra are in accordance with the explanation described above (figure 69). 
Protons 4 and 3, attached to the pyridine ring (A), where the first protonation occurs,  
show comparable influences as these of the previously studied ligands L1 and L20. 
Proton 4 is shifted lowfield (cf. proton 4 of L1 in figure, and proton 4 of L20 in 
figure), whereas proton 3 remains unchanged. The protons of the unprotonated 
pyridine rings are shifted to highfield, which can be explained by the conformation 
change to the closed form. Another indication for a fixed conformation is given by the 
protons 3’, 7 and 9a. All these signals are broad in the free ligand and give sharp 
signals upon protonation. 
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The second protonation leads to the cis-conformation of the bpy moieties 
(bathochromic shift in the UV- (figure 67) and CD-spectra (figure 68)). The bpy-
moieties are now conjugated through both pyridine rings in a similar way as already 
seen in L1 (figure 57) and L20 (figure 61). The conservation of the large CD-intensity 
can be explained by an analogous conformation as in the mono-protonated species. 
Despite of an expected strong electronic repulsion of the two positive charges in the 
cavity, no reopening of the ligand occurs. One reason could be the distribution of the 
positive charges by π-conjugation (scheme 29). 
The 15N-chemical shifts show a strong highfield shift of N(B) upon the second 
protonation. The slight shift to low field of N(A) can be explained by a small 
participation of N(B) at the proton mainly bound to N(A). This is another reason for 
the cis-conformation of the bpy-moieties (scheme 33). 
A second proton distribution II can be taken into account, where the two protons are 
bound in the cavity (scheme 34).  
NN
N
N HH
NN
N
N H
H
22
I II
 
scheme 34: two possible proton distribution in the closed form of L15. 
 
This distribution II would lead to a sharing of the two protons over all four nitrogen 
atoms (the same chemical shift of N(A) and N(B) is expected (table 11). From the 
chemical shifts observed in 15N-experiments, the following distribution of the two 
protons can be assumed (table 11), which is in line with the proposed one (I). 
The protons of the pyridine ring B (3’, 4’, 5’ and 6’) are downfield shifted upon the 
second protonation (figure 69). This is in accordance with the 15N-experiments, where 
nitrogen B is strongly downfield shifted (figure 71). The protons in ligand L1 (figure 
58) and L20 (figure 63) behave in a similar way. Proton 4 is slightly shifted back to 
high field (figure 69), which is in line with the chemical shift of nitrogen N(A)(figure 
71).  
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I II 
N(A)1: 0.4 N(A)2: 0.4 N(A)1: 0.5 N(A)2: 0.5 
N(B)1: 1.0 N(B)2: 0.2 N(B)1: 0.5 N(B)2: 0.5 
table 11: estimated distribution of the two proton. 
 
 
3.4. Protonation behaviour of {2-DAMI}-[5,6]-CHIRAGEN[0] (L19) 
 
L19 was designed as a combination of the previously described [5,6]-CHIRAGEN[0] 
(L19) and the proton sponge (1,8-bis-(dimethylamino)-naphthalene, scheme 35). The 
skeleton of the [5,6]-CHIRAGEN[0] is represented in the pinene-py-units and the 
dimethylamino-function should provide a higher basicity. 
 
N
N
N
N N NN N
N NL19L15
A
B
 
scheme 35: L19 as combination of L15 and the proton sponge. 
 
While the CHIRAGEN[0] derivatives (such as L15 and L20) consist of two 
chromophors (bpy-units), which lead to exciton couplings in the CD-spectra, no 
information about the conformation can be obtained for L19 from UV- and CD-
spectroscopy, because of the lack of suitable π-π*-transitions. Therefore only NMR-
studies gave some information about the protonation behaviour of L19. 
The NMR-titrations were recorded in the same manner as for the other ligands. Due to 
even lower solubility, the solvent mixture was changed (CDCl3/ CD3CN : 5/1).  
In the 1H-NMR-titration, not only the aromatic protons are shifted, but also the 
aliphatic ones show some changes upon protonation. In the aromatic part two trends 
are observable. Both protons (3 and 4) are shifted downfield upon the addition of two 
equivalents of acid (figure 72). Then proton 3 is shifted back to high field, whereas 
proton 4 is still shifted downfield. The protons 7 and 9a are broad in the free ligand and 
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sharpen at the addition of around 4 acid equivalents (figure 73). The other aliphatic 
protons of the pinene system are not significantly shifted upon addition of acid. The 
methyl groups attached to N(B) and to carbon 2’ show large changes upon protonation. 
The methyl groups at N(B) show a sharp singlet at 2.07 ppm in the free ligand. This 
signal is shifted to lowfield and is split after the addition of almost two equivalents of 
acid, indicating the fixing of the nitrogen inversion. The splitting can be attributed to 
the diastereotopicity of the methyl groups at the protonated aliphatic nitrogen. No 
significant change is observed afterwards. Two broad signals were observed for the 
other two methyl groups (at C(2’)). By adding acid, these signals merge to a broad 
singlet, which is shifted to lowfield. After addition of two equivalents no further 
changes of the chemical shifts is observed, but they split into two sharp singlets at 
about four equivalents (figure 73). 
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figure 72: aromatic protons of L19. 
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figure 73: aliphatic protons of L19. 
 
The low solubility of L19 poses a problem for the measurements of the 2D-inverse 
experiments. The acquisition time was kept short, so that no precipitation could occur 
during the acquisition time. Therefore not all signals (especially the broad ones) could 
be observed for each measurement. 
While in the 1H-NMR-titrations, no significant variation after one equivalent could be 
observed, the chemical shifts for the aromatic carbons (figure 74) are changing 
significantly. 
1H-15N-HMBC-experiments were recorded twice. Once in the range of –50 ppm to       
–100 ppm for the pyridine nitrogen N(A) and once in the range of –300 ppm to –350 
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ppm for the tertiary amine N(B). N(A) shows only a slight downfield shift upon 
protonation (figure 75). 
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figure 74: chemical shifts of the aromatic carbons of L19 upon protonation. 
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figure 75: chemical shift of N(A) upon protonation. 
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A correlation to the amine nitrogen was only observed at 0.0 equivalents of acid (δ = -
340 ppm) and then again at four equivalents (δ = -325 ppm). In between, the signals of 
methyl groups are too broad (cf 1H-NMR, figure 73) and a much longer acquisition 
time would be needed to observe the correlations (even on the 700 MHz spectrometer).  
The information of all these NMR-titrations was not sufficient to give a complete and 
final conclusion. Even tough, it seems to be evident, that the two dimethylamino-
functions are protonated after addition of two equivalents of acid (scheme 36). The 
dimethylamino function is much more basic than pyridine and bpy and can even be 
protonated by TFA. After the addition of two equivalents the protonation is complete. 
This is indicated by the splitting of the corresponding signals (N-inversion is 
inhibited). Although the 1H-15N-correlation at two equivalents was not observed, the 
chemical shift at four equivalents (δ = -325 ppm) indicates strongly this protonation. 
Chemical shifts of analogous amines and their protonated species are given in table 12 
and are comparable. 
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scheme 36: protonation of the dimethylamino groups. 
 
The original reason for the design of this ligand was the binding of a proton  between 
the two dimethylamino-functions. The pronounced change of the 13C-chemical shifts 
at one equivalent of acid could be an indication of such a closed form (scheme 36). In 
contrast to that is the continuous shift of the proton signals up to two equivalents. No 
special effect at one equivalent could be observed. Therefore it cannot be proven, if the 
mono-protonated species is in a closed or in an open conformation. 
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R N
 
Amine 
δ15N (ppm/CH3NO2) 
Hydrochloride 
δ15N (ppm/CH3NO2) 
CH3 -363.1 -349.4 
C2H5 -315.3 -340.0 
n-C3H7 -352.8 -340.9 
(CH3)2CH -347.5 -333.7 
n-C4H9 -352.8 -340.9 
CH3CH2-CH(CH3) -349.6 -333.6 
(CH3)2CH-CH2 -354.8 -342.3 
(CH3)3 -339.8 -326.5 
CH3)2CH-CH2-CH2 -352.9 -340.8 
CH3CH2-C(CH3)2 -344.9 -326.7 
table 12: tri-substituted amine and the corresponding hydrochlorides.[143] 
 
The sharpening of the protons 7 and 9a and the splitting of the methyl groups at C(2’) 
at four equivalents is an indication of a fixed conformation (figure 73). 15N-shifts of 
the pyridine nitrogen atoms are not very pronounced, a complete protonation does not 
occur. Whether it adopts a closed conformation or a fixed open conformation cannot 
be determined. 
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scheme 37: possibilities for a third protonation. 
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4. Conclusion 
 
A series of new enantiopure pinene-bpy derivatives L3-L9 were synthesised and fully 
characterized. The {6’-bromo}-pinene-bpy derivatives L5 and L6 are important key 
molecules for the synthesis of other 6’-substituted pinene-bpy ligands. They are 
available from these key molecules in one step via Suzuki cross-coupling reactions. 
A combination of the pinene-bpy moiety and the proton sponge lead to ligand L10, 
which consists of a pinene-py-unit and a dimethylamino-function. 
With the ligands L3 to L10 new tetradentate ligands were synthesised in one step. 
These CHIRAGEN derivatives can be divided into two families. In the first one, both 
pinene-bpy moieties are linked together via an bridge such as p-xylyl or m-xylyl 
giving the CHIRAGEN[bridge] derivatives L11-L14, in the second one, both pinene-
bpy- or pinene-N-py-moieties are directly linked giving CHIRAGEN[0] derivatives 
L16 to L19. 
 
The CHIRAGEN[p-xyl]-derivatives L11 to L13 were further used for the formation of 
hexanuclear circular helicates. The structures of these complexes were analysed in 
solution and can be attributed to circular helicates.  
Mononuclear silver(I)-complexes were synthesised from the CHIRAGEN[0]-
derivatives L16 and L18. These complexes were characterized in solution. 
 
An extended protonation study was carried out with the non-substituted ligands L1, 
L15 and L20, but also the ligand L19 was examined. 
L1 show the same protonation behaviour as bpy. Upon protonation, the free ligand L1 
is in equilibrium with its mono-protonated analogue. The mono-protonated species is 
stabilised in the cis-conformation by hydrogen bonding.  
L20 consists of two pinene-bpy moieties, which are arranged in such a way, that no 
proton exchange can take place between them. Both pinene-bpy moieties are 
independently mono-protonated upon protonation. The conformation of the ligands 
does not change considerably. 
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L15 has the ability to form helical mononuclear complexes with several metal cations. 
But not only are metal cations able to fit into the cavity of the ligand, but also a proton, 
as the smallest cation, can fix the ligand in a helical conformation. Upon a first 
protonation, the ligand changes its conformation to a closed form, where the proton is 
shared between the two nitrogen atoms near the bridge. Upon the second protonation, 
the bpy-moieties are arranged in the cis-conformation, but the ligand keeps its 
conformation in a closed form. 
L19 can be easily protonated twice due to the strong basicity of the dimethylamino-
function. The conformation of the triply-protonated L19 could not be determined. 
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 EXPERIMENTAL PART 
 
1. General 
1.1. Reagents  
Solvents and reagents were purchased from Fluka, Merck, Acros, Aldrich and Strem 
chemicals. Pyridine was dried over KOH and freshly distilled prior to use. Ammonium 
acetate was dried for several days under vacuum. Diethyl ether and THF were distilled 
from sodium/benzophenone prior to use.  
 
1.2. Measurements 
NMR spectra were recorded on a 'Varian Gemini 300' (300.08 MHz for 1H; 75.4 MHz 
for 13C) or on a 'Bruker Avance DRX400' (400.13 MHz for 1H; 100.62 MHz for 13C) 
spectrometer. Chemical shifts are given in ppm using the solvent as internal standard, 
coupling constants J are given in Hertz. The assignment of the 1H- and 13C signals was 
performed by 1H,1H-COSY, DEPT, and 1H-13C-HECTOR, 1H-13C-HMQC/HMBC-
techniques. The diastereotopic protons are generally labelled as Ha and Hb. The 
diastereotopic protons at carbon 9 of the pinene-bpy derivatives are labelled as Ha for 
the endo-oriented protons and Hb for the exo-oriented protons. The exo methyl groups 
of the pinene-moieties are assigned as 12, the endo oriented ones as 13. For the 
methoxy-phenyl derivatives, the protons 8’, 9’, 11’ and 12’ form a spin-coupling 
system AA’XX’, but are labelled as doublets with the coupling constant 3JA,X. Mass 
spectral data was acquired either on a 'VG Instrument 7070E' equipped with a FAB 
inlet system, on a Hewlett Packard 5988A quadrupol mass spectrometer with an 
electron ionization (EI) source and or on a Bruker FTMS 4.7 T BioApex II using a 
standard electrospray ion source (ESI). UV/Visible spectra were measured on a Perkin 
Elmer Lambda 40 spectrometer. Wavelengths are given in nm and molar absorption 
coefficients (ε) in M-1 cm-1. Circular dichroism (CD) spectra were recorded on a Jasco 
J-715 spectropolarimeter and the results are given in ∆ε [M-1 cm-1]. Elemental analyses 
were obtained from EIF (Ecole d'ingénieurs de Fribourg, Switzerland). X-ray 
measurements were carried out at the university of Neuchâtel, Switzerland. 
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2. Precursor syntheses 
2.1. Synthesis R,R-(+)-Pinocarvone (1) 
 
1O2
8h, RT
O
 
 
R,R-(+)-pinocarvone (1) was synthesized according to the published method of 
Mihelich et al.[71] Starting from (-)-α-pinene (52.28 g, 0.38 mole), a slightly yellow 
liquid (48.44 g; 85%) is obtained after distillation under high vacuum. The spectral 
properties of R,R-(+)-pinocarvone (1) correspond to those reported by Mihelich.[71] 
1H-NMR (300 MHz, CDCl3): δ 5.91(d, 1H, H(10a), 2J10a, 10b = 1.7 Hz); 4.95 5.91(d, 
1H, H(10b), 2J10b, 10a = 1.7 Hz); 2.71 (dd, 1H, H(1), 3J1,7b =6.0 Hz, 4J1,5 = 6.0 Hz); 2.67-
2.57 (m, 2H, H(7b), H(4)); 2.46 (dd, 1H, H(4b), 2J4b,4a = 19.2 Hz, 3J4b,5=3.1 Hz); 2.15 
(m, 1H, H(5)); 1.31 (s, 3H, H(8)); 1.24 (d, 1H, H(7a),2J7a,7b = 10.3 Hz); 0.75 (s, 3H, 
H(9)). 
O
1
4 5
7
8
9
10
C10H14O
 150.22  
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2.2. 1-(2-Acetylpyridyl)-pyridinium bromide (4) 
 
N
O Br2
N
O
Br N
O
N
Br
py
 
 
The synthesis of 1-(2-acetylpyridyl)-pyridinium bromide (4) was performed following 
the published procedure.[70] After the bromination, using acetylpyridine (36.1 g, 0.3 
mole), the intermediate bromo-compound was used without isolation to from the 
corresponding pyridinium bromide with a slightly better yield (61%) compared to the 
published method. The spectral data corresponds to the published ones[37,69,70,134] 
1H-NMR (300 MHz, DMSO-d6): δ = 9.02 (dd, 2H, H(10), 3J10,11 = 6.7 Hz, 4J10,12 = 1.3 
Hz), 8.86 (ddd, 1H, H(6), 3J6,5 = 4.7 Hz, 4J6,4 = 1.6 Hz, 5J6,3 = 1.0 Hz), 8.72 (tt, 1H, 
H(12), 3J12,11 = 7.8 Hz, 4J12,10 = 1.3 Hz), 8.27 (dd, 2H, H(11), 3J11,10 = 6.7 Hz, 3J11,12 = 
7.8 Hz), 8.12 (ddd, 1H, H(4), 3J4,3 = 7.5 Hz, 3J4,5 = 7.5 Hz, 4J4,6 = 1.6 Hz), 8.06 (ddd, 
1H, H(3), 3J3,4 = 7.5 Hz, 4J3,5 = 1.5 Hz, 5J3,6 = 1.0 Hz), 7.85 (ddd, 1H, H(5), 3J5,4 = 7.5 
Hz, 3J5,6 = 4.7 Hz, 4J5,3 =1.5 Hz), 6.51 (s, 2H, H(8)). 
 
N
O
N
Br
C12H11BrN2O
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2
34
5
6 8
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2.3. 2-Acetyl-5-(p-methoxyphenyl)-pyridine (12) 
 
O
N
Br O
N
O1) BuLi, THF
2) DMAA  
 
The introduction of the acetyl function starting from 2-bromo-5-(p-methoxyphenyl) 
pyridine (20) was carried out in similar manner as described for compound 13. [87,88]. 
2-Bromo-5-(p-methoxyphenyl)-pyridine (20) (2g, 7.6 mmole) was dissolved in dry 
diethyl ether (250 ml) under argon and cooled to –60°C,  n-butyllithium (5 ml, 1.6M in 
hexane) was added dropwise over 45 minutes. After stirring for 1 ¼ hours, N,N-
dimethylacetamide (0.75 ml, 8mmole) in diethyl ether (10 ml) was added over an hour. 
Overnight, the solution was allowed to warm to room temperature, quenched with 
saturated ammonium chloride solution and extracted five times with diethyl ether. 
Further purification was carried out by column chromatography (Hexane/ ethyl 
acetate/ trimethylamine: 8/1/0.5) yielding a white solid (1.04 g, 60 %). The spectral 
data was in accordance to the literature.[76] 
1H-NMR (400 MHz, CDCl3): δ 8.88 (d, 1H, H(6), 4J6,4 = 2.2 Hz, 5J6,3 = 1.0 Hz), 8.07 
(dd, 1H, H(4), 3J4,3 = 8.1 Hz, 4J4,6 = 2.2 Hz ), 7.94 (d, 1H, H(3), 3J3,4 = 8.1 Hz 5J3,6 = 1.1 
Hz), 7.62 (d, 2H, H(9), H(11), 3J8,9 = 8.9 Hz), 7.04 (d, 2H, H(8), H(12), 3J9,8 = 8.9 Hz), 
3.87 (s, 3H, H(13)), 2.75 (s, 3H, H(15)). 
 
O
N
O
C14H13NO2
227.26
34
6
89
11 1213 15
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2.4. 2-Acetyl-6-bromopyridine (13) 
 
NBr
O
NBr Br
1) BuLi, THF
2) DMAA
 
 
The introduction of the acetyl function starting from 2,6-dibromo-pyridine (21) was 
carried out according to the literature. [87,88,135]. 2,6-Dibromo-pyridine (21) (61.8 g, 
0.26 mol) were transformed into 2-acetyl-6-bromopyridine (13) (31.6 g, 60 %), 
purified by recrystallisation in diethyl ether / pentane. The spectral properties 
correspond to those reported. 
1H-NMR (400 MHz, CDCl3): 7.95 (dd, 1H, H(5), 3J5,4 = 7.2 Hz, 4J5,3 = 1.3 Hz); 7.65 
(dd, 1H, H(4), 3J4,5 = 7.2 Hz, 3J4,3 = 7.9 Hz); 7.63 (dd, 1H, H(3), 3J3,4 = 7.9 Hz, 4J3,5 = 
1.3 Hz); 2.69 (s. 3H, C(8)). 
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O
3
4
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2.5. 2-Acetyl-6-phenyl pyridine (14) 
 
NBr
O
N
O
B
HO OH
Pd(PPh3)4, toluene
K2CO3, water+
 
 
The synthesis was carried out according to the published method.[135] 2-Acetyl-6-
bromopyridine (13) (7.75 g, 38.74 mmole) was dissolved in dry xylene (75 ml). 
Phenylboronic acid (7.09 g, 58.11 mmole), freshly purified Pd(PPh3)4 (5% eq) and 
potassium carbonate (10.71 g, 77.48 mmole) were added, stirred for 2hours at room 
temperature. Water (500 ml) was added and the reaction mixture was extracted by 
dichloromethane (500 ml). The resulting organic layers were dried over sodium sulfate 
and the solvent was evaporated to afford, after recrystallisation in hexane/ethylacetate, 
the desired compound (6.95 g, 91%). 
1H-NMR (300 MHz, CDCl3): δ 8.03 (dd, 2H, H(8), (12)), 7.91-7.8 (m, 3H, H(3), H(4), 
H(5)), 7.44-7.38 (m, 3H, H(9), H(10), H(11)), 2.75 (s, 3H, H(14)); 
MS-EI: 197(100), 154(80), 127(25), 77(15). 
 
N
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5
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C13H11NO
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2.6. 2-Acetyl-6-(p-methoxyphenyl)-pyridine (15) 
 
N
O
O
NBr
O B
O
HO OH
Pd(PPh3)4, toluene
K2CO3, water
 
 
A mixture of 2-acetyl-6-bromopyridine (13) (2.00 g, 10 mmole), p-
methoxyphenylboronic acid (347 mg, 10 mmole), and Pd(PPh3)4 (0.2% eq, 0.02 
mmole) as catalyst, was heated at 120°C for 15 hours in a solvent mixture of toluene 
(100 ml) and an aqueous solution of K2CO3 ((50 ml, 8.5 M). After cooling to room 
temperature the two layers were separated and the aqueous layer extracted three times 
with dichloromethane. The combined organic layers were washed with water until 
pH=7 with water, dried over magnesium sulfate and the solvent was evaporated. 
Further purifications by recrystallization (ethylacetate/hexane: 1/4) yielded compound 
15 (1.45 g, 64%). 
1H-NMR (300 MHz, CDCl3): δ 8.04 (d, 2H, H(8), H(12)), 3J8,9 = 8.9 Hz); 7.89 (dd, 
1H, H(4); 3J = 6.0 Hz, 3J = 2.8 Hz); 7.83 (d, 1H, H(5) or H(3), 3J = 2.5 Hz); 7.81 (d, 
1H, H(3) or H(5) 3J = 6.0 Hz); 7.01 (d, 2H, H(9), H(11), 3J10,11 = 8.9 Hz); 3.87 (s, 3H, 
H(13)); 2.80 (s, 3H, H(15)).  
13C-NMR (75 MHz, CDCl3): 200.8 (Cq, C(14)); 160.9 (Cq); 156.2 (Cq); 153.3 (Cq); 
137.5 (CH, C(5) or C(3)); 131.1 (Cq); 128.2 (CH, C(8), C(12)); 122.7 (CH, C(3) or 
C(5)); 119.1 (CH, C(4)); 114.3 (CH, C(9), C(11)); 55.4 (CH3, C(13)); 25.8 (CH3, 
C(15)). 
MS-EI: m/z = 227 (100%); 199 (51%); 170 (58%); 142 (16%). 
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2.7. 2-N,N-Dimethylamino-2-methyl-butan-3-one (16) 
 
O
Br
HNMe2
H2O N
O
 
 
The synthesis was carried out according the published procedure by Gaset.[136] To a 
to 0 °C cooled solution of 2-bromo-2-methyl-butan-3-one (23) (10g, 0.06 mmole), 
dimethylamine (22 ml, 0.12 mmole, 5.6 M in ethanol) was added over a period of 5 
minutes. The reaction solution was stirred overnight at 0 °C, then warmed to 40 °C for 
70 minutes. After cooling to room temperature the reaction mixture was filtered and 
the residual solid was washed with cold ethanol. To the filtrate hydrochloric acid (66 
ml, 4M) was added. Ethanol was removed under reduced pressure. To the acidic 
solution, sodium hydroxide (2M) was added, until the pH > 7. The alkaline solution 
was extracted three times with diethyl ether. The combined organic extracts were dried 
over magnesium sulfate and the solvent was removed under reduced pressure. The 
desired product was obtained (5.87 g, 76%). The spectral properties correspond to 
those reported. 
1H-NMR (300 MHz, CDCl3): δ 2.18 (s, 3H, H(4)), 2.13 (s, 6H, H(6), H(8)), 1.06 (s, 
6H, H(1), H(5)).  
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2.8. 2-Amino-5-iodopyridine (18) 
 
N
I
NH2N NH2
I2, DMSO
 
 
The synthesis was carried out according to a published method.[77] 2-amino-pyridine 
(17) (10 g, 0.11 mole) and iodine (54 g, 0.21 mole) were dissolved in dimethyl 
sulfoxide (200 ml) and heated for 3h at 100 °C. Overnight, the solution was allowed to 
cool to room temperature. The excess of iodine was destroyed by addition of a solution 
of sodium thiosulfate (5%). The pH was adjusted to 4, to remove the side product (2-
amino-3,5-diiodopyridine) by extraction with diethyl ether (three times), then the pH 
was raised to 14 and the aqueous solution was extracted three times with diethyl ether, 
yielding  a pure, white product (17.4 g, 74%). The spectral properties correspond to 
those reported.[77]  
1H-NMR (400 MHz, DMSO-d6): δ 8.21 (d, 1H, H(6), 4J6,4 = 2.1 Hz), 7.61 (dd, 1H, 
H(4), 3J4,3 = 8.7 Hz, 4J4,6 = 2.1 Hz ), 6.82 (d, 1H, H(3), 3J3,4 = 8.7 Hz), 6.34 (s, broad, 
2H, NH2). 
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I
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2.9. 2-Bromo-5-iodopyridine (19) 
 
N
I
BrN
I
NH2
1) HBr (65%), Br2
2) NaNO2
 
 
The synthesis was carried out according to published methods.[79-82] Starting from 2-
amino-5-iodopyridine (18) (5.0,g 23 mmole), the desired pure product was obtained 
(3.7g, 57% ). The spectral properties correspond to those reported. 
1H-NMR (400 MHz, CDCl3): δ 8.59 (d, 1H, H(6), 4J6,4 = 2.6 Hz), 7.82 (dd, 1H, H(4), 
3J4,3 = 8.0 Hz, 4J4,6 = 2.6 Hz ), 7.29 (d, 1H, H(3), 3J3,4 = 8.7 Hz). 
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I
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2.10. 2-Bromo-5-(p-methoxyphenyl) pyridine (20) 
 
N
I
Br
O
N
Br
B
O
HO OH
Pd(PPh3)4, toluene
K2CO3, water
 
 
A mixture of 2-bromo-5-iodopyridine (19) (5.67 g, 20 mmole), p-methoxyphenyl-
boronic acid (3.34 g, 20 mmole) and Pd(PPh3)4 (0.02 mmole) as catalyst, was heated at 
120 °C for 4 days in a mixture of toluene (80 ml) and an aqueous solution of K2CO3 
(80 ml, 80g, 8.5 M). After cooling to room temperature, the two layers were separated 
and the aqueous layer extracted three times with dichloromethane. The combined 
organic layers were washed until pH = 7 with water, dried over magnesium sulfate and 
the solvent was evaporated. Further purification was carried out by column 
chromatography (Hexane/ ethyl acetate/ trimethylamine: 5/1/0.1), yielding the desired 
product (5.3g, 99 %) . 
1H-NMR (400 MHz, CDCl3): δ 8.55 (d, 1H, H(6), 4J6,4 = 2.6 Hz), 7.69 (dd, 1H, H(4), 
3J4,3 = 8.0 Hz, 4J4,6 = 2.6 Hz ), 7.51 (d, 1H, H(3), 3J3,4 = 8.0 Hz), 7.47 (d, 2H, H(9), 
H(11), 3J9,8 = 8.0 Hz), 7.01(d, 2H, H(8), H(12), 3J8,9 = 8.0 Hz), 3.85 (s, 3H, H(13)). 
MS(EI): m/z = 265, 263 (M+, 100%, 96%), 250, 248 (M+- CH3, 30%, 31 %), 222, 220 
(M+-C2H3O, 27%, 28%),  184 (M+- Br, 19%), 169 (M+- CH3, 21%). 
Elemental analysis calculated C: 54.57%, H:3.82% , N:5.30% , found C: 54.80%, H: 
3.92%, N: 5.15%. 
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2.11. 2-Bromo-2-methyl-butan-3-one (23) 
 
O Br2
CCl4
O
Br
 
 
To a solution of 2-methylbutan-3-one (22) (25.85 g, 0.3 mole) in carbon tetrachloride 
(120 ml), bromine (48.0 g, 0.3 mole) in carbon tetrachloride (30 ml) was added 
dropwise under reflux over a period of 2 hours. After the addition the reaction mixture 
was kept under reflux for another 2 hours, then cooled to room temperature. Unreacted 
bromine was destroyed with sodium thiosulfate solution (10%). The organic layer was 
separated, dried with magnesium sulfate, the solvent was removed under reduced 
pressure. The crude product was further purified by vacuum distillation (100 mbar, 
60°C), yielding a colourless liquid (30.1 g, 60%). The spectral properties correspond 
to those reported.[137] 
1H-NMR (300 MHz, CDCl3): δ 2.43 (s, 3H, H(4)), 1.84 (s, 6H, H(1), H(5)).  
 
O
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2.12. 1-Bromo-1,1-diphenyl-propan-2-one (25) 
 
O Br2
CCl4
O
Br
 
 
To a solution of 1,1-diphenyl-propan-2-one (24) (15.0 g, 71mmole) in carbon 
tetrachloride (80 ml), bromine (12.5 g, 78 mmole) in carbon tetrachloride (20 ml) was 
added dropwise under reflux over a period of 2 hours. After the addition the reaction 
mixture was kept under reflux for another 2 hours, then cooled to room temperature. 
Unreacted bromine was destroyed with sodium thiosulfate. The organic layer was 
separated, dried with magnesium sulfate, the solvent was removed under reduced 
pressure. The crude product was further purified by recrystallization, yielding a 
colourless solid (18.23 g, 82%).  
1H-NMR (300 MHz, CDCl3): δ 7.25-7.38 (m, 10H, H(5), H(6), H(7)), 2.47 (s, 3H, 
H(1)) 
 
O
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2.13. N,N-dimethyl- 3,3-diphenyl-propionamide (26) 
 
O
Br
N
O
H2O
HNMe2
 
 
To a to 0 °C cooled solution of 1-bromo-1,1-diphenyl-propan-2-one (25) (2.0 g, 6.9 
mmole), dimethylamine (2.5 ml, 13.8 mmole, 5.6 M in ethanol) was added over a 
period of 5 minutes. The reaction solution was stirred overnight at 0 °C, then warmed 
to 40 °C for 70 minutes. After cooling to room temperature, hydrochloric acid (50 ml, 
4M) was added to the reaction mixture. Ethanol was removed under reduced pressure. 
To the acidic solution, sodium hydroxide (2M) was added, until the pH > 7. The 
alkaline solution was extracted three times with diethyl ether. The combined organic 
layers were dried over magnesium sulfate and the solvent was removed under reduced 
pressure, yielding product 26 (1.66 g 95%). The spectral properties correspond to 
those reported.[90,91] 
1H-NMR (300 MHz, CDCl3): δ 7.16-7.29 (m, 10H, H(5), H(6), H(7)), 4.68 (t, 1H, 
H(3), 3J3,2 = 7.4 Hz), 3.03 (d, 2H, H(2), 3J2,3 = 7.4 Hz), 2.84 (s, 6H, H(8)). 
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2.14. 1-(2-Acetyl-5-(p-methoxyphenyl)-pyridyl)-pyridinium iodide (31) 
 
N
O
O
I
N
O
N
O I2, py
N
HI
+
 
A mixture of pyridine (10 ml), iodine (280 mg, 1.1 mmole) and 2-acetyl-5-(p-
methoxyphenyl)-pyridine (12) (210 mg, 0.925 mmole) was kept at 100 °C for 2 hours 
and at 0 °C for 20 min. After addition of dry diethyl ether, the desired product and 
pyridinium iodide precipitated and was filtered. The crude product (305 mg) was used 
without further purification: The ratio between 31 (1.3 eq, 223 mg, 59%) and the 
pyridinium iodide (1eq, 82 mg) was determined by 1H-NMR-spectroscopy. 
1H-NMR (400 MHz, DMSO-d6): δ 9.19 (d, 1H, H(6), 4J6,4 = 2.0 Hz), 9.01 (d, 2H, 
H(16), 3J16,17 = 5.7 Hz), 8.73 (dd, 1H, H(18), 3J18,17 = 7.8 Hz), 8.37 (dd, 1H, H(4), 3J4,3 
= 8.3 Hz, 4J4,6 = 2.0 Hz), 8.27 (dd, 2H, H(17), 3J17,18 = 7.8 Hz), 8.09 (d, 1H, H(3), 3J3,4 
= 8.3 Hz), 7.88 (d, 2H, H(9), H(11), 3J9,8 = 8.8 Hz), 7.13 (d, 2H, H(8), H(12), 3J8,9 = 8.8 
Hz), 6.52 (s, 2H, H(14)), 3.84 (s, 3H, H(13’)).  
MS(ESI): m/z = 305.14 M+-I- 
Pyridinium iodide: 1H-NMR (400 MHz, DMSO-d6): δ 8.91 (d, 2H, H(a), 3Ja,b = 6.6 
Hz); 8.55 (dd, 1H, H(c), Jc,b = 7.7 Hz); 8.03 (dd, 1H, H(b), 3Jb,a = 6.6 Hz, 3Jb,c = 7.7 
Hz). 
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2.15. 1-(2-Acetyl-6-bromopyridyl)-pyridinium iodide (32) 
 
N
O
N
Br I
NBr
O
I2, py
N
HI
 
 
A mixture of pyridine (200 ml), iodine (40.1g, 0.16 mol) and 2-acetyl-6-
bromopyridine (13) (31.2 g, 0.16 mol) was kept at 130 °C for 3 hours and then at 0 °C 
for 20 min. The pyridine was then removed by distillation (75 °C at 240 mbar). After 
addition of dry diethyl ether, the desired product and pyridinium iodide precipitated 
and was filtered. The crude product (84.5 g) was used without further purification: The 
ratio between 32 (1.1 eq, 57.9g, 92%) and pyridinium iodide (1 eq, 26.6 g) was 
determined by 1H-NMR-spectroscopy. 
1H-NMR (300 MHz, DMSO-d6): δ 8.96 (d, 1H, H(10), 3J10,11 = 5.5 Hz); 8.74 (m, 1H, 
H(12)); 8.28 (dd, 1H, H(11), 3J11,10 = 5.5 Hz, 3J11,12 = 6.8 Hz); 8.10 (m, 3H, H(3), H(4), 
H(5)); 6.46 (s, 2H, H(8)). 
MS-FAB (Matrix: NBA) : m/z = 279, 277 (M+-I-, 100%); 198, 200 (M+-py, 30%, 
20%) ; 154 (40%); 136 (48%) 
Pyridinium iodide: cf. 3.2.14 p.16 
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2.16. 1-(2-Acetyl-6-phenylpyridyl)-pyridinium iodide (33) 
 
N
O
I
NN
O
N
HI
I2, py
 
 
A mixture of pyridine (5 ml), iodine (0.64 g, 2.5 mmole) and 2-acetyl-6-
phenylpyridine (14) (0.5 g, 2.5 mmole) was kept at 120 °C for 3 hours and then at 0 °C 
for a night. The pyridine was evaporated under reduced pressure. The residual solid 
was suspended in dry diethyl ether and filtered to yield a black solid (1.36 g). The ratio 
between 33 (1.2 eq, 0.95 g, 93%) and pyridinium iodide (1eq, 0.41 g) was determined 
by 1H-NMR-spectroscopy. 
1H-NMR (300 MHz, DMSO-d6): δ 9.02 (dd, 2H, H(16),3J16,17 = 6.6 Hz, 4J16,17 = 1.2 
Hz), 8.74 (dd, 1H, H(6), 3J17,16 = 7.8 Hz, 4J17,15 = 1.2 Hz), 8.42 (dd, 1H, (H(arom)), 
8.33-8.25 (m, 4H, H(arom)), 8.22 (dd, 1H, H(arom)), 7.96 (dd, 1H, H(arom)), 7.64-
7.51 (m, 3H, H(arom)), 6.69 (s, 2H, H(2)).  
Pyridinium iodide: cf. 3.2.14 p.16 
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2.17. 1-(3-N,N-Dimethylamino-3-methyl-2-oxo-butyl)-pyridinium iodide 
(34) 
 
N
O
NN
O
I
I2, py
N
HI  
 
A mixture of pyridine 160 ml), iodine (36.0 g, 142 mmole) and 2-N,N-dimethylamino-
2-methyl-butan-3-one (16) (17.6 g, 136 mmole) was kept at 130 °C for 3 hours and 
then at 0 °C for 20 min. After addition of dry diethyl ether the desired product and 
pyridinium iodide precipitated and was filtered. The crude product was used without 
further purification: The ratio between 34 (1 eq, 16.2, 36 %) and pyridinium iodide 
(2.2 eq, 22.1 g) was determined by 1H-NMR-spectroscopy. 
1H-NMR (400 MHz, DMSO-d6): δ 9.10 (d, 2H, H(8), 3J8,9 = 5.6 Hz), 8.78 (dd, 1H, 
H(10), 3J10,9 = 7.8 Hz), 8.31 (dd, 2H, H(9), 3J9,10 = 7.8 Hz), 6.43 (s, 2H, H(1)), 2.77 (s, 
6H, H(6), H(7)), 1.72 (s, 6H, H(4), H(5)).  
MS(ESI): m/z = 207.16 M+-I- 
Pyridinium iodide: cf. 3.2.14 p.16 
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3. Ligand syntheses 
 
3.1. [5,6]-Pinene-bpy (L1)*** 
 
N
O
N
NH4OAc
HOAc
Br
N
N
O
 
 
The synthesis of [5,6]-pinene-bpy (L1) was performed following the published 
procedure[134]. A mixture of 1-(2-acetylpyridyl)-pyridinium bromide (4) (22.5, 80 
mmole), ammonium acetate (53.4 g, dried under vacuum) and R,R-(+)-pinocarvone (1) 
(12.2 g, 81 mmole) was suspended in acetic acid (100 ml) and slowly heated over 20 
hours from 50 °C up to 115 °C. After addition of water, the pH was adjusted to 9 by 
addition of sodium carbonate. The aqueous solution was extracted ten times with 
hexane and the combined organic layers were washed with water and dried over 
magnesium sulfate with activated charcoal. The solvent was evaporated under reduced 
pressure. The residual solid was further purified by column chromatography 
(hexane/diethyl ether/trimethylamine: 14/6/1, yielding of pure L1 (14.8 g, 74%). The 
spectral properties correspond to those reported. 
1H-NMR (300 MHz, CDCl3): δ = 8.64 (ddd, 1H, H(6’), 3J6’,5’ = 4.8 Hz, 4J6’,4’ =1.8 Hz, 
5J6’,3’ = 0.9 Hz), 8.32 (ddd, 1H, H(3’), 3J3’,4’ = 8.0 Hz, 4J3’,5’ = 1.1 Hz, 5J6’,3’ = 0.9 Hz), 
8.02 (d, 1H, H(3), 3J3,4 = 7.8 Hz), 7.76 (ddd, 1H, H(4’), 3J4’,3’ = 8.0 Hz, 3J4’,5’ =7.5 Hz, 
4J4’,6’ = 1.8 Hz), 7.31 (d, 1H, H(4), 3J4,3 = 7.8 Hz), 7.23 (ddd, 1H, H(5’), 3J5’,4’ = 7.5 
Hz, 3J5’,6’ = 4.8 Hz, 4J5’,3’ = 1.2 Hz), 3.17 (d, 1H, H(7), 3J7,8 = 2.8 Hz); 2.79 (dd, 1H, 
H(10), 3J10,9b = 5.7 Hz, 4J10,8 = 5.7 Hz); 2.68 (ddd, 1H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b,10 = 
                                              
*** R,R-[5,6]-pinene-bpy: (5R, 7R)-5,6,7,8-tetrahydro-6,6-dimethyl-2(2’-pyridyl)-5,7-
methano-quinoline. 
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5.7 Hz, 3J9b,8 = 5.7 Hz); 2.38 (ddt, 1H, H(8) 3J8,9b = 5.7 Hz, 4J8,10 = 5.7 Hz, 3J8,7 = 2.8 
Hz); 1.40 (s, 3H, H(12)); 1.29 (d, 1H, H(9a), 2J9a,9b = 9.6 Hz);0.66 (s, 3H, H(13)). 
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3.2. 15N-[5,6]-Pinene-bpy (15N-L1) 
 
N
N15N
O
N
15NH4OAc
HOAc
Br
O
 
 
The synthesis was carried out according the procedures described for L1. The 
ammonium acetate used was a mixture of 99 %15N-labelled ammonium acetate, (0.2 g) 
and unlabelled ammonium acetate, (1.8 g), yielding a 10 % 15N-labelled [5,6]-pinene-
bpy (15N-L1). 1-(2-acetylpyridyl)-pyridinium bromide (4), (1.45 g, 5.2 mmole),  
ammonium acetate, (2.0 g, 26 mmole, 10% 15N-labelled) and R,R-(+)-pinocarvone (1), 
(1.45g, 81 mmole) form pure the compound 15N-L1 (0.7 g, 53 % ). The spectral 
properties correspond to those of the analogous non-labelled L1. 
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3.3. [4,5]-Pinene-bpy (L2)††† 
 
N
N
N
O
N
Br
NH4OAc
Formamide
O  
 
The synthesis of [4,5]-pinene-bpy (L2) was performed following the improved 
procedure[70]. A mixture of 1-(2-acetylpyridyl)-pyridinium bromide (4) (18.6, 66.7 
mmole), ammonium acetate (10.3 g, dried under vacuum) and R,R-(-)-myrtenal (2) 
(10.0 g, 66.7 mmole) was suspended in formamide (80 ml) and slowly heated over 20 
hours from 50 °C up to 115 °C. After addition of water, the solution was extracted ten 
times with hexane and the combined organic layers were washed with water and dried 
over magnesium sulfate with activated charcoal. The solvent was evaporated under 
reduced pressure. The residual solid was further purified by column chromatography 
(hexane/ethyl acetate/ trimethylamine: 2/1/0.1), yielding pure L2 (10.8 g, 65%). The 
spectral properties correspond to those reported. 
1H-NMR (300 MHz, CDCl3 ): δ = 8.62 (dd, 1H, H(6’), 3J6’,5’ = 4.0 Hz, 4J6’,4’ =1.8 Hz), 
8.31 (dd, 1H, H(3’), 3J3’,4’ = 8.0 Hz, 4J3’,5’ = 1.1 Hz), 8.17 (s, 1H, H(3)), 8.15 (d, 1H, 
H(6)), 7.75 (ddd, 1H, H(4’), 3J4’,3’ = 8.0 Hz, 3J4’,5’ =7.5 Hz, 4J4’,6’ = 1.8 Hz), 7.23 (ddd, 
1H, H(5’), 3J5’,4’ = 7.5 Hz, 3J5’,6’ = 4.0 Hz, 4J5’,3’ = 1.1 Hz), 3.01 (d, 1H, H(7)); 2.83 
(dd, 1H, H(10), 3J10,9b = 5.5 Hz, 4J10,8 = 5.5 Hz); 2.67 (ddd, 1H, H(9b), 2J9b,9a = 9.5 Hz, 
3J9b,10 = 5.5 Hz, 3J9b,8 = 5.5 Hz); 2.27 (ddt, 1H, H(8) 3J8,9b = 5.5 Hz, 4J8,10 = 5.5 Hz); 
1.37 (s, 3H, H(12)); 1.20 (d, 1H, H(9a), 2J9a,9b = 9.5 Hz);0.61 (s, 3H, H(13)). 
 
                                              
††† R,R-[4,5]-Pinene-bpy: IUPAC name: (6R, 8R)-5,6,7,8- tetrahydro-7,7-dimethyl-3-(2’-
pyridyl)-6,8-methano-isoquinoline. 
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3.4. {5’-p-Methoxyphenyl}-[5,6]-pinene-bpy (L3) 
 
N
O
O
I
O
N
N
NH4OAc
HOAc
O
N
 
 
A mixture of 1-(2-acetyl-5-(p-methoxyphenyl)-pyridyl)-pyridinium iodide (31) (3.8 g, 
8.79 mmole), ammonium acetate (6.93 g, dried under vacuum) and R,R-(+)-
pinocarvone (1) (1.35 g, 9.0 mmole) was suspended in acetic acid (5 ml) and slowly 
heated over 42 hours from 50 °C up to 115 °C. After addition of water, the pH was 
adjusted to 9 by addition of sodium carbonate. This aqueous solution was extracted ten 
times with hexane and the combined organic layers were washed with water and dried 
over magnesium sulfate with activated charcoal. The solvent was evaporated under 
reduced pressure. The residual solid was further purified by column chromatography 
(hexane/ ethyl acetate/ trimethylamine: 8/1/0.1) yielding a slightly yellow product L3 
(936mg, 30%) . 
1H-NMR (400 MHz, CDCl3): δ 8.84 (d, 1H, H(6’), 4J6’,4’ = 2.0 Hz); 8.35 (d, 1H, H(3’), 
3J3’,4’ = 8.3 Hz); 8.04 (d, 1H, H(3), 3J3,4 = 7.8 Hz); 7.91 (dd, 1H, H(4’), 3J4’,3’ = 8.3 Hz, 
4J4’,6’ = 2.0 Hz) ; 7.56 (d, 2H, H(9’), H(11’), 3J9’,8’ = 8.8 Hz); 7.30 (d, 1H, H(4), 3J4,3 = 
7.8 Hz); 6.99 (dd, 2H, H(8’), H(12’), 3J8’,9’ = 8.8 Hz); 3.84 (s, 3H, H(13’)); 3.18 (d, 1H, 
H(7), 3J7,8 = 2.8 Hz); 2.82 (dd, 1H, H(10), 3J10,9b = 5.7 Hz, 4J10,8 = 5.7 Hz); 2.69 (ddd, 
1H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b,10 = 5.7 Hz, 3J9b,8 = 5.7 Hz); 2.38 (ddt, 1H, H(8) 3J8,9b = 
5.7 Hz, 4J8,10 = 5.7 Hz, 3J8,7 = 2.8 Hz)); 1.40 (s, 3H, H(12)); 1.30 (d, 1H, H(9a), 2J9a,9b = 
9.6 Hz); 0.66 (s, 3H, H(13)). 
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13C-NMR (100 MHz, CDCl3): δ 160.2 (Cq); 157.0 (Cq); 155.4 (Cq); 153.8 (Cq); 
147.6 (CH, C(6’)); 142.6 (Cq); 135.8 (Cq); 135.0 (CH, C(4’)); 134.2 (CH, C(4)); 
130.7 (Cq); 128.5 (CH, C(9’), C(11’));  121.1 (CH, C(3’)); 118.2 (CH, C(3)); 115.0 
(CH, C(8’), C(12’)); 55.8 (CH3, C(13’)); 47.0 (CH, C(10)); 40.7 (CH, C(8)); 40.0 (Cq, 
C(11)); 37.2 (CH2, C(7)); 32.4 (CH2, C(9)); 26.5 (CH3, C(12)); 21.7 (CH3, C(13)). 
MS(EI): m/z = 356 (M+, 54%), 341 (M+-CH3, 12%), 313 (M+-COCH3; 100%), 298 
(M+-C3H6O,18%). 
UV/Vis: (CHCl3): 317nm (3.3*104), 273 nm (1.3 *104; sh). 
Elemental analysis calculated C: 80.87%, H 6.79 %, N: 7.86 %, found C: 80.41%, H: 
6.68%, N: 7.75%. 
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X-ray crystallography 
Suitable crystals of L3 were obtained as colourless blocks from a 
Chloroform/methanol solution. The intensity data was collected at 153K on a Stoe 
Image Plate Diffraction System[138] using MoKα graphite monochromated radiation. 
Image plate distance 70mm, φ oscillation scans 0 - 200°, step ∆φ = 1.5°, 2θ range 3.27 
– 52.1°, dmax -dmin = 12.45 - 0.81 Å.  The structure was solved by Direct methods and 
Fourier expansion using the programme SHELXS-97.[139] The refinement and all 
further calculations were carried out using SHELXL-97.[140] The H-atoms were 
located from Fourier difference maps and refined isotropically. The non-H atoms were 
refined anisotropically, using weighted full-matrix least-squares on F2.  
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3.5. {5’-p-Methoxyphenyl}-[4,5]-pinene-bpy (L4) 
 
N
O
O
I
N O
N
N
NH4OAc
Formamide
O  
 
A mixture of 1-(2-acetyl-5-(p-methoxyphenyl)-pyridyl)-pyridinium iodide (31) (223 
mg, 0.52 mmole), ammonium acetate (560 mg, dried under vacuum) and R,R-(-)-
myrtenal (2) (90mg, 0.6 mmole) was suspended in formamide (20 ml) and stirred at 
room temeparture for 5 days, then it was slowly heated over 24 hours from 50 °C up to 
100 °C. To the reaction mixture 50 ml of water was added and extracted five times 
with hexane and the combined organic layers were washed with water and dried over 
magnesium sulfate with activated charcoal. The solvent was evaporated under reduced 
pressure. The residual solid was further purified by column chromatography (hexane/ 
ethyl acetate/ trimethylamine: 4/1/0.25), yielding the desired product(85 mg, 24 %).  
1H-NMR (400 MHz, CDCl3): δ 8.84 (d, 1H, H(6’), 4J6’,4’ = 2.0 Hz); 8.35 (d, 1H, H(3’), 
3J3’,4’ = 8.3 Hz); 8.20 (s, 2H, H(3), H(6)); 7.93 (dd, 1H, H(4’), 3J4’,3’ = 8.3 Hz, 4J4’,6’ = 
2.0 Hz); 7.57 (d, 2H, H(9’), H(11’), 3J9’,8’ = 8.8 Hz); 7.00 (d, 2H, H(8’), H(12’), 3J8’,9’ = 
8.8 Hz);  3.85 (s, 3H, H(13’)); 3.05 (d, 1H, H(7), 3J7,8 = 2.7 Hz); 2.86 (dd, 1H, H(10), 
3J10,9b = 5.7 Hz, 4J10,8 = 5.7 Hz); 2.70 (ddd, 1H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b,10 = 5.7 Hz, 
3J9b,8 = 5.7 Hz); 2.30 (ddt, 1H, H(8) 3J8,9b = 5.7 Hz, 4J8,10 = 5.7 Hz, 3J8,7 = 2.7 Hz)); 1.41 
(s, 3H, H(12)); 1.23 (d, 1H, H(9a), 2J9a,9b = 9.6 Hz); 0.65 (s, 3H, H(13)). 
13C-NMR (100 MHz, CDCl3): δ 159.8 (Cq); 154.8 (Cq); 154.2 (Cq); 147.0 (CH, 
C(6’)); 145.6 (CH, C(6)); 145.5 (Cq); 142.9 (Cq); 135.6 (Cq); 134.6 (CH, C(4’)); 
130.1 (Cq); 128.1 (CH, C(9’), C(11’)); 120.7 (CH, C(3’)); 120.4 (CH, C(3)); 114.6 
(CH, C(8’), C(12’)); 55.4 (CH3, C(13’)); 44.5 (CH, C(10)); 40.1 (CH, C(8)); 39.3 (Cq, 
C(11)); 32.9 (CH2, C(7)); 31.8 (CH2, C(9)); 26.0 (CH3, C(12)); 21.4 (CH3, C(13)). 
MS(ESI): m/z = 357 (M+). 
UV/Vis: (CHCl3), λ (ε): 314 nm (2.9*104), 274 nm (1.2 *104; sh). 
132  Experimental Part 
Elemental analysis calculated C: 80.87%, H: 6.79%, N: 7.86% , found C:79.82%, 
H:6.59%, N: 7.73%. 
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3.6. {6’-Bromo}-[5,6]-pinene-bpy (L5) 
 
N
O
N
Br I N
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A mixture of 1-(2-acetyl-6-bromopyridyl)-pyridinium iodide (32) (27.75 g, 47 
mmole), ammonium acetate (31.3 g, dried under vacuum) and R,R-(+)-pinocarvone (1) 
(7.0 g, 47 mmole) was suspended in acetic acid (60 ml) and slowly heated over 20 
hours from 50 °C up to 115 °C. After addition of water, the pH was adjusted to 9 by 
addition of sodium carbonate. This aqueous solution was extracted ten times with 
hexane and the combined organic layers were washed with water and dried over 
magnesium sulfate with activated charcoal. The solvent was evaporated under reduced 
pressure. After filtration over silica gel (chloroform), a white powder of L5 (7.69 g, 
50%) was obtained. 
1H-NMR (400 MHz, CDCl3): δ 8.34 (d, 1H, H(3’), 3J3’,4’ = 7.8 Hz); 8.07 (d, 1H, H(3), 
3J3,4 = 7.8 Hz); 7.61 (dd, 1H, H(4’), 3J4’,3’ = 7.8 Hz, 3J4’,5’ = 7.8 Hz); 7.42 (d, 1H, H(5’), 
3J5’,4’ = 7.8 Hz); 7.31; (d, 1H, H(4), 3J4,3 = 7.8 Hz); 3.16 (d, 1H, H(7), 3J7,8 = 2.8 Hz); 
2.81 (dd, 1H, H(10), 3J10,9b = 5.7 Hz, 4J10,8 = 5.7 Hz); 2.69 (ddd, 1H, H(9b), 2J9b,9a = 9.6 
Hz, 3J9b,8 = 5.7 Hz, 3J9b,10 = 5.7 Hz); 2.38 (ddt, 1H, H(8), 3J8,9b = 5.7 Hz, 4J8,10 = 5.7 Hz, 
3J8,7 = 2.8 Hz); 1.40 (s, 3H, H(12)); 1.28 (d, 1H, H(9a), 2J9a,9b = 9.6 Hz); 0.65 (s, 3H, 
H(13)).  
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13C-NMR (100 MHz, CDCl3):  δ 158.0 (Cq); 156.6 (Cq); 151.8 (Cq); 143.0 (Cq); 
141.5 (Cq); 139.0 (CH, C(4’)); 133.8 (CH, C(4)); 127.2 (CH, C(5’)); 120.7 (CH, 
C(6)); 119.4 (CH, C(3’)); 118.4 (CH, C(3)); 46.5 (CH, C(10)); 40.2 (CH, C(8)); 39.5 
(Cq, C(11)); 36.6 (CH2, C(7)); 31.9 (CH2, C(9)); 26.0 (CH3, C(12)); 21.3 (CH3, 
C(13)). 
MS-FAB (Matrix: NBA) : m/z = 331,329 (M+, 100%) ; 285,287 (M+-i-Pr, 40%), 154 
(C11H8N+, 50%), 136 (30%). 
UV/Vis: (CHCl3), λ (ε): 303 nm (2.0*104), 252 nm (0.9*104). 
Elemental analysis calculated C: 62.02%, H: 5.20%, N: 8.51%, found C: 61.57%, H: 
5.22%, N: 7.91%. 
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X-ray crystallography 
Suitable crystals of L5 were obtained as colourless rod-like crystals by slow 
evaporation from a solution in chloroform. The intensity data was collected at 153K on 
a Stoe Image Plate Diffraction System[138] using MoKα graphite monochromated 
radiation. Image plate distance 70mm, φ oscillation scans 0 - 185°, step ∆φ = 1.5°, 2θ 
range 3.27 – 52.1°, dmax -dmin = 12.45 - 0.81 Å.  The structure was solved by Patterson 
and Fourier methods using the programme SHELXS-97.[139] The refinement and all 
further calculations were carried out using SHELXL-97.[140] The H-atoms were 
located from Fourier difference maps and refined isotropically. The non-H atoms were 
refined anisotropically, using weighted full-matrix least-squares on F2. An empirical 
absorption correction was applied using the DIFABS routine in PLATON.[141] The 
coordinates correspond to the absolute structure of the molecule in the crystal. 
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3.7. {6’-Bromo}-[4,5]-pinene-bpy (L6) 
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A mixture of 1-(2-acetyl-6-bromopyridyl)-pyridinium iodide (32) (3.0 g, 7.4 mmole),  
ammonium acetate (6.0g, dried under vacuum) and R,R-(-)-myrtenal (2) (1.1 g, 7.5 
mmole) was suspended in formamide (100 ml) and stirred at room temperature for 4d, 
then slowly heated over 24 hours from 50 °C up to 115 °C. To the reaction mixture of 
water (75 ml) was added and extracted five times with hexane and the combined 
organic layers were washed with water and dried over magnesium sulfate with 
activated charcoal. The product was obtained after purification by column 
chromatography (hexane/ ethyl acetate/ trimethylamine: 5/1/0.1) as a white powder 
(706 mg, 29 %). 
1H-NMR (400 MHz, CDCl3): δ 8.30 (dd, 1H, H(3’), 3J3’,4’ = 7.8 Hz, 3J3’,5’ = 0.8 Hz); 
8.19 (s, 2H, H(3), H(6)); 7.61 (dd, 1H, H(4’), 3J4’,3’ = 7.8 Hz, 3J4’,5’ = 7.8 Hz); 7.42 (d, 
1H, H(5’), 3J5’,4’ = 7.8 Hz, 3J5’,3’ = 0.8 Hz); 3.01 (d, 1H, H(7), 3J7,8 = 2.7 Hz); 2.84 (dd, 
1H, H(10), 3J10,9b = 5.5 Hz, 4J10,8 = 5.5 Hz) ; 2.68 (ddd, 1H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b,8 
= 5.7 Hz, 3J9b,10 = 5.7 Hz)); 2..29 (ddt, 1H, H(8)), 3J8,9b = 5.7 Hz, 4J8,10 = 5.8 Hz, 3J8,7 = 
2.7 Hz); 1.39 (s, 3H, H(12)); 1.19 (d, 1H, H(9a), 2J9a,9b = 9.6 Hz); 0.61 (s, 3H, H(13)). 
13C-NMR (100 MHz, CDCl3): δ 157.9 (Cq); 152.7 (Cq); 145.6 (Cq); 145.5 (CH, C(3) 
or C(6)); 143.7 (Cq); 141.4 (Cq); 139.1 (CH, C(4’)); 127.4 (CH, C(5’)); 120.8 (CH, 
C(6) or C(3)); 119.4 (CH, C(3’)); 118.4 (CH, C(3)); 44.5 (CH, C(10)); 40.1 (CH, 
C(8)); 39.2 (Cq, C(11)); 32.9 (CH2, C(7)); 31.7 (CH2, C(9)); 26.0 (CH3, C(12)); 21.3 
(CH3, C(13)). 
UV/Vis: (CHCl3), λ (ε): 297 nm (2.0*104), 253 nm (1.0*104). 
Elemental analysis calculated C: 62.02%, H: 5.2%, N:8.51%, found C: 62.35%, H: 
5.30%, N: 8.28%. 
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X-ray Crystallography 
 Suitable crystals of L6 were grown from a chloroform/methanol mixture as 
large colourless blocks. Intensity data was collected at room temperature (293K) on a 
Stoe AED2 4-circle diffractometer[138] using CuKα graphite monochromated 
radiation (λ = 1.54186 Å) with ω/2Θ scans in the 2Θ range 5 - 125°. The structure was 
solved by direct methods using the programme SHELXS-97.[139] The refinement and 
all further calculations were carried out using SHELXL-97.[140] H-atoms are placed 
in calculated positions and refined as riding atoms using SHELXL-97 default 
parameters. The non-H atoms were refined anisotropically, using weighted full-matrix 
least-squares on F2 . 
The compound crystallises in the non-centrosymmetric space group P212121 [Flack 
parameter x = 0.01(3)]. An absorption correction was applied using PSI-scans 
(Tmin=0.140, Tmax=0.283). The coordinates correspond to the absolute structure of the 
molecule in the crystal. 
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3.8. {6’-Phenyl}-[5,6]-pinene-bpy (L7) 
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The synthesis of {6’-phenyl}-[5,6]-pinene-bpy (L7) was performed following the 
published procedure.[135] A mixture of 1-(2-acetyl-6-phenylpyridyl)-pyridinium 
iodide (33) (1.02 g, 2.5 mmole), ammonium acetate (1.7 g, dried under vacuum) and 
R,R-(+)-pinocarvone (1) (0.38 g, 2.5 mmole) was suspended in acetic acid (5 ml) and 
slowly heated over 20 hours from 50 °C up to 110 °C. Then the solution was cooled to 
room temperature and water (15ml) was added. The aqueous solution was extracted 
five times with dichloromethane. The combined organic layers were washed with 
water and dried over magnesium sulfate with activated charcoal. The solvent was 
evaporated under reduced pressure. The residual solid was further purified by 
recrystallization yielding a yellow powder (586 mg 71%). 
1H-NMR (300 MHz, CDCl3): δ 8.37 (d, 1H, H(3’), 3J3’,4’ = 8.0 Hz); 8.31 (d, 1H, H(3), 
3J3,4 = 8.0 Hz); 8.13 (dd, 2H, H(8’), H(12’), 3J8',9' = 8.0 Hz, 4J8',10' = 2.1 Hz,); 7.85 (dd, 
2H, H(4’), 3J = 7.4 Hz,); 7.72 (dd, 1H, H(5’), 3J5’,4’ = 7.8 Hz, 4J = 0.8 Hz); 7.48 (dd, 
2H, H(9’),H(11’), 3J = 7.4 Hz); 7.42 (dd, 1H, H(10’), 3J = 7.9 Hz,); 7.37 (d, 1H, H(4), 
3J = 8.0 Hz); 3.22 (m, 2H, H(7)); 2.83 (dd, 1H, H(10), 3J = 5.6 Hz); 2.71 (ddd, 1H, 
H(9b)); 2.40 (ddt, 1H, H(8), 3J = 3.2 Hz); 1.42 (s, 3H, H(12)); 1.32 (d, 1H, H(9a), 3J9a,9b 
= 9.5Hz); 0.68 (s, 3H, H(13)). 
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X-ray crystallography 
 Suitable crystals of L7 were grown from acetone as colourless blocks. Intensity 
data was collected at room temperature on a Stoe AED2 4-circle diffractometer using 
MoKα graphite monochromated radiation (λ = 0.71073 Å) with ω/2Θ scans in the 
2Θ range 5 - 55°. The structure was solved by direct methods using the programme 
SIR-97.[142] The refinement and all further calculations were carried out using 
SHELXL-97.[141] H-atoms were located from difference Fourier maps and refined 
isotropically. The non-H atoms were refined anisotropically, using weighted full-
matrix least-squares on F2 .  
The absolute structure of the molecule in the crystal was assigned to the known 
absolute configuration of the pinene-moiety. The bond distances and angles are normal 
within experimental error. 
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3.9. {6’-Phenyl}-[4,5]-pinene-bpy (L8) 
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A mixture of (2-acetyl-6-phenylpyridyl)-pyridinium iodide (33) (0.80 g, 2.0 mmole), 
ammonium acetate (0.8 g, dried under vacuum) and R,R-(-)-myrtenal (2) (0.30 g, 2.0 
mmole) was suspended in formamide (10 ml) and slowly heated over 20 hours from 
50°C up to 115°C. To the reaction mixture, water (50 ml) was added and extracted five 
times with dichloromethane. The combined organic layers were washed with water 
and dried over magnesium sulfate with activated charcoal. The solvent was evaporated 
under reduced pressure. The residual solid was further purified by column 
chromatography: (hexane/ ethyl acetate/ trimethylamine: 4/1/0.25) giving 0.19 g (52 
%) of the desired product L8. 
1H-NMR (300 MHz, CDCl3): δ 8.41 (s, 1H, H(3)); 8.33 (d, 1H, H(3’), 3J3’,4’ = 7.8 Hz); 
8.21 (s, 1H, H(6)); 8.14 (dd, 2H, H(8’), H(12’), 3J8',9' = 8.2 Hz); 7.85 (dd, 2H, H(4’), 
3J4’,5’ = 7.8 Hz. 3J4’,3’ = 7.8 Hz); 7.72 (d, 1H, H(5’), 3J5’,4’ = 7.8 Hz); 7.50 (dd, 2H, 
H(9’), H(11’), 3J9’,8’ = 8.2 Hz, 3J9’,10’= 8.2 Hz); 7.42 (dd, 1H, H(10’), 3J10’,9’ = 8.2 Hz); 
3.09 (d, 1H, H(7), 3J7,8 = 2.8 Hz); 2.87 (dd, 1H, H(10), 3J10,9b = 5.6 Hz, 4J10,8 = 5.6 Hz); 
2.70 (ddd, 1H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b,8 = 5.6 Hz, 3J9b,10 = 5.6 Hz); 2.33 (ddt, 1H, 
H(8), 3J8,9b = 5.5 Hz, 4J8,10 = 5.6 Hz, 3J8,7 = 2.8 Hz); 1.42 (s, 3H, H(12)); 1.25 (d, 1H, 
H(9a), 3J9a-9b = 9.6 Hz); 0.66 (s, 3H, H(13)).  
13C-NMR (100MHz, CDCl3): δ 156.4 (Cq); 156.1 (Cq); 154.5 (Cq); 145.5 (Cq); 145.3 
(CH, C(6)); 143.1 (Cq); 139.5 (Cq); 137.6 (CH, C(4’)); 128.9 (CH, C(10’)); 128.7 
(CH, C(9’), C(11’)); 127.0 (CH, C(8’), C(12’)); 120.7 (CH, C(3)); 119.9 (CH, C(5’)); 
119.1 (CH, C(3’)); 44.6 (CH, C(10)); 40.1 (CH, C(8)); 39.3 (Cq, C(11)); 33.1 (CH2, 
C(7)); 31.8 (CH2, C(9)); 26.0 (CH3, C(12)); 21.4 (CH3, C(13)). 
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MS(ESI): m/z = 327 (M+)  
UV/Vis: (CHCl3), λ (ε): 300 nm (1.7*104), 253 nm (2.4*104). 
Elemental analysis calculated C: 84.63% H: 6.79% N: 8.58%, found C: 84.47%, H: 
7.05%, N: 8.48%. 
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3.10. {6’-p-Methoxyphenyl}-[5,6]-pinene-bpy (L9) 
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K2CO3, water
 
 
A mixture of {6’-bromo}-[5,6]-pinene-bpy (L5) (3.3 g, 10 mmole), p-
methoxyphenylboronic acid (1.65 g, 10 mmole) and Pd(PPh3)4 (0.2% eq) as catalyst, 
was heated at 120 °C for 4 days in a mixture of toluene (100 ml) and an aqueous 
solution of K2CO3 (50 ml, 8.5 M). After cooling to room temperature the two layers 
were separated and the aqueous layer extracted three times with dichloromethane. The 
combined organic layers were washed until pH=7 with water, dried over magnesium 
sulfate and the solvent was evaporated. Without further purification pure L9 (3.59 g, 
99%) was obtained. 
1H-NMR (400 MHz, CDCl3): δ 8.29 (d, 1H, H(3), 3J3,4 = 7.8 Hz); 8.28 (d, 1H, H(3’), 
3J3’,4’ = 7.8 Hz,) 8.10 (d, 2H, H(8’), H(12’), 3J8’,9’ = 8.8 Hz); 7.81 (dd, 1H, H(4’), 3J4’,5’ 
= 7.8 Hz, 3J4’,3’ = 7.8 Hz); 7.42 (d, 1H, H(5’), 3J5’,4’ = 7.8 Hz); 7.35 (d, 1H, H(4), 3J4,3 = 
7.8 Hz); 7.01 (d, 2H, H(9’), H(11’), 3J9’,11’= 8.8 Hz); 3.87 (s, 3H, H(13’)); 3.19 (d, 1H, 
H(7), 3J7,8 = 2.8 Hz); 2.82 (dd, 1H, H(10), 3J10,9b = 5.8 Hz, 4J10,8 = 5.8 Hz); 2.71 (ddd, 
1H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b,10 = 5.8 Hz, 3J9b,8 = 5.8 Hz); 2.40 (ddt, 1H, H(8) 3J8,9b = 
5.8 Hz, 4J8,10 = 5.8 Hz, 3J8,7 = 2.8 Hz); 1.42 (s, 3H, H(12)); 1.32 (d, 1H, H(9a), 2J9a,9b = 
9.6 Hz); 0.69 (s, 3H, H(13)). 
13C-NMR (100 MHz, CDCl3): δ 160.4 (Cq); 156.2 (Cq); 156.1 (Cq); 155.9 (Cq); 
153.8 (Cq); 142.2 (Cq); 137.4 (CH, C(4’)); 133.7 (CH, C(4)); 132.2 (Cq); 128.2 (CH, 
C(8’), C(12’)); 118.9 (CH, C(5’)); 118.3 (CH, C(3)); 118.0 (CH, C(3’)); 114.0 (CH, 
C(9’), C(11’)); 55.3 (CH3, C(13’)); 46.5 (CH, C(10)); 40.3 (CH, C(8)); 39.5 (Cq, 
C(11)); 36.7 (CH2, C(7)); 31.9 (CH2, C(9)); 26.1 (CH3, C(12)); 21.3 (CH3, C(13)). 
UV/Vis: (CHCl3), λ (ε): 281 nm (2.8*104).  
MS-FAB (Matrix: NBA) : m/z = 357 (M+, 100%) ; 154 (C11H8N+, 10%), 136 (6%). 
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Elemental analysis calculated  C: 80.87%, H: 6.79%, N : 7.86%, found C: 81.22%, H: 
6.80%, N: 7.45%. 
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X-ray crystallography 
 Suitable crystals of L9 * CHCl3 solvate were obtained as colourless plates by 
slow evaporation. The intensity data was collected at 153K on a Stoe Image Plate 
Diffraction System[138] using MoKα graphite monochromated radiation. Image plate 
distance 70mm, φ oscillation scans 0 - 200°, step ∆φ = 1.0°, 2θ range 3.27 – 52.1°, 
dmax -dmin = 12.45 - 0.81 Å.  The structure was solved by direct methods using the 
programme SHELXS-97.[139] The refinement and all further calculations were 
carried out using SHELXL-97.[140] The H-atoms were located from Fourier 
difference maps and refined isotropically. The non-H atoms were refined 
anisotropically, using weighted full-matrix least-squares on F2.  
Owing to the anomalous dispersion of the chlorine atoms in the CHCl3 solvate 
molecule, present per molecule of L9, the absolute configuration of the molecule in 
the crystal could be determined. 
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3.11. {2-DAMI}-[5,6]-pinene-py (L10) 
 
N
O
N
O
I
NH4OAc
HOAc N
N
 
 
A mixture of 1-(3-dimethylamino-3-methyl-2-oxo-butyl)-pyridinium iodide (34) (8.6 
g, 25 mmole), ammonium acetate (23.1 g, dried under vacuum) and R,R-(+)-
pinocarvone (1) (4.5 g, 47 mmole) was suspended in acetic acid (100 ml) and slowly 
heated over 20 hours from 50 °C up to 115 °C. After addition of water, the pH was 
adjusted to 9 by addition of sodium carbonate. This aqueous solution was extracted ten 
times with hexane and the combined organic layers were washed with water and dried 
over magnesium sulfate with activated charcoal. A viscous liquid (1.6 g, 29 %) was 
obtained after purification by column chromatography: (hexane/ ethyl acetate/ 
trimethylamine: 5/1/0.1). 
1H-NMR (400 MHz, CDCl3): δ = 7.2 (d, 1H, H(3), 3J3,4 = 7.8 Hz); 7.09 (d, 1H, H(4), 
3J4,3 = 7.8 Hz); 3.06 (d, 1H, H(7), 3J7,8 = 2.7 Hz); 2.69 (dd, 1H, H(10), 3J10,9b = 5.7 Hz, 
4J10,8 = 5.7 Hz); 2.62 (ddd, 1H, H(9b), 2J9b,9a = 9.2 Hz, 3J9b,10 = 5.7 Hz, 3J9b,8 = 5.7 Hz); 
2.38 (ddt, 1H, H(8) 3J8,9b = 5.7 Hz, 4J8,10 = 5.7 Hz, 3J8,7 = 2.8 Hz); 2.18 (s, 6H, H(5’), 
H(6’)); 1.38 (s, 6H, H(2’), H(3’)); 1.37 (s, 3H, H(12)); 1.25 (d, 1H, H(9a), 2J9a,9b = 9.2 
Hz); 0.61 (s, 3H, H(13)). 
MS(ESI): m/z = 259.2(HM+). 
Elemental analysis calculated C: 79.02%, H: 10.14%, N: 10.84%, found C: 79.52%, 
H: 10.1%, N: 11.91%. 
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3.12. {5’-p-Methoxyphenyl}-[5,6]-CHIRAGEN[p-xyl] (L11) 
 
O
N
N
O
N
N
O
N
N
2 1) LDA, THF, -40°C2) α,α'-Dibromo-p-xylene
 
 
To dry THF (40 ml) at –40 °C diisopropylamine (0.2 ml, 1.4 mmole) was added, 
followed by n-butyllithium (0.85 ml, 1.35 mmole, 1.6 M in hexane). The temperature 
was allowed to increase to 0 °C for 30 minutes and then lowered to –40 °C. {5’-p-
Methoxyphenyl}-[5,6]-pinene-bpy (L3) (400 mg, 1.12 mmole) dissolved in dry THF 
(10 ml) was added dropwise over 1 hour. After stirring the solution at –40 °C for 2 
hours, α,α’-dibromo-p-xylene (148 mg, 0.56 mmole) dissolved in THF (10 ml) was 
injected slowly (1 hour). The solution was warmed gradually to room temperature, 
quenched by water (50 ml). The aqueous solution was extracted three times with 
diethyl ether. The combined organic layers were dried over magnesium sulfate, and the 
solvent was evaporated. The residual solid was further purified by column 
chromatography or recrystallization (hexane/ethyl acetate/trimethylamine: 1/1/0.5), 
yielding a slightly yellow powder (303 mg, 64%) . 
1H-NMR (400 MHz, CDCl3): δ 8.86 (dd, 2H, H(6’), 4J6’,4’ = 2.4 Hz, 5J6’,3’ = 0.6 Hz); 
8.50 (b, 2H, H(3’) 3J3’,4’ = 8.3 Hz, 5J3’,6’ = 0.6 Hz); 8.14 (d, 2H, H(3), 3J3,4 = 7.8 Hz); 
7.94 (dd, 2H, H(4’), 3J4’,3’ = 8.3 Hz, 4J4’,6’ = 2.4 Hz); 7.59 (d, 2H, H(9’), H(11’), 3J9’,8’ = 
8.7 Hz); 7.35 (d, 2H, H(4), 3J4,3 = 7.8 Hz); 7.28 (s, 4H, H(3’’), H(4’’), H(5’’), H(6’’)); 
7.01 (d, 4H, H(8’), H(12’), 3J8’,9’ = 8.8 Hz); 3.86 (m, 2H, H(1b’’)); 3.85 (s, 6H, H(13’)); 
3.43 (ddd, 2H, H(7) 3J7,1a’’ = 10.8 Hz, 3J7,1b’’ = 2.7 Hz, 3J7,8’’ = 2.7 Hz); 2.82 (dd, 2H, 
H(10), 3J10,9b = 5.6 Hz, 4J10,8 = 5.6 Hz); 2.76 (dd, 2H, H(1a’’), 2J1a’’,1b’’ = 13.6 Hz, 3J1a’’,7 
= 10.8 Hz); 2.59 (ddd, 2H, H(9b), 2J9b,9a = 9.8 Hz, 3J9b,10 = 5.6Hz, 3J9b,8 = 5.6 Hz); 2.18 
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(ddd, 2H, H(8), 3J8,9b = 5.6 Hz, 4J8,10 = 5.6 Hz, 3J8,7 = 2.7 Hz); 1.45 (d, 2H, H(9a), 2J9a,9b 
= 9.8 Hz); 1.36 (s, 6H, H(12)); 0.64 (s, 6H, H(13)). 
13C-NMR (100 MHz, CDCl3): δ 159.7 (Cq); 158.8 (Cq); 155.1 (Cq); 153.1 (Cq); 
147.1 (CH, C(6’)); 142.2 (Cq); 138.6 (Cq); 135.4 (Cq)); 134.5 (CH, C(4’)); 133.7 
(CH, C(4)); 130.3 (Cq); 129.3 (CH, C(3’’)); 128.1 (CH, C(9’), C(11’)); 120.7 (CH, 
C(3’)); 117.8 (CH, C(3)); 114.6 (CH, C(8’), C(12’)); 55.4 (CH3, C(13’)); 46.9 (CH, 
C(10)); 46.2 (CH, C(7)); 42.7  (CH2, C(8)); 41.2 (Cq, C(11)); 38.5 (CH2, C(1’’)); 28.4 
(CH2, C(9)); 26.3 (CH3, C(12)); 20.9 (CH3, C(13)). 
MS(ESI): m/z = 815 (M+) 
UV/Vis: (CHCl3), λ (ε): 317 nm (7.1*104), 272 nm (2.6 *104; sh). 
Elemental analysis calculated C:82.52%; H:7.10%, N: 6.87% , found C:81.59%, 
H:7.10%, N: 6.63%. 
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3.13. {6’-Phenyl}-[5,6]-CHIRAGEN[p-xyl] (L12) 
 
N
N
N
NN
N
2 1) LDA, THF, -40°C
2) α,α'-Dibromo-p-xylene
 
 
To dry THF (5 ml) at –20 °C diisopropylamine (0.41 ml, 2.9 mmole) was added, 
followed by n-butyllithium (1.6 ml, 1.9 mmole, 1.2 M in hexane). The temperature 
was allowed to increase to room temperature for 20 minutes and then lowered to         
–40 °C. {6’-phenyl}-[5,6]-pinene-bpy (L7) (500 mg, 1.53 mmole) dissolved in 5 ml 
dry THF was added dropwise over 1 hour). After stirring the solution at –40 °C for 3 
hours, α,α’-dibromo-p-xylene (202 mg, 0.77 mmole) dissolved in THF (8 ml) was 
injected slowly (1 hour). The solution was warmed gradually to room temperature, 
quenched by water (3 ml). The solvent was removed under reduced pressure and a 
saturated aqueous solution of NaHCO3 (10ml) was added to the resulting solid. The 
aqueous solution was extracted three times with dichloromethane. The combined 
organic layers were dried over magnesium sulfate, and the solvent was evaporated 
under reduced pressure. The residual solid was further purified by column 
chromatography (hexane/ ethyl acetate/ trimethylamine: 2/1/0.1) yielding the desired 
product L12 (395 mg, 68%). 
1H-NMR (300 MHz, CDCl3): δ 8.48 (d, 2H, H(3’), 3J3’,4’ = 7.7 Hz); 8.39 (d, 2H, H(3), 
3J3,4 =7.7 Hz); 8.17 (dd, 4H, H (8’), H(12’), 3J8’,9’ = 7.0 Hz); 7.90 (dd, 2H, H (4’), 3J4’,3’ 
= 7.7 Hz, 3J4’,5’= 7.8 Hz); 7.76 (d, 2H, H (5’) 3J5’,4’ = 7.8 Hz); 7.52 (dd, 4H, H (9’), 
H(11’), 3J9’,10’ = 7.8 Hz, 3J9’,8’ = 7.0 Hz); 7.47-7.36 (m, 2H, H(10’), 3J10’,9’ = 7.8 Hz); 
7.38 (s, 4H, H(3’’), H(4’’), H(5’’), H(6’’)); 3.87 (dd, 2H, H (1’’b), 2J1b’’, 1a’’ = 13.5 Hz, 
3J1b’’,7 = 3.6 Hz); 3.44 (d (broad), 2H, H(7) 3J7,1a’’ = 11.0 Hz, 3J7, 1b’’ = 3.6 Hz); 2.83 
(dd, 2H, H (10), 3J10,9b = 5.5 Hz, 3J10,8 = 5.5 Hz); 2.75 (dd, 2H, H(1’’a), 2J, 1a’’, 1b’’ = 
13.5 Hz, 3J, 1a’’,7 = 11.0 Hz); 2.58 (ddd 2H, H(9b), 2J9b,9a = 9.9 Hz, 3J9b,8 = 5.5 Hz, 3J9b,10 
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= 5.5 Hz); 2.18 (m, 2H, H(8)); 1.46 (d, 2H, H(9a), 2J9a,9b = 9.9 Hz); 1.37 (s, 6H, 
H(12)); 0.70 (s, 6H, H(13)); 
13C-NMR (75.4 MHz, CDCl3): δ 158.8 (Cq); 156.5 (Cq); 153.6 (Cq); 142.6 (Cq); 
139.8 (Cq); 138.8 (Cq); 137.7 (CH, C(4’)); 134.0 (CH, C(4)); 132.4 (Cq); 129.5 (CH, 
C(3’’)); 129.1 (CH, C(8’)); 128.9 (CH, C(10’)); 127.1 (CH, C(3’)); 119.9 (CH, C(5’)); 
119.4 (CH, C(3)); 118.5 (CH, C(9’)); 47.2 (CH, C10); 46.4 (CH, C7); 43.0 (CH, C8); 
41.4 (Cq, C11); 38.7 (CH2, C1’’); 28.6 (CH2, C9); 26.5 (CH3, C12); 21.2 (CH3, C13);  
FAB-MS (Matrix: NBA): m/z = 755 (M+); 325 (M+-C24H28N2). 
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X-ray crystallography 
Suitable crystals of L12 were grown from methanol/dichloromethane as colourless 
rods. Intensity data was collected at 153K on a Stoe Image Plate Diffraction system 
equipped with a φ circle, using MoKα graphite monochromated radiation. Image plate 
distance 70mm, φ oscillation scans 0 - 200°, step ∆φ = 1°, 2θ range 3.27 – 52.1°, dmax -
dmin = 12.45 - 0.8 1 Å.  The structure was solved by direct methods using the 
programme SHELXS-97.[139] The refinement and all further calculations were 
carried out using SHELXL-97.[140] The H-atoms were located from difference 
Fourier maps and refined isotropically. The non-H atoms were refined anisotropically, 
using weighted full-matrix least-squares on F2. The absolute structure of the molecule 
in the crystal was assigned to the known absolute configuration of the pinene-moiety. 
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3.14. {6’-p-Methoxyphenyl}-[5,6]-CHIRAGEN[p-xyl] (L13) 
 
N
N
N
NN
N
2 1) LDA, THF, -40°C
2) α,α'-Dibromo-p-xylene
O
O O
 
 
To dry THF (20 ml) at –20 °C diisopropylamine (0.6 ml, 4 mmole) was added, 
followed by n-butyllithium (2.1 ml, 3.4 mmole, 1.6 M in hexane). The temperature 
was allowed to increase to 0 °C for 30 minutes and then lowered to –40 °C. {6’-p-
Methoxyphenyl}-[5,6]-pinene-bpy (L9) (1.0 g, 2.8 mmole) dissolved in dry THF (10 
ml) was added dropwise over 1 hour. After stirring the solution at –40 °C for 2 hours  
α,α’-dibromo-p-xylene (0.37 g, 1.4 mmole) dissolved in THF (8 ml) was injected 
slowly (1 hour). The solution was warmed gradually to room temperature, quenched 
by water (3 ml), followed by addition of dichloromethane and a saturated aqueous 
solution of NaHCO3. The aqueous solution was extracted three times with 
dichloromethane. The combined organic layers were dried over magnesium sulfate, 
and the solvent was evaporated. The residual solid was further purified by filtration 
over over silica gel (hexane/ethyl acetate/triethylamine : 8/1/0.5), yielding of L19 
(1.35 g, 95%). 
1H-NMR (400 MHz, CDCl3): δ 8.39 (d, 2H, H(3’), 3J3’,4’ = 7.8 Hz); 8.35 (d, 2H, H(3), 
3J3,4 = 7.8 Hz); 8.12 (d, 4H, H(8’), H(12’), 3J8’,9’ = 8.8 Hz); 7.83 (dd, 2H, H(4’), 3J4’,3’ = 
7.8 Hz, 3J4’,5’ = 7.8 Hz); 7.67 (d, 2H, H(5’), 3J5’,4’ = 7.8 Hz); 7.37 (d, 2H, H(4), 3J4,3 = 
7.8 Hz); 7.29 (s, 4H, H(3’’), H(4’’), H(6’’), H(7’’)); 7.02 (d, 4H, H(9’), H(11’’), 3J9’,8’ 
= 8.8 Hz); 3.87 (s, 6H, H(13’)); 3.86 (m, 2H, H(1b’’)); 3.43 (ddd, 2H, H(7), 3J7,1b’’ = 
10.8 Hz, 3J7,1a’’ = 2.7 Hz, 3J7,8 = 2.7 Hz); 2.82 (dd, 2H, H(10), 3J10,9b = 5.6 Hz, 4J10,8 = 
5.6 Hz); 2.74 (dd, 2H, H(1a’’), 2J1a’’,1b’’ = 13.6 Hz, 3J1a’’,7 = 10.8 Hz); 2.59 (ddd, 2H, 
H(9b), 2J9b,9a = 9.8 Hz, 3J9b, 10 = 5.6 Hz, 3J9b, 8 = 5.6 Hz); 2.18 (ddd, 2H, H(8), 3J8,9b = 5.6 
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Hz, 4J8, 10 = 5.6 Hz, 3J8,7  = 2.7 Hz); 1.45 (d, 2H, H(9a) 2J9a,9b = 9.8 Hz); 1.37 (s, 6H, 
H(12)); 0.65 (s, 6H, H(13)). 
 13C-NMR (75MHz, CDCl3): δ160.4 (Cq); 158.6 (Cq); 156.2 (Cq); 155.9 (Cq); 153.6 
(Cq); 142.2 (Cq); 138.6 (Cq); 137.4 (CH, C(4’)); 133.6 (CH, C(4)); 132.3 (Cq); 129.2 
(CH, C(3’), C(4’), C(6’), C(7’)); 128.2 (CH, C(8’), C(12’)); 118.9 (CH, C(5’)); 118.4 
(CH, C(3’)); 118.1 (CH, C(3)); 114.0 (CH, C(9’), C(11’)); 55.4 (CH3, C(13’)); 47.0 
(CH, C(10)); 46.2 (CH, C(7)); 42.7 (CH, C(8)); 41.2 (Cq, C(11)); 38.5 (CH2, C(1’’)); 
28.4 (CH2, C(9)); 26.3 (CH3, C(12)); 20.9 (CH3, C(13)). 
MS-FAB (Matrix: NBA): m/z = 816 (MH+, 82%); 355 (M+/2-bridge, 100%); 341 
(M+/2-bridge- CH2, 95%); 154 (C11H8N+, 23%) 
UV/Vis: (CHCl3), λ (ε): 279 nm (5.2*104) 
Elemental analysis calculated C: 82.52%, H: 6.68%, N: 6.87%, found C: 82.40%, H: 
6.76%, N: 6.2%. 
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3.15. {6’-p-Methoxyphenyl}-[5,6]-CHIRAGEN[m-xyl] (L14) 
 
N
N
N
N
OO
N
N
1) LDA, THF, -40°C
2) α,α'-Dibromo-m-xylene
O
 
 
To dry THF (20 ml) at –20 °C diisopropylamine (0.6 ml, 4 mmole) was added, 
followed by n-butyllithium (2.1 ml, 3.4 mmole, 1.6 M in hexane). The temperature 
was allowed to increase to 0 °C for 30 minutes and then lowered to –40 °C. {6’-p-
Methoxyphenyl}-[5,6]-pinene-bpy (L9) (1.0 g, 2.8 mmole) dissolved in dry THF (10 
ml) was added dropwise over 1 hour. After stirring the solution at –40 °C for 2 hours 
α,α’-dibromo-m-xylene (0.37 g, 1.4 mmole) dissolved in THF (8 ml) was injected 
slowly (1 hour). The solution was warmed gradually to room temperature, quenched 
by water (3 ml), followed by addition of dichloromethane and a saturated aqueous 
solution of NaHCO3. The aqueous solution was extracted three times with 
dichloromethane. The combined organic layers were dried over magnesium sulfate, 
and the solvent was evaporated. After several purifications via column 
chromatography (Hexane/ ethyl acetate/ trimethylamine: 8/1/0.5) and via 
recrystallisation (chloroform/methanol) white crystals of L14 (0.15g 13%) were 
obtained. 
1H-NMR (300 MHz, CDCl3): δ8.39 (d, 2H, H(3’), 3J3’,4’ = 7.2 Hz); 8.34 (d, 2H, H(3), 
3J3,4 = 8 Hz); 8.12 (d, 4H, H(8’), H(12’), 3J8’,9’ = 8.8 Hz); 7.82 (dxd, 2H, H(4’), 3J4’,3’ = 
7.1 Hz, 3J4’,5’ = 7.2 Hz); 7.66 (d, 2H, H(5’), 3J5’,4’ = 7.1 Hz); 7.37 (d, 2H, H(4), 3J4,3 = 8 
Hz); 7.32-7.25 (broad, 3H, H(3’’), H(5’’), H(7’’)); 7.17 (d, 1H, H(6’’), 3J6’’,5’’ = 7.1 
Hz); 7.02 (d, 4H, H(9’), H(11’), 3J9’,8’ = 8.8 Hz); 3.90 (m, 2H, H(1b’’)); 3.87 (s, 6H, 
H(13’)); 3.43 (ddd, 2H, H(7), 3J7,1a’’ = 10.8 Hz, 3J7,1b’’ = 2.8 Hz, 3J7,8 = 2.8 Hz); 2.82 
(dxd, 2H, H(10), 3J10,9b = 5.6 Hz, 4J10,8 = 5.6 Hz); 2.73 (dxd, 2H, H(1a’’), 2J1a’’,1b’’ = 
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13.8 Hz, 3J1a’’,7 = 10.8 Hz); 2.57 (ddd, 2H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b, 10 = 5.6 Hz, 3J9b, 
8 = 5.6 Hz); 2.14 (ddd, 2H, H(8), 3J8,9b = 5.6 Hz, 4J8, 10 = 5.6 Hz, 3J8,7  = 2.8 Hz); 1.47 (d, 
2H, H(9a), 2J9a,9b = 9.6 Hz); 1.36 (s, 6H, H(12)); 0.64 (s, 6H, H(13)).  
UV/Vis: (CHCl3), λ (ε): 280 nm (4.9*104) 
Elemental analysis: calculated C: 82.52%, H: 6.68%, N: 6.87%, found C: 81.88%, H: 
6.63%, N: 6.28%. 
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3.16. [5,6]-CHIRAGEN[0] (L15) 
 
N
N
2 1) LDA, THF, -40°C
2) I2
N
N
N
N
H H
 
 
The synthesis of L15 was carried out according to the published procedure. [60] To 
dry THF (20 ml) at –20 °C diisopropylamine (1.2 ml, 7.0 mmole) was added, followed 
by n-butyllithium (4.2 ml, 6.6 mmole 1.6 M in hexane). The temperature was allowed 
to increase to 0 °C for 30 minutes and then lowered to –40 °C. L1 (1.5 g, 6 mmole) 
dissolved in dry THF (20 ml) was added dropwise over 1 hour. After stirring the 
solution at –40 °C for 2 hours of iodine (0.79 g, 3.1 mmole) dissolved in THF (20 ml) 
was injected slowly (1 hour). The solution was warmed gradually to room temperature, 
quenched by water (3 ml), followed by addition of dichloromethane and a saturated 
aqueous solution of NaHCO3. The aqueous solution was extracted three times with 
dichloromethane. The combined organic layers were dried over magnesium sulfate, 
and the solvent was evaporated. The residual solid was further purified by 
recrystallization (chloroform/methanol) yielding pure L15 (0.8 g, 54 %). The spectral 
properties correspond to those reported 
1H-NMR (300 MHz, CDCl3): δ = 8.61 (ddd, 2H, H(6’), 3J6’,5’ = 4.8 Hz, 4J6’,4’ =1.8 Hz, 
5J6’,3’ = 0.8 Hz), 8.33 (ddd, 2H, H(3’), 3J3’,4’ = 7.8 Hz), 8.02 (d, 2H, H(3), 3J3,4 = 7.8 
Hz), 7.71 (ddd, 2H, H(4’), 3J4’,3’ = 7.8 Hz, 3J4’,5’ =6.0 Hz, 4J4’,6’ = 1.8 Hz), 7.34 (d, 2H, 
H(4), 3J4,3 = 7.8 Hz), 7.21 (ddd, 2H, H(5’), 3J5’,4’ = 6.0 Hz, 3J5’,6’ = 4.8 Hz, 4J5’,3’ = 1.2 
Hz), 4.58 (s, broad, 2H, H(7)), 2.78 (dd, 2H, H(10), 3J10,9b = 5.7 Hz, 4J10,8 = 5.7 Hz); 
2.49 (ddd, 2H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b,10 = 5.7 Hz, 3J9b,8 = 5.7 Hz); 2.13 (dd, 2H, 
H(8) 3J8,9b = 5.7 Hz, 4J8,10 = 5.7 Hz); 1.38 (d, 2H, H(9a), 2J9a,9b = 9.6 Hz); 1.30 (s, 6H, 
H(12)), 0.76 (s, 6H, H(13)). 
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3.17. 15N-[5,6]-CHIRAGEN[0] (15N-L15) 
 
N
15N
2 1) LDA, THF, -40°C
2) I2
N
15N
N
15N
H H
 
 
The same procedure as described above was used for the synthesis of the 15N-L15, 
using 15N-L1 as starting material. 15N-L1 (0.4 mg, 1.6 mmole) lead after 
recrystallisation to the desired product 15N-L15 (290 mg,73%). The spectral data 
corresponds to that of the non-labelled compound (L15). 
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3.18. {5’-p-Methoxyphenyl}-[5,6]-CHIRAGEN[0] (L16) 
 
O
N
N
O
N
NO
N
N
2 1) LDA, THF, -40°C
2) I2
H H
 
 
To dry THF (40 ml) at –40 °C diisopropylamine (0.2 ml, 1.4 mmole) was added, 
followed by n-butyllithium (0.85 ml, 1.35 mmole, 1.6 M in hexane). The temperature 
was allowed to increase to 0 °C for 30 minutes and then lowered to –40 °C. {5’-p-
Methoxyphenyl}-[5,6]-pinene-bpy (L3) (400 mg, 1.12 mmole) dissolved in dry THF 
(10 ml) was added dropwise over 45 minutes. After stirring the solution at –40°C for 2 
hours  of iodine (148 mg, 0.56 mmole) dissolved in THF (10 ml) was injected slowly 
(1 hour). The solution was warmed gradually to room temperature, quenched by water 
(50 ml), followed by addition of dichloromethane and a saturated aqueous solution of 
NaHCO3.  The aqueous solution was extracted three times with diethyl ether. The 
combined organic layers were dried over magnesium sulfate, and the solvent was 
evaporated. The residual solid was further purified by column chromatography 
(Hexane/ ethyl acetate/ trimethylamine: 1/1/0.5) and recrystallisation yielding the 
desired product (63 mg, 16%) . 
1H-NMR (400 MHz, CDCl3): δ 8.81 (br, 2H, H(6’)); 8.37 (br, 2H, H(3’)); 8.14 (d, 2H, 
H(3), 3J3,4 = 7.7 Hz); 7.89 (dd, 2H, H(4’), 3J4’,3’ = 8.3 Hz, 4J4’,6’ = 2.2 Hz); 7.55 (d, 4H, 
H(9’), H(11’), 3J9’,8’ = 8.7 Hz); 7.37 (d, 2H, H(4), 3J4,3 = 7.7 Hz); 6.99 (d, 4H, H(8’), 
H(12’), 3J8’,9’ = 8.7 Hz); 4.60 (br, 2H, H(7)); 3.84 (s, 6H, H(13’)); 2.81 (dd, 2H, H(10), 
3J10,9b = 5.5 Hz, 4J10,8 = 5.5 Hz); 2.51 (m, 2H, H(9b)); 2.16 (dd, 2H, H(8) 3J8,9b = 5.5 Hz, 
4J8,10 = 5.5 Hz); 1.43 (d, 2H, H(9a)); 1.34 (s, 6H, H(12)); 0.79 (s, 6H, H(13)). 
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13C-NMR (100 MHz, CDCl3): δ 159.7 (Cq); 158.3 (Cq); 155.1 (Cq); 152.6 (Cq); 
146.8 (CH, C(6’)); 143.0 (Cq); 135.4 (Cq); 134.6 (CH, C(4’)); 133.6 (CH, C(4)); 
130.2 (Cq); 128.0 (CH, C(9’), C(11’)); 120.7 (CH, C(3’)); 117.6 (CH, C(3)); 114.5 
(CH, C(8’), C(12’)); 55.4 (CH3, C(13’)); 46.5 (CH, C(7)); 46.2 (CH, C(10)); 42.70 
(Cq, C(11) ); 41.9 (CH, C(8)); 29.0 (CH2, C(9)); 26.3 (CH3, C(12)); 21.0 (CH3, C(13)). 
MS(ESI): m/z = 711 (M+) 
UV/Vis: (CHCl3), λ (ε): 319 nm (7.1*104), 274 nm (2.5 *104 ; sh). 
CD: (CHCl3), λ (∆ε): 332 (-87), 300 (61) 
Elemental analysis calculated C: 81.10%, H: 6.52%, N: 7.88% , found C: 79.93%, H: 
6.72%, N: 7.70% . 
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3.19. {6’-Phenyl}-[5,6]-CHIRAGEN[0] (L17) 
 
N
N
N
N
N
N
2 1) LDA, THF, -40°C
2) I2
H H
 
 
To dry THF (5 ml) at –20 °C diisopropylamine (0.33 ml, 2.3 mmole) was added, 
followed by n-butyllithium (1.9 ml, 2.1 mmole, 1.1 M in hexane). The temperature 
was allowed to increase to room temperature for 15 minutes and then lowered to         
–40 °C. {6’-Phenyl}-[5,6]-pinene-bpy (L7) (494 mg, 1.5 mmole) dissolved in dry THF 
(5 ml) was added dropwise over 1 hour). After stirring the solution at –40 °C for 4 
hours iodine (192 mg, 0.76 mmole) dissolved in THF (5 ml) was injected slowly (15 
minutes). The solution was warmed to room temperature overnight, quenched by water 
(2 ml). The solvent was removed under reduced pressure and a saturated aqueous 
solution of NaHCO3 (10 ml) was added to the resulting solid. The aqueous solution 
was extracted three times with dichloromethane. The combined organic layers were 
dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. 
The residual solid was further purified by recrystallization (methanol/ 
dichloromethane) yielding the pure compound L17(345 mg, 70 %) . 
1H-NMR (300 MHz, CDCl3): δ 8.32 (d, 2H, H(3) 3J3,4 = 7.8 Hz); 8.31 (br, 2H, H(3’)); 
8.14 (d, 4H, H(8’), H(12’) , 3J8’,9’ = 7.3 Hz); 7.80 (dd, 2H, H(4’), 3J4’,3’ =7.8 Hz, 3J4’,5’ = 
7.8 Hz); 7.69 (d, 2H, H(5’),3J5’,4’ = 7.8 Hz); 7.49 (dd, 4H, H(9’), H(11’),3J9’,8’ = 7.3 Hz, 
3J9’,10’ =7.3 Hz); 7.41 (dd, 2H, H(10’)); 3J10’,9’ =7.3 Hz); 7.38 (d, 2H, H(4) 3J4,3 = 7.8 
Hz); 4.65 (m, 2H, H(7)); 2.81 (dd, 2H, H(10), 3J10,9b = 5.6 Hz, 4J10,8 = 5.6 Hz); 2.50 
(ddd, 2H, H(9b), 2J9b,9a = 9.8 Hz, 3J9b,10 = 5.6Hz, 3J9b,8 = 5.6 Hz)); 2.16 (dd, 2H, H(8), 
3J8,9b = 5.6 Hz, 4J8,10 = 5.6 Hz); 1.38 (b, 2H, H-C(9a)); 1.31 (s, 6H, H-C(12)); 0.79 (s, 
6H, H(13)). 
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13C-NMR (75 MHz, CDCl3): δ 158.2 (Cq); 156.7 (Cq); 156.7.2 (Cq); 153.3 (Cq); 
143.1 (Cq); 139.6 (Cq); 137.4 (CH, C(4’)); 133.4 (CH, C(4)); 128.9 (CH, C(10’)); 
128.6 (CH, C(9’), C(11’)); 126.9 (CH, C(8’), C(12’)); 119.5 (CH, C(5’)); 119.1 (CH, 
C(3’)); 117.9 (CH, C(3)); 46.3 (CH, C(7)); 46.2 (CH, C(10)); 42.6 (CH, C(8)); 41.9 
(Cq, C(11)); 29.1 (CH2, C(9)); 26.3 (CH3, C(12)); 21.0 (CH3, C(13)). 
FAB-MS (matrix: NBA): m/z = 651.6 (M+); 575.3 (M-C6H5+); 557.7 (M-C12H10+); 
326.4 (C23H21N2, M/2+); 283.3 (M/2-C3H7+); 218.2 (C14H14N2+); 154.1 (C10H6N2+). 
Elemental analysis calculated for C46H42N4: C 84.89%, H 6.50%, N 8.61%; found C 
83.33%, H 6.55%, N 8.43%. 
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3.20. {6’-p-Methoxyphenyl}-[5,6]-CHIRAGEN[0] (L18) 
 
N
N
N
N
N
N
2 1) LDA, THF, -40°C
2) I2
O
O O
H H
 
 
To dry THF (20 ml) at –20 °C diisopropylamine (0.6 ml, 4 mmole) was added, 
followed by n-butyllithium (2.1 ml, 3.4 mmole, 1.6 M in hexane). The temperature 
was allowed to increase to 0 °C for 30 minutes and then lowered to –40°C. {6’-p-
Methoxyphenyl}-[5,6]-pinene-bpy (L9) (1.0 g, 2.8 mmole) dissolved in dry THF (10 
ml) was added dropwise over 1 hour. After stirring the solution at –40 °C for 2 hours 
iodine (0.37 g, 1.4 mmole) dissolved in THF (8 ml) was injected slowly (1 hour). The 
solution was warmed gradually to room temperature, quenched by water (3 ml), 
followed by addition of dichloromethane and a saturated aqueous solution of NaHCO3. 
The aqueous solution was extracted three times with dichloromethane. The combined 
organic layers were dried over magnesium sulfate, and the solvent was evaporated. 
The residual solid was further purified by recrystallization (methanol/chloroform), 
yielding white crystals (0.53 g, 53%) 
1H-NMR (400 MHz, CDCl3): δ 8.31 (d, 2H, H(3), 3J3,4 = 7.8 Hz); 8.25 (b, 2H, H(3’)); 
8.11 (d, 4H, H(8’), H(12’), 3J8’,9’ = 8.8 Hz); 7.76 (dd, 2H, H(4’), 3J4’,3’ = 7.8 Hz, 3J4’,5’ = 
7.8 Hz); 7.62 (d, 2H, H(5’), 3J5’,4’ = 7.8 Hz); 7.37 (d, 2H, H(4), 3J4,3 = 7.8 Hz); 7.01 (d, 
4H, H(9’), H(11’), 3J9’,8’ = 8.8 Hz); 4.65 (b, 2H, H(7)); 3.87 (s, 6H, H(13’); 2.80 (dd, 
2H, H(10), 3J10,9b = 5.6 Hz, 4J10,8 = 5.6 Hz); 2.50 (ddd, 2H, H(9b), 2J9b,9a= 9.8 Hz, 3J9b,10 
= 5.6 Hz, 3J9b,8 = 5.6 Hz); 2.16 (dd, 2H, H(8), 3J8,10 = 5.6 Hz, 3J8,9b = 5.6 Hz), 1.38 (b, 
2H, H(9a)); 1.31 (s, 6H, H(12)); 0.79 (s, 6H, H(13)). 
13C-NMR (100 MHz, CDCl3): δ 160.4 (Cq); 158.2 (Cq); 156.5 (Cq); 155.8 (Cq); 
153.3 (Cq); 143.0 (Cq); 137.4 (CH, C(4’)); 133.4 (CH, C(4)); 132.3 (Cq); 128.2 (CH, 
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C(8’), C(12’)); 118.8 (CH, C(5’); 118.4 (CH, C(3’)); 117.8 (CH, C(3)); 114.0 (CH, 
C(9’), C(11’)); 55.4 (CH3, C(13’); 46.3 (CH, C(7)); 46.2 (CH, C(10)); 42.6 (CH, 
C(8)); 41.8 (Cq, C(11)); 29.1 (CH2, C(9)); 26.3 (CH3, C(12)); 21.0 (CH3,C(13)). 
MS-FAB (Matrix: NBA) : m/z = 712 (M+, 58%); 341 (M+/2-Me, 26%); 307 (52%); 
154 (C11H8N+, 100%), 136 (93%). 
UV/Vis: (CHCl3), λ (ε): 280 (5.3*104). 
CD: (CHCl3), λ (∆ε): 310 (-22), 287 (+32), 266 (-21.5) 
Elemental analysis calculated: C: 81.10%, H: 6.52%, N: 7.88%, found C: 80.37%, H: 
6.41%, N: 7.37%. 
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X-ray crystallography 
 Suitable crystals of L18 were obtained as colourless rod-like crstals by 
evaporation of a chloroform solution. The intensity data was collected at 153K on a 
Stoe Image Plate Diffraction System[138] using MoKα graphite monochromated 
radiation. Image plate distance 70mm, φ oscillation scans 0 - 200°, step ∆φ = 1.0°, 2θ 
range 3.27 – 52.1°, dmax -dmin = 12.45 - 0.81 Å.  The structure was solved by direct 
methods using the programme SHELXS-97.[139] The refinement and all further 
calculations were carried out using SHELXL-97.[140] The H-atoms were located from 
Fourier difference maps and refined isotropically. The non-H atoms were refined 
anisotropically, using weighted full-matrix least-squares on F2.  
The molecule possesses C2 crystallographic symmetry. The absolute structure of the 
molecule in the crystal was assigned to the known absolute configuration of the 
pinene-moiety.
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3.21. {2-DAMI}-[5,6]-CHIRAGEN[0] (L19) 
 
2 1) LDA, THF, -40°C
2) I2 N N
N N
N
N
H H
 
 
To dry THF (20 ml) at –20 °C diisopropylamine (1.6 ml, 11.3 mmole) was added 
followed by n-butyllithium (5.8 ml, 9.3 mmole, 1.6 M in hexane). The temperature 
was allowed to increase to 0 °C for 30 minutes and then lowered to –40 °C. {2-
DAMI}-[5,6]-pinene-py (L10) (0.8 g, 3.1 mmole) dissolved in dry THF (10 ml) was 
added dropwise over 1 hour. After stirring the solution at –40 °C for 2 hours iodine 
(0.5 g, 0.2 mmole) dissolved in 8 ml THF was injected slowly (1 hour). The solution 
was warmed gradually to room temperature, quenched by water (3 ml), followed by 
addition of dichloromethane and a saturated aqueous solution of NaHCO3. The 
aqueous solution was extracted three times with dichloromethane. The combined 
organic layers were dried over magnesium sulfate, and the solvent was evaporated. 
The residual solid was further purified by recrystallization (methanol/chloroform), 
yielding white crystals (0.16 g, 20%). 
1H-NMR (400 MHz, CDCl3/CD3CN): δ = 7.08 (d, 2H, H(3), 3J3,4 = 7.8 Hz), 7.03 (d, 
2H, H(4), 3J4,3 = 7.8 Hz), 4.30 (s, br, 2H, H(7)), 2.56 (dd, 2H, H(10), 3J10,9b = 5.6 Hz, 
4J10,8 = 5.6 Hz), 2.27 (ddd, 2H, H(9b), 2J9b,9a = 9.4 Hz, 3J9b,10 = 5.6 Hz, 3J9b,8 = 5.6 Hz), 
2.07 (s, 12H, H(6’), H(5’)), 1.92-1.76 (m, 2H, H(8)), 1.31 (s, 6H, H(3’)), 1.27 (s, 6H, 
H(4’)), 1.14 (s, 6H, H(12)), 1.08 (s, br, 2H, H(9a)), 0.58 (s, 6H, H(13)). 
13C-NMR (CDCl3/CD3CN, 400 MHz): δ = 163.54 (Cq, C(6)), 157.15 (Cq, C(2)), 
140.28 (Cq, C(5)), 132.64 (CH, C(4)), 117.51 (CH, C(3)), 62.00 (Cq, C(2’)), 46.11 
(CH, C(10)), 41.52 (Cq, C(11)), 39.65 (CH3, C(5’), C(6’)), 26.54 (CH3, C(12)), 24.72 
(CH3, C(3’)), 22.71 (CH3, C(4’)), 31.30 (CH3, C(13)). 
MS(ESI): m/z = 515.5 (HM+) 
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UV/Vis: (CHCl3), λ (ε): 276 (1.1*104). 
CD: (CHCl3), λ (∆ε): 269 (13.7). 
Elemental analysis calculated: C: 79.33%, H: 9.79%, N: 10.88%, found C: 79.7%, H: 
9.86%, N: 10.74%. 
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X-ray crystallography 
 Suitable crystals of L19 were obtained as colourless rod-like crystals by slow 
evaporation of a Chloroform/methanol solution. The intensity data was collected at 
153K on a Stoe Image Plate Diffraction System[138] using MoKα graphite 
monochromated radiation. Image plate distance 70mm, φ oscillation scans 0 - 198°, 
step ∆φ = 1.0°, 2θ range 3.27 – 52.1°, dmax -dmin = 12.45 - 0.81 Å.  The structure was 
solved by Direct methods using the programme SHELXS-97.[139] The refinement and 
all further calculations were carried out using SHELXL-97.[140] The H-atoms were 
included in calculated positions and treated as riding atoms using SHELXL default 
parameters. The non-H atoms were refined anisotropically, using weighted full-matrix 
least-squares on F2. The molecule possesses C2 symmetry. The absolute structure of 
the molecule in the crystal was assigned to the known absolute configuration of the 
pinene-moiety. 
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3.22. [4,5]-CHIRAGEN[0] (L20) 
 
N
N
2 1) LDA, THF, -40°C
2) I2
N
N
N
N
H H
 
 
The synthesis was carried out according to the published method[36], giving a slightly 
better yield. To dry THF (15 ml) at –20 °C diisopropylamine (0.15 ml, 1 mmole) was 
added, followed by n-butyllithium (0.6 ml, 0.96 mmole,1.6 M in hexane). The 
temperature was allowed to increase to 0 °C for 30 minutes and then lowered to          
–40 °C. [4,5]-Pinene-bpy (L2) (200 mg, 0.8 mmole) dissolved in dry THF(10 ml) was 
added dropwise over 1 hour. After stirring the solution at –40 °C for 2 hours, iodine 
(0.13 g, 0.5 mmole) dissolved in THF (10 ml) was injected slowly (1 hour). The 
solution was warmed gradually to room temperature, quenched by water (3 ml), 
followed by addition of dichloromethane and a saturated aqueous solution of NaHCO3. 
The aqueous solution was extracted three times with dichloromethane. The combined 
organic layers were dried over magnesium sulfate, and the solvent was evaporated. 
The residual solid was further purified by recrystallization (methanol/chloroform), 
yielding of pure product (135 mg, 69%). 
1H-NMR (300 MHz, CDCl3, ): δ = 8.65 (ddd, 2H, H(6’), 3J6’,5’ = 3.9 Hz, 4J6’,4’ = 1.7 
Hz), 8.45 (s, 2H, H(3), 8.36 (ddd, 2H, H(3’), 3J3’,4’ = 8.0 Hz), 8.26 (s, 2H, H(6)), 7.79 
(ddd, 2H, H(4’), 3J4’,3’ = 8.0 Hz, 3J4’,5’ = 8.0 Hz, 4J4’,6’ = 1.7 Hz), 7.26 (ddd, 2H, H(5’), 
3J5’,4’ = 6.0 Hz, 3J5’,6’ = 4.8 Hz, 4J5’,3’ = 1.2 Hz), 4.03 (s, 2H, H(7)), 2.82 (dd, 2H, 
H(10), 3J10,9b = 5.5 Hz, 4J10,8 = 5.5 Hz); 2.50 (ddd, 2H, H(9b), 2J9b,9a = 9.8 Hz, 3J9b,10 = 
5.5 Hz, 3J9b,8 = 5.5 Hz); 2.09 (dd, 2H, H(8) 3J8,9b = 5.5 Hz, 4J8,10 = 5.5 Hz); 1.28 (s, 6H, 
H(12)), 1.24 (d, 2H, H(9a), 2J9a,9b = 9.8 Hz); 0.70 (s, 6H, H(13)). 
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4. Complex syntheses 
 
4.1. [Ag6L116](PF6)6 (C3) 
 
 
O
N
N
O
N
N
CH3CN/CHCl3
AgPF6
 
AgPF6 (15.5 mg, 0.061 mmol) dissolved in acetonitrile (6 ml) was added to a solution 
of L11 (50 mg, 0.061 mmol) in chloroform (2 ml) and acetonitrile (2 ml). This mixture 
was stirred for 10 minutes at room temperature and the solvent was evaporated under 
reduced pressure. The white solid (quantitative yield) was used without further 
purification for the analysis.  
1H-NMR (400 MHz, CD3CN): δ 8.74 (d, 2H, H(6’), 3J6’,4’ = 2.0 Hz); 8.29 (d, 2H, 
H(3), 3J3,4 = 8.3 Hz); 8.24 (d, 4H, H(3’), 3J3’,4’ = 8.2 Hz); 8.14 (d, 2H, H(4’), 3J4’,3’ = 8.2 
Hz); 7.85 (d, 2H, H(4), 3J4,3 = 8.3 Hz); 7.44 (d, 2H, H(9’), H(11’), 3J9’,8’ = 8.6 Hz); 6.89 
(d, 2H, H(8’), H(12’), 3J8’,9’ = 8.6 Hz); 5.95 (s, 4H, H(3’’), H(4’’), H(6’’), H(7’’)); 3.83 
(d, 2H, H(1b’’), 2J1b’’,1a’’ = 12.6 Hz); 3.75 (s, 6H, H(13’)); 2.97 (m, 2H, H(10)); 2.89 
(m, 2H, H(7), 3J7,1b’’ = 10.5 Hz); 2.59 (m 2H, H(9b),  2J9b,9a = 9.1 Hz); 2.46 (m, 2H, 
H(1a’’)); 1.60 (d, 2H, H(9a), 2J9a,9b = 9.1 Hz); 1.45 (m, 2H, H(8)); 1.22 (s, 6H, H(12)); 
0.14 (s, 6H, H(13)). 
13C-NMR (100 MHz, CD3CN): δ 161.5 (Cq); 160.1 (Cq); 151.3 (Cq); 149.1 (Cq); 
146.0 (CH, C(6’)); 138.4 (Cq); 137.8 (CH, C(4’)); 137.4 (CH, C(4)); 137.3 (Cq); 
129.2 (CH, C(3’’)); 128.9 (CH, C(9’), C(11’)); 123.5 (CH, C(3’)); 122.1 (CH, C(3)); 
115.6 (CH, C(8’), C(12’)); 56.1 (CH3, C(13’)); 49.6 (CH, C(7)); 47.4 (CH, C(10)); 
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43.2 (CH, C(8)); 41.6 (Cq, C(11)); 38.5 (CH2, C(1’’)); 28.2 (CH2, C(9)); 26.6 (CH3, 
C(12)); 21.8 (CH3, C(13)). 
ESI-MS (CH3CN): m/z = 1737.52 (1+, [AgL112]+); 1457.96 (4+, [Ag6L116](PF6)24+; 
2+, [Ag3L113]PF62+); 1136.53 (5+, [Ag6L116](PF6)25+]+); 922.51 (1+, [AgL11]+). 
UV/Vis: (c= 9.7*10-6 M for [AgL11]PF6, CH3CN, λ (ε)): 317 (7.1*104), 273 
(2.6*104). 
CD: (c= 9.7*10-6 M for [AgL11]PF6, CH3CN, λ(∆ε)): 342 (11.8), 303 (-8.0), 230       
(-16.1). 
Elemental analysis calculated C: 62.98%, H: 5.10%, N: 5.25%, found C: 62.4%, H: 
4.96, N: 4.58%. 
 
 
4.2. [Cu6L116](PF6)6 (C4) 
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[Cu(CH3CN)4]PF6[108] (22.8 mg, 0.061 mmol) dissolved in acetonitrile (6 ml) was 
added to a solution of (50 mg, 0.061 mmol) L11 in chloroform (2 ml) and acetonitrile 
(2 ml). Immediately the solution became orange-red. This colored mixture was stirred 
for 10 minutes at room temperature and the solvent was evaporated under reduced 
pressure. The red solid (60.5mg, 97%) was used without further purification for the 
analysis.  
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1H-NMR (400 MHz, CD3CN): δ 8.48 (d, 2H, H(6’), 4J6’,4’ = 2.0 Hz); 8.33 (d, 2H, 
H(3’), 3J3’,4’ = 8.5 Hz); 8.32 (d, 4H, H(3), 3J3,4 = 8.1 Hz); 8.16 (d, 2H, H(4’), 3J4’,3’ = 8.5 
Hz, 4J4’,3’ = 2.0 Hz); 7.88 (d, 2H, H(4), 3J4,3 = 8.1 Hz); 7.40 (d, 2H, H(9’), H(11’), 3J9’,8’ 
= 8.6 Hz); 6.90 (d, 2H, H(8’), H(12’), 3J8’,9’ = 8.6 Hz); 5.78 (s, 4H, H(3’’), H(4’’), 
H(6’’), H(7’’)); 3.80 (d, 2H, H(1b’’), 2J1b’’,1a’’ = 12.6 Hz); 3.75 (s, 6H, H(13’)); 3.05 
(dd, 2H, H(10), 3J10,9b = 5.7 Hz, 4J10,8 = 5.7 Hz); 2.77 (d, 2H, H(7), 3J7,1b’’ = 11.7 Hz); 
2.58 (ddd 2H, H(9b),  2J9b,9a = 10.1 Hz, 3J9b,10 = 5.7 Hz, 3J9b,8 = 5.7 Hz); 2.33 (m, 2H, 
H(1a’’)); 1.63 (d, 2H, H(9a), 2J9a,9b = 10.1 Hz); 1.40 (m, 2H, H(8)); 1.17 (s, 6H, 
H(12)); 0.09 (s, 6H, H(13)). 
13C-NMR (100 MHz, CD3CN): δ 160.7 (Cq); 159.0 (Cq); 151.4 (Cq); 150.9 (Cq); 
145.9 (CH, C(6’)); 138.7 (Cq); 136.6 (CH, C(4’)); 135.9 (CH, C(4)); 135.5 (Cq); 
128.7 (CH, C(3’’)); 128.5 (CH, C(9’), C(11’)); 121.8 (CH, C(3’)); 120.9 (CH, C(3)); 
114.8 (CH, C(8’), C(12’)); 55.4 (CH3, C(13’)); 49.0 (CH, C(7)); 46.7 (CH, C(10)); 
42.6 (CH, C(8)); 41.8 (Cq, C(11)); 37.3 (CH2, C(1’’)); 27.4 (CH2, C(9)); 25.8 (CH3, 
C(12)); 21.7 (CH3, C(13)). 
ESI-MS (CH3CN): m/z = 1693.76 (1+, [CuL112]+); 1560.88 (3+, [Cu5L115](PF6)23+); 
1390.02 (2+, [Cu3L113]PF62+); 1219.79 (2+, [Cu4L114]PF63+); 1134.42 (4+, 
[Cu5L115]PF64+); 879.35 (1+, 3+, 6+, [CunL11n]n+); 815.43 (1+, [HL11]+); 470.15 (2+, 
[Cu2L11]2+); 439.18 (2+, [CuL11]2+). 
UV/Vis: (c= 1.44*10-6 M for [CuL11]PF6, CH3CN, λ (ε)): 317 (6.4*104). 
CD: (c= 1.44*10-6 M for [CuL11]PF6, CH3CN, λ(∆ε)): 345 (10.1), 282 (-3.6), 242 
(3.0), 229 (-10.0). 
 
166  Experimental Part 
 
4.3. [Cu6L136](PF6)6 (C5) 
 
 
 
N
N
N
N
OO
Cu(CH3CN)4PF6
CH3CN/CHCl3
 
 
 
[Cu(CH3CN)4]PF6[108] (22.9 mg, 0.061 mmol) dissolved in acetonitrile (6 ml) was 
added to a solution of L13 (50 mg, 0.061 mmol) in chloroform (2 ml) and acetonitrile 
(2 ml). Immediately the solution became orange-red. This colored mixture was stirred 
for 10 minutes at room temperature and then about 6 ml of the solvent was evaporated 
under reduced pressure. The remaining solution was precipitated with diethyl ether. 
The precipitate was filtrated over Kieselgur, washed with hexane and chloroform and 
redissolved in acetonitrile. The solvent was removed under reduced pressure. The 
orange-red powder was dried in vacuum, yielding the complex C5 (49 mg, 78%). 
1H-NMR (400 MHz, CD3CN): δ 8.12 (d, 2H, H(3), 3J3,4 = 8.1 Hz); 7.90 (d, 2H, H(4), 
3J4,3 = 8.1 Hz); 7.68 (m, 4H, H(3’), H(4’)); 7.28 (dd, 2H, H(5’), 3J5’,4’ = 7.3 Hz, 3J5’,3’ = 
2.6 Hz); 7.08 (d, 2H, H(8’), H(12’), 3J8’,9’ = 8.6 Hz); 6.24 (d, 2H, H(9’), H(11’), 3J9’,8’ = 
8.6 Hz); 5.69 (s, 4H, H(3’’), H(4’’), H(6’’), H(7’’)); 4.26 (dd, 2H, H(1b’’), 2J1b’’,1a’’ = 
12.5 Hz, 3J1b’’,7 = 3.6 Hz); 3.64 (s, 6H, H(13’)); 3.10 (dd, 2H, H(10), 3J10,9b = 5.6 Hz, 
4J10,8 = 5.6 Hz); 2.93 (m, 2H, H(7), 3J7,1b’’ = 11.7 Hz); 2.64 (ddd, 2H, H(9b),  2J9b,9a = 
10.0 Hz, 3J9b, 10 = 5.6 Hz, 3J9b, 8 = 5.6 Hz); 2.56 (m, 2H, H(1a’’), J = 12 Hz); 1.77 (d, 
2H, H(9a), 2J9a,9b = 10.0 Hz); 1.45 (m, 2H, H(8)); 1.21 (s, 6H, H(12)); 0.14 (s, 6H, 
H(13)). 
 
Experimental Part  167 
  
ESI-MS (CH3CN): m/z = 1691.75 (1+, [CuL132]+); 1560.55 (3+, [Cu5L135](PF6)23+); 
1133.43 (4+, [Cu5L135]PF64+); 879.36 (1+, 3+, 6+, [CunL13n]n+); 815.43 (1+, 
[HL13]+); 470.15 (2+, [Cu2L13]2+); 439.19 (2+, [CuL13]2+). 
UV/Vis: (c= 1.45*10-6 M for [CuL13]PF6, CH3CN, λ (ε)): 313 (sh, 3.2*104), 261 ( 
5.3*104), 209 (6.4*104),  
CD: (c= 1.45*10-6 M for [CuL13]PF6, CH3CN, λ(∆ε)): 318 (+7.5); 276 (3.0); 258      
(-6.3), 226 (-20.9). 
Elemental analysis calculated C: 65.71%, H: 5.32%, N: 5.47%, found C: 63.26%, H: 
5.39%, N: 5.14%. 
 
 
4.4. [Cu6L126](ClO4)6 (C6) 
 
 
 
N
N
N
N Cu(CH3CN)4ClO4
CH3CN/CHCl3
 
 
 
{6’-Phenyl}-[5,6]-pinene-CHIRAGEN[p-xyl] (L12) (50 mg, 0.066 mmol) was 
dissolved in dichloromethane (2 ml) and a solution of Cu(CH3CN)4ClO4 (22,mg, 0.66 
mmol) in acetonitrile (2 ml) was added. The colour changed from yellow to deep red. 
The mixture was stirred for 30 minutes and the solvent was removed under reduced 
pressure. The red residue was dissolved in acetonitrile and the complex was 
precipitated adding 5ml of diethyl ether. The red solid was filtered and dried in vacuo, 
yielding the complex C6 (60 mg, 99%). 
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1H-NMR (300 MHz, CD3CN): δ 8.10 (d, 2H, H(3), 3J3,4 = 8.1 Hz); 7.91 (d, 2H, H(4), 
3J4,3 = 8.1 Hz); 7.71 (m, 4H, H(3’), H(4’)); 7.35 (dd, 2H, H(5’), 3J5’,4’ = 7.68 Hz, 3J5’,3’ = 
2.6 Hz); 7.13 (d, 4H, H(8’), H(12’), 3J8’,9’ = 7.5 Hz); 7.02 (d, 2H, H(10’), 3J10’,9’ = 7.5 
Hz); 6.76 (dd, 4H, H(9’), H(11’), 3J9’,8’ = 7.5 Hz, 3J9’10’ = 7.5 Hz); 5.69 (s, 4H, H(3’’), 
H(4’’), H(6’’), H(7’’)); 4.26 (m, 2H, H(1b’’)); 3.12(dd, 2H, H(10), 3J10,9b = 5.5 Hz, 
3J10,8 = 5.5 Hz); 2.92 (m, 2H, H(7)); 2.66-2.52 (m, 2H, H(9b), H(1a’’)); 1.75 (d, 2H, 
H(9a), 2J9a,9b = 9.9 Hz); 1.45 (m, 2H, H(8)); 1.21 (s, 6H, H(12));  0.14 (s, 6H, H(13)). 
13C-NMR (75.4 MHz, CD3CN): δ 158.6 (Cq); 158.3 (Cq); 153.6 (Cq); 147.0 (Cq); 
139.8 (Cq); 139.3 (Cq); 137.0 (CH, C(4’)); 136.5 (CH, C(4)); 129.5 (Cq); 129.4 (CH, 
C(3’’)); 128.5 (CH, C(8’)); 128.2 (CH, C(10’)); 126.3 (CH, C(3’)); 122.4 (CH, C(5’)); 
121.9 (CH, C(3)); 118.2 (CH, C(9’)); 48.4 (CH, C10); 47.4 (CH, C7); 43.3 (CH, C8); 
41.0 (Cq, C11); 37.3 (CH2, C1’’); 27.9 (CH2, C9); 26.5 (CH3, C12); 22.8 (CH3, C13);  
ESI-MS (CH3CN): m/z = 1573.55 (1+, [CuL122]+); 1430.50 (3+, [Cu5L125](ClO4)23+); 
1277.54 (2+, [Cu3L123]ClO42+); 1048.03 (4+, [Cu5L125]ClO44+); 817.38 (1+, 2+, , 
[CunL12n]n+); 755.45 (1+, [HL12]+); 441.15 (2+, [Cu2L12]2+);  
UV/Vis: (c= 2.01*10-5 M for [CuL12]PF6, CH3CN, λ (ε)): 302 (3.92*104), 288 
(3.21*104), 253 (4.8*104). 
CD: (c= 2.01*10-6 M for [CuL12]PF6, CH3CN, λ(∆ε)): 306 (6.3), 252 (-6.0), 226 (-
21.0). 
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4.5. [AgL16]PF6 (C8) 
 
N
N
O
N
N
O
AgPF6
N
N
O
N
N
O
Ag
PF6
CH3CN/CHCl3
H H HH
 
 
Under argon and light protection, AgPF6 (11.2 mg, 0.045 mmol) dissolved in 
acetonitrile (6 ml) and added to a solution of 5,6-CHIRAGEN[0] (31.5 mg, 0.045 
mmol) in chloroform (6 ml) and actonitrile (4 ml). This mixture was stirred for 30 
minutes at room temperature. The solvent was removed under reduced pressure. After 
drying, a white solid was obtained (42.5 mg, quantitative yield) and was analysed 
without further purification. 
1H-NMR (400 MHz, CH3CN): δ 8.98 (s, 2H, H(6’)); 8.21 (br, 4H, H(3’), H(4’)); 7.99 
(d, 2H, H(3), 3J3,4 = 7.8 Hz); 7.55 (br, 4H, H(9’), H(11’)); 7.37 (br, 2H, H(4)); 7.03 (d, 
4H, H(8’), H(12’), 3J8’,9’ = 8.7 Hz); 4.10 (br, 2H, H(7)); 3.83 (s, 6H, H(13’)); 2.98 (m, 
2H, H(10)); 2.85 (m, 2H, H(9b)); 2.61 (m, 2H, H(8)); 1.51 (d, 2H, H(9a), 2J9a,9b = 9.8 
Hz); 1.40 (s, 6H, H(12)); 0.63 (s, 6H, H(13)). 
13C-NMR (100 MHz, CH3CN): δ 161.5 (Cq); 160.7 (Cq); 151.5 (Cq); 150.6 (Cq); 
149.2 (CH, C(6’)); 145.3 (Cq); 137.3 (Cq); 136.6 (CH, C(4’)); 135.2 (CH, C(4)); 
133.1 (Cq); 128.7 (CH, C(9’), C(11’)); 122.7 (CH, C(3’)); 120.1 (CH, C(3)); 115.0 
(CH, C(8’), C(12’)); 55.4 (CH3, C(13’)); 47.7 (CH, C(7)); 46.0 (CH, C(10)); 41.8 (Cq, 
C(11)); 41.4 (CH, C(8)); 31.2 (CH2, C(9)); 25.9 (CH3, C(12)); 20.6 (CH3, C(13)). 
MS(ESI): m/z = 817.3 (1+, AgL16-H+), 711.3 (1+, L16+). 
UV/Vis:  (CH3CN), λ (ε): 321 nm (6.1*104), 271 nm (2.2 *104; sh). 
CD: (CH3CN), λ (∆ε): 337 (-100), 302 (47). 
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Elemental analysis calculated C: 59.82%, H: 4.81%, N: 5.81% , found C: 59.83%, H: 
4.88%, N: 5.45% . 
 
 
4.6. [AgL18]PF6 (C9) 
 
N
N
N
N
OO
AgPF6
N
NN
N
Ag
OO
PF6
CH3CN/CHCl3
H HH H
 
 
Under argon and light protection, AgPF6 (17.7 mg, 0.07 mmol) dissolved in 
acetonitrile (6 ml) was added to a solution of 5,6-CHIRAGEN[0] (50 mg, 0.07 mmol) 
in chloroform (20 ml) and actonitrile (5 ml). This mixture was stirred for 3 hours at 
room temperature. The solvent was removed under reduced pressure. After drying, a 
white solid was obtained in quantitative yield, and was analysed without further 
purification. 
1H-NMR (400 MHz, CH3CN): δ 8.16 (d, 2H, H(3), 3J3,4 = 7.7 Hz)); 8.15 (d, 2H, H(3’), 
3J3’,4’ = 7.8 Hz); 7.95 (dd, 2H, H(4’), 3J4’,3’ = 7.8 Hz, 3J4’,5’ = 7.8 Hz); 7.79 (d, 2H, 
H(5’), 3J5’,4’ = 7.8 Hz, ); 7.52(d, 2H, H(4), 3J4,4 = 7.7 Hz); 7.35 (d, 4H, H(8’), H(12’), 
3J8’,9’ = 8.7 Hz); 6.47 (br, 4H, H(9’), H(11’)); 4.08 (br, 2H, H(7)); 3.61 (s, 6H, H(13’)); 
3.01 (m, 2H, H(10)); 2.81 (m, 2H, H(9b)); 2.60 (m, 2H, H(8));1.46 (d, 2H, H(9a), 2J9a,9b 
= 9.8 Hz); 1.39 (s, 6H, H(12)); 0.65 (s, 6H, H(13)). 
MS(ESI): m/z = 817.3 (1+, AgL18-H+), 711.3 (1+, L18+). 
UV/Vis: (CH3CN), λ (ε): 318 nm (4.9*104), 267 nm (5.2 *104; sh). 
CD: (CH3CN), λ (∆ε): 337 (-67), 292 (21), 224 (-35). 
Elemental analysis calculated C: 59.82%, H: 4.81%, N: 5.81% , found C: 59.3%, H: 
4.67%, N: 5.23% . 
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5. Protonation studies 
 
5.1. NMR-Titrations 
 
5.1.1 Measurements 
The NMR-spectra (1H, 1H-13C-HMQC, 1H-13C-HMBC, 1H-15N-HMBC) were 
measured either on a Bruker Avance DRX 400 or on a Bruker Avance DRX 700 NMR 
spectrometer. The spectrometers operate at 400.13 MHz or 700.13 MHz for 1H, at 
100.62 MHz for 13C and at 40.54 MHz or 70.96 MHz for 15N. CDCl3 was used as 
internal reference for 1H (7.26 ppm) and 13C (77.0 ppm). For the 15N-experiments 
nitromethane at (0.0 ppm) was used as internal reference. 
 
5.1.2 Preparation of the solutions 
From commercially available trifluoroacetic acid (Aldrich) a solution (2.7 M) in 
CD3CN was freshly prepared for each acidic titration. The ligands L1 (100.0 mM), 
L15 (50.0 mM) and L20 (50.0 mM) were dissolved in a mixture of CDCl3/CD3CN= 
3:1. Ligand L19 (48.6 mM) was dissolved in mixture of CDCl3/CD3CN= 5:1 
 
5.1.3 Titrations 
Titration with trifluoroacetic acid 
Titrations were carried out by adding small aliquots (typically 2.23 µl) of the TFA-
solution to the ligand solutions (0.6ml). 22.30µl of TFA solution corresponds to 1.0 
equivalent of L1, 11.16µl to 1.0 equivalent of L15 and L20. For L19, 11.15µl of the 
TFA-solution corresponds to 1.03 equivalents. 
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5.2. Spectrophotometric titrations 
 
5.2.1 Measurements 
UV/Visible spectra were measured on a Perkin Elmer Lambda 40 spectrometer. 
Wavelength are given in nm and molar absorption coefficients (ε) in M-1 cm-1. Circular 
dichroism (CD) spectra were recorded on a Jasco J-715 spectropolarimeter and the 
results are given in ∆ε M-1 cm-1. The pH was measured with a micro-combination pH 
electrode (Orion model 9863). UV-titrations were carried out with a Mettler Titrator 
DL21 with 1ml and 10ml burettes.  
 
5.2.2 Calibration of the electrode 
Assuming that hydrochloric acid is completely dissociated forming H3O+ in aqueous 
solution containing methanol. The calculated H+-concentration were attributed to the 
measured potential Emeas according to the following equation: pH = a*Emeas + b. For 
further titrations the pH was calculated with the measured potential. 
 
5.2.3 Preparation of the solutions 
0.1 M HCl (methanol/water (60% v/v)), 1M HCl (methanol/water (60% v/v)), 0.1M 
(methanol/water (90% v/v)) and 1M (methanol/water (90% v/v)) were used for the 
titrations. The ligand solutions for L1 and bpy consisted of 0.001M NaOH, 0.1M NaCl 
and 5*10-5M L1 and bpy in a mixture of methanol water (60% v/v). The ligand 
solutions for L15 and L20 consisted of 0.001M NaOH, 0.1M NaCl and 2.5*10-5 M or 
5*10-5 M of L15 and L20 in methanol water (90% v/v). 
 
5.2.4 Titrations 
In the pH-range from 10 to 3, HCl solution (0.1M) was added in 2µl steps to 2ml of 
the ligand solutions by the Mettler Titrator DL21 (1ml burette) for the UV/Vis- 
titration. In the pH-range from 3 to 1 HCl solution (1M) was used. pH of the stirred 
solution was measured directly in the cuvette by a micro electrode. The CD-titrations 
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were carried out by adding the corresponding aliquots of acid with a micropipette 
without pH-measurements. Acid solutions in methanol/water (60% v/v) were used for 
L1 and bpy, acid solutions in methanol/water (90% v/v) for L15 and L20.  
 
All spectra represented in the previous chapter are baseline and volume corrected. 
Calculations of the equilibrium constants were carried out with the program Specfit®. 
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5.3. Additional spectral data of L1, L15, L19 and L20 (incl. protonation) 
 
5.3.1 [5,6]-Pinene-bpy (L1) 
 
N
N
2
3 4
5
6
7 8
9
10
12
13
2'
3'4'
5'
6'
 
Free Ligand L1: 
1H-NMR (400 MHz, CDCl3/CD3CN): δ 8.47 (d, 1H, H(6’)), 8.18 (ddd, 1H, H(3’)), 
7.87 (d, 1H, H(3), 3J3,4 = 8.0 Hz), 7.64 (ddd, 1H, H(4’)), 7.18 (d, 1H, H(4), 3J4,3 = 8.0 
Hz), 7.12 (d, 1H, H(5’), 3J5’,4’ = 7.1 Hz, 3J5’,6’ = 7.1 Hz, 4J5’,3’ = 2.0 Hz), 3.00 (m, 2H, 
H(7)), 2.67 (dd, 1H, H(10), 3J10,9b = 5.6 Hz, 3J10,8 = 5.6 Hz), 2.56 (ddd, 1H, H(9b), 
2J9b,9a = 10.4 Hz, 3J9b,10 = 5.8 Hz, 3J9b,8 = 5.8 Hz), 2.24 (ddt, 1H, H(8), 3J8,9b = 5.8 Hz, 
3J8,10 = 5.8 Hz, 3J8,7 = 2.8 Hz), 1.26 (s, 3H, H(12)), 1.13 (d, 1H, H(9a), 0.51 (s, 3H, 
H(13)). 
15N-NMR (40 and 71 MHz, CDCl3/CD3CN): δ -77 (N), -74 (N’). 
UV/Vis: (MeOH/H2O (60% v/v)),  λ (ε): 293 (1.9*104). 
 
Mono-protonated ligand HL1+ (3 eq. CF3COOH)  
1H-NMR (400 MHz, CDCl3/CD3CN): δ 8.60 (d, 1H, H(6’)), 8.17 (ddd, 1H, H(3’)), 
8.14 (ddd, 1H, H(4’)), 7.93 (d, 1H, H(3), 3J3,4 = 8.0 Hz), 7.65 (d, 1H, H(4), 3J4,3 = 8.0 
Hz), 7.60 (d, 1H, H(5’), 3J5’,4’ = 7.1 Hz, 3J5’,6’ = 7.1 Hz, 4J5’,3’ = 2.0 Hz), 3.16 (m, 2H, 
H(7)), 2.87 (dd, 1H, H(10), 3J10,9b = 5.6 Hz, 3J10,8=5.6 Hz), 2.65 (ddd, 1H, H(9b), 2J9b,9a 
= 10.4 Hz, 3J9b,10 = 5.8 Hz, 3J9b,8 = 5.8 Hz), 2.31 (ddt, 1H, H(8), 3J8,9b = 5.8 Hz, 3J8,10 = 
5.8 Hz, 3J8,7 = 2.8 Hz), 1.29 (s, 3H, H(12)), 1.15 (d, 1H, H(9a), 2J9a,9b = 10.4 Hz), 0.51 
(s, 3H, H(13)). 
15N-NMR (40 and 71 MHz, CDCl3/CD3CN): δ –134 (N, N’). 
UV/Vis: (MeOH/H2O (60% v/v)), λ (ε): 312 (2.0*104). 
 
 
Experimental Part  175 
  
5.3.2 [5,6]-CHIRAGEN[0] (L15) 
 
N
N
N
N
2
3
4
5
6 7
8
9
10
12 13
2'
3'
4'
5'
6'
 
 
Free Ligand L15: 
1H-NMR (400 MHz, CDCl3/CD3CN): δ 8.43 (d, 2H, H(6’)), 8.10 (s, br, 2H, H(3’)), 
7.93 (d, 2H, H(3), 3J3,4 = 7.6 Hz), 7.59 (ddd, 2H, H(4’), 3J4’,3’ = 7.8 Hz, 3J4’,5’ = 5.8 Hz, 
4J4’,6’ = 1.8 Hz), 7.23 (d, 2H, H(4), 3J4,3 = 7.6 Hz), 7.09 (ddd, 2H, H(5’), 3J5’,4’ = 5.8 Hz, 
3J5’,6’ = 4.8 Hz, 4J4’,3’ = 1.0 Hz), 4.36 (s, br, 2H, H(7)), 2.68 (dd, 2H, H(10), 3J10,9b = 5.6 
Hz, 3J10,8 = 5.6 Hz), 2.39 (ddd, 2H, H(9b), 2J9b,9a = 9.6 Hz, 3J9b,10 = 5.6 Hz, 3J9b,8 = 5.6 
Hz), 2.00 (dd, 2H, H(8), 3J8,9b = 5.6 Hz, 3J8,10 = 5.6 Hz), 1.29 (s, br, 2H, H(9a)), 1.17 (s, 
6H, H(12)), 0.61 (s, 6H, H(13)). 
15N-NMR (40 and 71 MHz, CDCl3/CD3CN): δ –78 (N), -77 (N’). 
UV/Vis: (MeOH/H2O (90% v/v)), λ (ε): 295 (3.7*104). 
CD: (MeOH/H2O (90% v/v)), λ (ε): 305 (-27), 284 (22). 
 
Mono-protonated ligand HL15+ (2 eq. CF3COOH)  
1H-NMR (400 MHz, CDCl3/CD3CN): δ 7.96 (d, 2H, H(6’)), 7.91 (d, 2H, H(3), 3J3,4 = 
7.8 Hz), 7.67 (ddd, 2H, H(3’), 3J3’,4’ = 7.6 Hz), 7.72 (d, 2H, H(4), 3J4,3 = 8.1 Hz), 7.48 
(ddd, 2H, H(4’), 3J4’,3’ = 7.6 Hz, 3J4’,5’ = 7.6 Hz, 4J4’,6’ = 1.5 Hz), 6.98 (ddd, 2H, H(5’), 
3J5’,4’ = 7.3 Hz), 3.74 (s, 2H, H(7)), 2.94 (dd, 2H, H(10), 3J10,9b = 5.6 Hz, 3J10,8 = 5.6 
Hz), 2.66 (ddd, 2H, H(9b), 2J9b,9a = 10.1 Hz, 3J9b,10 = 5.6 Hz, 3J9b,8 = 5.6 Hz), 2.21 (dd, 
2H, H(8), 3J8,9b = 5.6 Hz, 3J8,10 = 5.6 Hz), 1.19 (d, 2H, H(9a), 2J9a,9b = 10.1 Hz), 1.33 (s, 
6H, H(12)), 0.61 (s, 6H, H(13)). 
15N-NMR (40 and 71 MHz, CDCl3/CD3CN): δ –127 (N), -87 (N’). 
UV/Vis: (MeOH/H2O (90% v/v)), λ (ε): 294 (2.7*104). 
176  Experimental Part 
CD: (MeOH/H2O (90% v/v)), λ (ε): 313 (-88), 289 (54). 
 
Di-protonated ligand H2L152+ (6 eq. CF3COOH)  
1H-NMR (400 MHz, CDCl3/CD3CN): δ 8.30 (d, 2H, H(6’)), 8.24 (ddd, 2H, H(3’)), 
8.24 (ddd, 2H, H(4’)), 7.88 (d, 2H, H(3), 3J3,4 = 7.8 Hz), 7.57 (ddd, 2H, H(5’)), 7.48 (d, 
2H, H(4)), 4.16 (s, 2H, H(7)), 2.83 (dd, 2H, H(10), 3J10,9b = 5.3 Hz, 3J10,8 = 5.3 Hz), 
2.52 (ddd, 2H, H(9b), 2J9b,9a = 10.1 Hz, 3J9b,10 = 5.6 Hz, 3J9b,8 = 5.6 Hz), 2.02 (dd, 2H, 
H(8), 3J8,9b = 5.8 Hz, 3J8,10 = 5.8 Hz), 1.20 (s, 6H, H(12)), 1.16 (d, 2H, H(9a), 2J9a,9b = 
10.1 Hz), 0.50 (s, 6H, H(13)). 
15N-NMR (40 and 71 MHz, CDCl3/CD3CN): δ -164 (N’), –107 (N).  
UV/Vis: (MeOH/H2O (90% v/v)),  λ (ε): 312 ((2.9*104). 
CD: (MeOH/H2O (90% v/v)), λ (ε): 329 (-92), 299 (59). 
 
 
5.3.3 {2-DAMI}-[5,6]-CHIRAGEN[0] (L19) 
 
23
4
5
6 7
8
9
10
12 13
2'
3'
4'
5'
6'
N N
N N
 
 
Free ligand L19 
1H-NMR (400 MHz, CDCl3/CD3CN): δ 7.08 (d, 2H, H(3), 3J3,4 = 7.8 Hz), 7.03 (d, 2H, 
H(4), 3J4,3 = 7.8 Hz), 4.30 (s, br, 2H, H(7)), 2.56 (dd, 2H, H(10), 3J10,9b = 5.6 Hz, 4J10,8 
= 5.6 Hz), 2.27 (ddd, 2H, H(9b), 2J9b,9a = 9.4 Hz, 3J9b,10 = 5.6 Hz, 3J9b,8 = 5.6 Hz), 2.07 
(s, 12H, H(5’, 6’)), 1.92-1.76 (m, 2H, H(8)), 1.31 (s, 6H, H(3’)), 1.27 (s, 6H, H(4’)), 
1.14 (s, 6H, H(12)), 1.08 (s, br, 2H, H(9a)), 0.58 (s, 6H, H(13)). 
13C-NMR (CDCl3/CD3CN, 100 MHz): δ 163.54 (Cq, C(6)), 157.15 (Cq, C(2)), 140.28 
(Cq, C(5)), 132.64 (CH, C(4)), 117.51 (CH, C(3)), 62.00 (Cq, C(2’)), 46.11 (CH, 
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C(10)), 41.52 (Cq, C(11)), 39.65 (CH3, C(5’), C(6’)), 26.54 (CH3, C(12)), 24.72 (CH3, 
C(3’)), 22.71 (CH3, C(4’)), 31.30 (CH3, C(13)). 
15N-NMR (40 and 71 MHz, CDCl3/CD3CN): δ  -340 (N’), –69 (N). 
 
Di-protonated ligand H2L152+ (2.22 eq. CF3COOH):  
1H-NMR (400 MHz, CDCl3/CD3CN): δ 7.21 (d, 2H, H(3), 3J3,4 = 7.8 Hz), 7.13 (d, 2H, 
H(4), 3J4,3 = 7.8 Hz), 4.31 (s, br, 2H, H(7)), 2.70 (s, 6H, H(5’)), 2.64 (dd, 2H, H(10), 
3J10,9b = 5.6 Hz, 4J10,8 = 5.6 Hz), 2.51 (s, 6H, H(6’)), 2.33 (ddd, 2H, H(9b), 2J9b,9a = 9.4 
Hz, 3J9b,10 = 5.6 Hz, 3J9b,8 = 5.6 Hz), 1.76(m, 2H, H(8)), 1.67 (s, 12H, H(3’, 4’)), 1.13 
(s, 6H, H(12)), 0.99 (s, br, 2H, H(9a)), 0.53 (s, 6H, H(13)). 
13C-NMR (CDCl3/ACN-d3, 100 MHz): δ 159.25 (C(6)), 154.13 (C(2)), 143.90 (C(5)), 
139.38 (C(4)), 123.42 (C(3)), 67.72 (C(2’)), 50.56 (C(10)), 50.60 (C(7)), 44.23 
(C(6’)), 31.29 (C(12)), 26.47 (C(3’, 4’)), 26.17 (C(13)). 
 
 
5.3.4 [4,5]-CHIRAGEN[0] (L20) 
 
N
N
N
N
2
3
4
5
6 7
8
9
10
12 13
2'
3'
4'
5'
6'
 
 
Free ligand L20: 
1H-NMR (400 MHz, CDCl3/CD3CN): δ 8.48 (ddd, 2H, H(6’)), 8.29 (s, 2H, H(3)), 8.19 
(ddd, 2H, H(3’)), 8.10 (s, 2H, H(6), 3J3,4 = 8.0 Hz), 7.66 (ddd, 2H, H(4’), 3J4’,3’ = 7.8 
Hz, 3J4’,5’ = 7.8 Hz, 4J4’,6’ = 1.5 Hz), 7.15 (ddd, 2H, H(5’), 3J5’,4’ = 7.6 Hz, 3J5’,6’ = 5.3 
Hz, 4J5’,3’ = 1.0 Hz), 3.88 (s, 2H, H(7)), 2.69 (dd, 2H, H(10), 3J10,9b = 5.3 Hz, 3J10,8 = 5.3 
Hz), 2.36 (ddd, 2H, H(9b), 2J9b,9a = 10.4 Hz, 3J9b,10 = 5.8 Hz, 3J9b,8 = 5.8 Hz), 1.94 (dd, 
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2H, H(8), 3J8,9b = 5.6 Hz, 4J8,10 = 5.6 Hz), 1.14 (s, 6H, H(12)), 1.09 (d, 2H, H(9a), 2J9a,9b 
= 10.4 Hz), 0.54 (s, 6H, H(13)). 
15N-NMR (40 and 71 MHz, CDCl3/CD3CN): δ –79 (N), -72 (N’). 
UV/Vis: (MeOH/H2O, 90% v/v), λ (ε): 288 (3.0*104). 
CD: (MeOH/H2O, 90% v/v), λ (ε): 295 (-15), 247 (-10). 
 
Di-protonated ligand H2L202+ (5 eq. CF3COOH) 
1H-NMR (400 MHz, CDCl3/CD3CN): δ 8.65 (ddd, 2H, H(6’)), 8.56 (s, 2H, H(3)), 
8.30 (ddd, 2H, H(3’)), 8.29 (s, 2H, H(6), 3J3,4 = 8.0 Hz), 8.05 (ddd, 2H, H(4’), 3J4’,3’ = 
7.8 Hz, 3J4’,5’ = 7.8 Hz, 4J4’,6’ = 1.5 Hz), 7.55 (ddd, 2H, H(5’), 3J5’,4’ = 7.6 Hz, 3J5’,6’ = 
5.3 Hz, 4J5’,3’ = 1.0 Hz), 4.16 (s, 2H, H(7)), 2.90 (dd, 2H, H(10), 3J10,9b = 5.3 Hz, 3J10,8 = 
5.3 Hz), 2.49 (ddd, 2H, H(9b), 2J9b,9a = 10.4 Hz, 3J9b,10 = 5.8 Hz, 3J9b,8 = 5.8 Hz), 1.95 
(dd, 2H, H(8), 3J8,9b = 5.6 Hz, 4J8,10 = 5.6 Hz), 1.18 (s, 6H, H(12)), 1.09 (d, 2H, H(9a), 
2J9a,9b = 10.4 Hz), 0.56 (s, 6H, H(13)). 
15N-NMR (40 and 71 MHz, CDCl3/CD3CN): δ –158 (N), -112 (N’). 
UV/Vis: (MeOH/H2O, 90% v/v), λ (ε): 312 (3.0*104). 
CD: (MeOH/H2O, 90% v/v), λ (ε): 324 (-17), 251 (-18). 
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Designed Molecules for Self-Assembly:
The Controlled Formation of Two Chiral
Self-Assembled Polynuclear Species with
Predetermined Configuration**
Thomas Bark, Mathias Düggeli, Helen Stoeckli-Evans,
and Alex von Zelewsky*
Self-assembly reactions are not yet as predictable to the
same degree as classical reaction sequences. Often, highly
interesting structures are obtained through a combination of
intuition, conjecture, and serendipity.[1] Herein, we report the
formation of two closely related supramolecular structures
that were obtained in a programmed way. Our intention is to
fabricate supramolecular complexes of the type A from
octahedrally coordinating metal ions.
Complexes of this type are chiral (D4 symmetry) as a
consequence of the special way the ligand strands enfold the
cations. Chirality is the main feature that distinguishes them
from the related grid-type complexes B investigated by J.-M.
Lehn and co-workers,[2a,b] and other recently reported molec-
ular squares.[2c,d]
To achieve such structures we had to design a ligand that
fulfils the following demands: 1) it must offer two terpyridine-
type binding sites to cover each half of the coordination
sphere of an OC-6 cation in a mer configuration; 2) it must be
geometrically rigid, and define the side of a square in a
tetranuclear self-assembled species; and 3) the orientation of
the binding vectors of the two terpyridine (terpy) units must
be antiparallel, in order to make the ligand coordinate to the
metal ions once from “above” and once from “below” the
plane defined by the four metal ions. These requirements, and
especially the relative orientation of the binding sites, are
fulfilled in ligand L1, in which two 2,2'-bipyridin-6-yl groups
are attached to a central pyrazine ring at positions 2 and 5.[3]
[10] a) C. Cheadle, Y. Ivashchenko, V. South, G. H. Searfoss, S. French, R.
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Nature 1993, 363, 83 – 85.
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Keller, C. Lehmann, M. Mutter, Tetrahedron 1999, 55, 413 – 422.
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This ligand yields the desired tetrameric assembly with Zn2
ions. The solution behavior of [Zn4(L1)4](PF6)8 (1) in MeCN
was investigated by electrospray-ionization mass spectrome-
try (ESI-MS) as well as by 1H and 13C NMR spectroscopy. The
mass spectrum (Figure 1 a) reveals the tetrameric structure of
1 and displays peaks that are attributed unambiguously (from
their isotopic distribution pattern) to fragments of the type
[Zn4(L1)4](PF6)n (n 3 – 6).
The 1H NMR spectrum of the complex in CD3CN displays
one half-set of hydrogen atoms that originate from L1; the
Figure 1. a) ESI mass spectrum of [Zn4(L1)4](PF6)8 (a) and
[Zn4(L2)4](PF6)8 (b) in MeCN. Inset: found (top in both) and calculated
(bottom in both) isotopic distribution for {[Zn4(L1)4](PF6)6}2 and
{[Zn4(L2)4](PF6)5}3, respectively.
symmetry of the ligand is thus not broken upon complexation.
All resonances have been identified by 2D experiments
(1H1H-COSY, NOE). The spectrum of 1 is always accompa-
nied by a minor species with the same number of signals and
the same coupling patterns. The relative amount of this minor
species increases at lower overall concentrations of 1 and
decreases at higher temperatures. Detailed studies revealed
the existence of an equilibrium between a trimer[4] of type C
and a tetramer, with the tetramer being the major species in
the concentration range investigated. The thermodynamic
parameters of this equilibrium are given in Figure 2.
Figure 2. Temperature dependence of the tetramer/trimer equilibrium.
The thermodynamic data were obtained by 1H NMR spectroscopy. The
equlibrium constants have been calculated from the integrals over three
different protons (^: HÿC(3'); ~: HÿC(5'); &: HÿC(3''')). The resulting
thermodynamic constants are: lgKo(303 K)ÿ (8.43 0.02); DHo
ÿ (74.5 10.0) kJ molÿ1; DSoÿ (406 12) J molÿ1 Kÿ1.
The formation of the trimeric form from the tetramer is
hence exothermic but endotropic. The negative DHo value
must be the result of a better solvation of the trimeric
complexes. The higher “ring strain” in the trimer resulting
from a strong deviation from the ideal octahedral coordina-
tion geometry at the Zn2 ions can probably be neglected
because of the absence of ligand-field stabilization in Zn2
ions. Thus the reduction of “void space” on going from the
tetramer to the trimer dominates the reaction enthalpy. The
negative reaction entropy is not easily understood, as both the
number of complex ions and the configurational diversity
increase upon the formation of the trimer. The same counter-
intuitive behavior has been reported very recently for the
equilibrium between the hexameric and tetrameric form of a
silver-containing circular helicate.[5]
Complex 1 crystallizes[6] from MeNO2/Et2O as a racemic
compound in the centrosymmetrical space group C2/c (Fig-
ure 3). The symmetry of the complex in the crystal is C2, and
the zinc ions define a symmetrical trapezoid which is close to a
square (a 89.49(0.01)8, b 90.51(0.01)8). The lengths of the
coordinative bonds are not unusual: ZnÿN(pyridine) varies
from 2.050 to 2.126 , while the bonds to the pyrazine
nitrogen atoms are considerably longer (2.244 – 2.311 ),
probably as a result of electronic communication through
the pyrazine ring. Two of the eight PF6ÿ counterions are in
close contact with the complex ion and occupy positions
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Figure 3. Crystal structure of the racemic compound [Zn4(L1)4](PF6)8.
Only the all-~D enantiomer is shown.
above and below the center of the square (Figure 3). Large
numbers of disordered solvent molecules complicated the
refinement of the structure. Related structures have been
reported with the commercial ligand bispyridyltetrazine.[7]
After having obtained the racemic complex 1, we envisaged
the stereoselective synthesis of similar molecular assemblies.
For this purpose we developed L2, a chiral derivative of L1. By
rendering the ligand chiral, the all-~D and all-~D isomers of the
complex, which are enantiomers in the case of achiral L1, will
become diastereomers with L2 (D and E in Scheme 1).
Scheme 1. Schematic representation of the two diastereomers of tetranu-
clear complexes with L2. The methyl groups of the pinene moieties in D
point to each other at the “corners” of the square, while in E their
orientation is along the sides of the quadrangle.
The “chiralization” (that is, chiral derivatization) of the
ligand was achieved quite straightforwardly by introducing
pinene moieties, a technique used many times before for
pyridine-type ligands.[8] The auto-assembly process delivers
the tetranuclear Zn2 complex (all-~D )-[Zn4((R,R)-L2)4](PF6)8
(2) as the major product with a high diastereomeric excess and
in high yield.
The 1H NMR spectrum shows that three minor species are
also present; these species are presumably the other diaster-
eomer of the tetramer and the two diastereomers of the
trimer. Although further quantitative analysis of the NMR
data is difficult because the signals are insufficiently sepa-
rated, we can confirm that for a concentration suitable for
NMR measurement (here 11.7 mmol Lÿ1), over 95 % of the
mass of complex 2 is present as the dominant diastereomer of
the tetrameric complex, which is the same as that found in the
solid state.
The crystal[9] contains only one diastereomer of 2 (type D,
Scheme 1). The asymmetric unit comprises one complex
molecule (Figure 4), and all the Zn2 ions are thus crystallo-
graphically inequivalent. The parameters of the coordinative
Figure 4. Crystal structure of [Zn4(L2)4](PF6)8.
bonds are in the usual range (ZnÿN(pyridine) 2.077 – 2.171 ,
ZnÿN(pyrazine) 2.234 – 2.359 ). Again, two PF6ÿ ions are in
close contact with the complex ion (not displayed). The X-ray
structure analysis does not only establish the relative config-
uration of the complex (configuration of the ligand$ config-
uration at the metal centers), but it also confirms the absolute
configuration ; the Flack parameter[10] converged to 0.016(13)
for the absolute structure containing the (R,R)/~D isomer of
the complex.
In conclusion, we have reported a new type of chiral square
complex and presented for the first time the configurational
predetermination of the metal centers in such a tetramer by
the use of a chiral ligand.
Experimental Section
The syntheses of L1 and L2 will be reported, together with isomeric and
related pyrazine containing ligands, in a forthcoming publication.
rac-[Zn4(L1)4](PF6)8 (1) was obtained by treating L1 with a stoichiometric
amount of Zn(ClO4)2 · 6 H2O in a small volume of MeCN. The ligand
dissolved within a few minutes, and after one day at RT, the complex was
isolated by precipitation from an aqueous NH4PF6 solution.
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By Overexpression in the Yeast Pichia pastoris
to Enhanced Enantioselectivity: New Aspects
in the Application of Pig Liver Esterase**
Anna Musidlowska, Stefan Lange, and
Uwe T. Bornscheuer*
Dedicated to Professor Günter Schmidt-Kastner
on the occasion of his 75th birthday
Lipases and esterases can be used as efficient biocatalysts
for the preparation of a wide variety of optically pure
compounds.[1] Whereas a range of lipases—especially of
microbial origin—are commercially available, only a few
esterases can be obtained for the kinetic resolution of
racemates or desymmetrization. In the majority of publica-
tions, pig liver esterase[2] (PLE) is used, which is isolated from
pig liver by extraction. Although it has been demonstrated
that this preparation can convert a broad range of compounds
at partially very high stereoselectivity, its application is
connected with a number of disadvantages. Besides a
variation of the esterase content between different batches,
the presence of other hydrolases particularly has to be
considered as problematic with respect to stereoselectivity.[3]
Furthermore, it has been shown that PLE consists of several
isoenzymes,[4] which in part differ considerably in their
substrate specificity. Thus, electrophoretic separation by
isoelectric focusing enabled access to PLE fractions that,
[Zn4(L2)4](PF6)8 (2) was prepared similarly, but the reaction mixture
needed to be refluxed and the subsequent PF6ÿ salt recrystallized from
MeCN/Et2O. The yields in both cases exceeded 95%. ATTENTION : The
intermediate perchlorate salts of the complexes are explosive.
Received: March 19, 2001 [Z 16796]
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